|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/15/13 Biolase, Inc 10-K 12/31/12 76:8.5M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.11M
2: EX-21.1 Subsidiaries List HTML 20K
3: EX-23.1 Consent of Experts or Counsel HTML 22K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 23K
52: R1 Document and Entity Information HTML 53K
41: R2 Consolidated Balance sheets HTML 144K
50: R3 Consolidated Balance sheets (Parenthetical) HTML 51K
54: R4 Consolidated Statements of Operations and HTML 121K
Comprehensive Loss
70: R5 Consolidated Statements of Shareholders' Equity HTML 97K
(Deficit)
43: R6 Consolidated Statements of Cash Flows HTML 180K
49: R7 Basis Of Presentation HTML 42K
37: R8 Summary Of Significant Accounting Policies HTML 97K
28: R9 Supplementary Balance Sheet Information HTML 67K
71: R10 Intangible Assets And Goodwill HTML 52K
56: R11 Lines Of Credit And Other Borrowings HTML 36K
55: R12 Income Taxes HTML 87K
61: R13 Commitments And Contingencies HTML 38K
62: R14 Stockholders' Equity HTML 108K
59: R15 Segment Information HTML 37K
63: R16 Concentrations HTML 25K
51: R17 Non-Recurring Event HTML 25K
53: R18 Subsequent Events HTML 23K
58: R19 Schedule II-Consolidated Valuation and Qualifying HTML 41K
Accounts and Reserves
76: R20 Basis Of Presentation (Policies) HTML 242K
66: R21 Summary Of Significant Accounting Policies HTML 59K
(Tables)
46: R22 Supplementary Balance Sheet Information (Tables) HTML 72K
57: R23 Intangible Assets And Goodwill (Tables) HTML 43K
48: R24 Income Taxes (Tables) HTML 84K
22: R25 Commitments And Contingencies (Tables) HTML 26K
67: R26 Stockholders' Equity (Tables) HTML 83K
73: R27 Segment Information (Tables) HTML 30K
32: R28 Schedule II-Consolidated Valuation and Qualifying HTML 39K
Accounts and Reserves (Tables)
31: R29 Basis of Presentation - Additional Information HTML 55K
(Detail)
35: R30 Estimated Useful Lives Of Property, Plant and HTML 28K
Equipment (Detail)
36: R31 Summary of Significant Accounting Policies - HTML 98K
Additional Information (Detail)
38: R32 Accrued Liabilities - Changes In Initial Product HTML 41K
Warranty Accrual and Expenses Under Initial and
Extended Warranties (Detail)
20: R33 Classification Of Compensation Expense Associated HTML 32K
With Share-Based Payments (Detail)
64: R34 Assumptions Used in Estimating Fair Value Of Stock HTML 34K
Options Granted (Detail)
45: R35 Components of Accounts Receivable, Net of HTML 30K
Allowance (Detail)
47: R36 Supplementary Balance Sheet Information - HTML 52K
Additional Information (Detail)
25: R37 Components of Inventory (Detail) HTML 34K
75: R38 Summary of Property,Plant and Equipment (Detail) HTML 39K
14: R39 Components of Accrued Liabilities (Detail) HTML 50K
39: R40 Summary of Deferred Revenue (Detail) HTML 40K
69: R41 Intangible Assets And Goodwill - Additional HTML 47K
Information (Detail)
24: R42 Intangible Assets Related to Accumulated HTML 54K
Amortization and Goodwill (Detail)
30: R43 Lines Of Credit And Other Borrowings - Additional HTML 128K
Information (Detail)
34: R44 Summary of Income Tax Current and Deferred HTML 65K
Provision (Benefit) (Detail)
42: R45 Federal Income Tax Provision Compared With HTML 63K
Statutory Rates (Detail)
19: R46 Summary of Net Deferred Tax Assets and Net HTML 83K
Deferred Tax Liabilities (Detail)
27: R47 Income Taxes - Additional Information (Detail) HTML 61K
16: R48 Summary of Unrecognized Tax Benefits (Detail) HTML 31K
68: R49 Commitments And Contingencies - Additional HTML 38K
Information (Detail)
23: R50 Future Minimum Rental Commitments Under Operating HTML 45K
Lease Agreements (Detail)
65: R51 Stockholders' Equity - Additional Information HTML 163K
(Detail)
26: R52 Summary of Option Activity (Detail) HTML 83K
40: R53 Options Outstanding and Exercisable (Detail) HTML 70K
15: R54 Cash Proceeds Along With Fair Value Disclosures HTML 41K
Related to grants Exercises And Vesting Options
(Detail)
17: R55 Segment Information - Additional Information HTML 32K
(Detail)
33: R56 Summary of Net Revenue by Geographic Location HTML 27K
(Detail)
21: R57 Concentrations - Additional Information (Detail) HTML 36K
72: R58 Non Recurring Event - Additional Information HTML 36K
(Detail)
44: R59 Subsequent Events - Additional Information HTML 30K
(Detail)
60: R60 Consolidated Valuation and Qualifying Accounts and HTML 36K
Reserves (Detail)
74: XML IDEA XML File -- Filing Summary XML 115K
29: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.02M
8: EX-101.INS XBRL Instance -- biol-20121231 XML 1.69M
10: EX-101.CAL XBRL Calculations -- biol-20121231_cal XML 251K
11: EX-101.DEF XBRL Definitions -- biol-20121231_def XML 1.09M
12: EX-101.LAB XBRL Labels -- biol-20121231_lab XML 1.77M
13: EX-101.PRE XBRL Presentations -- biol-20121231_pre XML 1.22M
9: EX-101.SCH XBRL Schema -- biol-20121231 XSD 255K
18: ZIP XBRL Zipped Folder -- 0001193125-13-110112-xbrl Zip 218K
| <?xml version="1.0" standalone="yes" encoding="windows-1252"?> | |||||||||||||||||||||
| <!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1 http://www.edgar-online.com/ --> | |||||||||||||||||||||
| <!-- Version: 6.20.1 --> | |||||||||||||||||||||
| <!-- Round: 4 --> | |||||||||||||||||||||
| <!-- Creation date: 2013-03-15T19:21:09Z --> | |||||||||||||||||||||
| <!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. --> | |||||||||||||||||||||
| <xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:biol="http://www.biolase.com/20121231" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2012-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2012-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr"> | |||||||||||||||||||||
| <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="biol-20121231.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase"/> | |||||||||||||||||||||
| <biol:LeaseFacilityArea contextRef="eol_PE753-----1210-K0003_STD_0_20060131_0" unitRef="sqft" decimals="0" id="id_888902_AE5CFA81-851C-4239-A747-6355570D033C_1001_1"> 57000 </biol:LeaseFacilityArea> | |||||||||||||||||||||
| <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="eol_PE753-----1210-K0003_STD_0_20100810_0_502360x564264" unitRef="shares" decimals="INF" id="id_888902_F8984708-319D-4BC9-B04D-FBC67D0ED533_1001_0"> 2000000 </us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased> | |||||||||||||||||||||
| <biol:TransactionFeePercentageOfAggregateValueOfSharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20101223_0_623961x532774" unitRef="pure" decimals="4" id="id_888902_F3D02B64-6824-4250-BB6B-E6FA671F3CC9_1001_1"> 0.0375 </biol:TransactionFeePercentageOfAggregateValueOfSharesIssued> | |||||||||||||||||||||
| <biol:MaximumIssuableSharesUnderOfferingAgreement contextRef="eol_PE753-----1210-K0003_STD_0_20101223_0_623961x532774" unitRef="shares" decimals="INF" id="id_888902_F3D02B64-6824-4250-BB6B-E6FA671F3CC9_1001_0"> 3000000 </biol:MaximumIssuableSharesUnderOfferingAgreement> | |||||||||||||||||||||
| <us-gaap:SharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20110228_0_507199x693142" unitRef="shares" decimals="INF" id="id_888902_BDE164F8-C0E0-47A8-90F9-E5EBE015A789_2001_0"> 78172 </us-gaap:SharesIssued> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE753-----1210-K0003_STD_0_20120507_0_504051x551546" unitRef="shares" decimals="INF" id="id_888902_AE56A57B-A0BC-4D6A-BCDE-FFC39653A8B1_2001_0"> 65000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE753-----1210-K0003_STD_0_20120524_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_43607B9E-D86B-4584-B9DE-397F911DD2AB_2_1"> 8000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity> | |||||||||||||||||||||
| <biol:FairValueOfWarrants contextRef="eol_PE753-----1210-K0003_STD_0_20120524_0" unitRef="iso4217_USD" decimals="0" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_3001_7"> 135000 </biol:FairValueOfWarrants> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE753-----1210-K0003_STD_0_20120524_0_501572x498232_507199x551171" unitRef="iso4217_USD" decimals="-5" id="id_888902_BC9E0ADC-B0CE-4F16-9F04-921B1E0A1306_3002_0"> 8000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE753-----1210-K0003_STD_0_20120524_0_507199x551171" unitRef="shares" decimals="0" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_6001_0"> 80000 </us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE753-----1210-K0003_STD_0_20120524_0_507199x551171" unitRef="iso4217_USD_per_A" decimals="2" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_6001_1"> 2.83 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE753-----1210-K0003_STD_0_20120524_0_507611x652001" unitRef="iso4217_USD" decimals="-5" id="id_888902_43607B9E-D86B-4584-B9DE-397F911DD2AB_2002_2"> 4000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE753-----1210-K0003_STD_0_20120524_0_507611x652129" unitRef="iso4217_USD" decimals="-5" id="id_888902_43607B9E-D86B-4584-B9DE-397F911DD2AB_3002_0"> 4000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity> | |||||||||||||||||||||
| <us-gaap:LongLivedAssetsHeldForSaleProceedsFromSale contextRef="eol_PE753-----1210-K0003_STD_0_20120821_0_501891x497675_510903x511397" unitRef="iso4217_USD" decimals="0" id="id_888902_25C32206-C119-4393-8649-46DE850C6709_1001_1"> 124000 </us-gaap:LongLivedAssetsHeldForSaleProceedsFromSale> | |||||||||||||||||||||
| <us-gaap:AssetsHeldForSaleLongLived contextRef="eol_PE753-----1210-K0003_STD_0_20120821_0_501891x497675_510903x511397" unitRef="iso4217_USD" decimals="0" id="id_888902_25C32206-C119-4393-8649-46DE850C6709_1001_0"> 136000 </us-gaap:AssetsHeldForSaleLongLived> | |||||||||||||||||||||
| <biol:RequiredMinimumSharePriceReachedToExerciseWarrants contextRef="eol_PE753-----1210-K0003_STD_0_20121108_0_504957x513639_509379x517821" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_5B9507FF-0F92-49B6-9E24-CDE916B5E9E4_2001_2"> 7.00 </biol:RequiredMinimumSharePriceReachedToExerciseWarrants> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE753-----1210-K0003_STD_0_20121108_0_504957x514053_509379x517821" unitRef="shares" decimals="0" id="id_888902_5B9507FF-0F92-49B6-9E24-CDE916B5E9E4_3001_0"> 50000 </us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE753-----1210-K0003_STD_0_20121108_0_509379x517821" unitRef="iso4217_USD_per_Unit" decimals="2" id="id_888902_5B9507FF-0F92-49B6-9E24-CDE916B5E9E4_4001_1"> 2.50 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights> | |||||||||||||||||||||
| <biol:TransactionFeePercentageOfAggregateValueOfSharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20110407_0_623961x624861" unitRef="pure" decimals="3" id="id_888902_387698F4-28CC-4DD4-B8AB-4392D7A7974B_1001_0"> 0.045 </biol:TransactionFeePercentageOfAggregateValueOfSharesIssued> | |||||||||||||||||||||
| <biol:StockIssuedDueToWarrantExercise contextRef="eol_PE753-----1210-K0003_STD_0_20130228_0_506663x511390_507199x551171" unitRef="shares" decimals="INF" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_4003_10"> 30515 </biol:StockIssuedDueToWarrantExercise> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE753-----1210-K0003_STD_0_20130228_0_506663x511390_507199x551171_508971x533701" unitRef="shares" decimals="0" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_5003_11"> 20000 </us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights> | |||||||||||||||||||||
| <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE753-----1210-K0003_STD_0_20130308_0" unitRef="shares" decimals="INF" id="id_888902_4E988BCD-90FE-4BF8-A71C-8F24A73B8EF0_2_500008"> 31343661 </dei:EntityCommonStockSharesOutstanding> | |||||||||||||||||||||
| <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="eol_PE753-----1210-K0003_STD_0_20100531_0_507199x693142" unitRef="pure" decimals="4" id="id_888902_E50077F7-D8A8-4D5E-BCB7-314CF1B9FC5E_2001_2"> 0.1425 </us-gaap:DebtInstrumentInterestRateEffectivePercentage> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE753-----1210-K0003_STD_0_20100531_0_507199x693142" unitRef="shares" decimals="0" id="id_888902_E50077F7-D8A8-4D5E-BCB7-314CF1B9FC5E_2001_3"> 101694 </us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE753-----1210-K0003_STD_0_20100531_0_507199x693142" unitRef="iso4217_USD_per_A" decimals="2" id="id_888902_E50077F7-D8A8-4D5E-BCB7-314CF1B9FC5E_2001_4"> 1.77 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights> | |||||||||||||||||||||
| <biol:NumberOfSecuredPromissoryNotesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20100531_0_507199x693142" unitRef="Securities" decimals="0" id="id_888902_E50077F7-D8A8-4D5E-BCB7-314CF1B9FC5E_2001_0"> 2 </biol:NumberOfSecuredPromissoryNotesIssued> | |||||||||||||||||||||
| <biol:IrWarrantsToPurchaseCommonStockGranted contextRef="eol_PE753-----1210-K0003_STD_0_20100930_0_623961x577488" unitRef="shares" decimals="0" id="id_888902_C34BC229-9A2F-4C6E-8FAB-6B3A2F3172C8_1001_0"> 50000 </biol:IrWarrantsToPurchaseCommonStockGranted> | |||||||||||||||||||||
| <us-gaap:SharePrice contextRef="eol_PE753-----1210-K0003_STD_0_20110630_0_623961x652398" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_C4D52BFF-0BD6-404C-A757-93A5546AA52C_2001_1"> 5.55 </us-gaap:SharePrice> | |||||||||||||||||||||
| <us-gaap:CommonStockSharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20110630_0_623961x652398" unitRef="shares" decimals="INF" id="id_888902_C4D52BFF-0BD6-404C-A757-93A5546AA52C_2001_0"> 1625947 </us-gaap:CommonStockSharesIssued> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE753-----1210-K0003_STD_0_20110630_0_623961x652398" unitRef="shares" decimals="0" id="id_888902_C4D52BFF-0BD6-404C-A757-93A5546AA52C_2001_3"> 812974 </us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE753-----1210-K0003_STD_0_20110630_0_623961x652398" unitRef="iso4217_USD_per_Unit" decimals="2" id="id_888902_C4D52BFF-0BD6-404C-A757-93A5546AA52C_2001_4"> 6.50 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights> | |||||||||||||||||||||
| <biol:CommonStockWarrantsTerm contextRef="eol_PE753-----1210-K0003_STD_0_20110630_0_623961x652398" id="id_888902_C4D52BFF-0BD6-404C-A757-93A5546AA52C_2001_2"> P5Y </biol:CommonStockWarrantsTerm> | |||||||||||||||||||||
| <biol:RequiredQuarterlyPaymentToMaintainExclusiveRights contextRef="eol_PE753-----1210-K0003_STD_0_20110930_0_512086x652097" unitRef="iso4217_USD" decimals="0" id="id_888902_9FA9B4F2-83B6-4521-B972-FED9701D81DB_1001_0"> 187500 </biol:RequiredQuarterlyPaymentToMaintainExclusiveRights> | |||||||||||||||||||||
| <dei:EntityPublicFloat contextRef="eol_PE753-----1210-K0003_STD_0_20120630_0" unitRef="iso4217_USD" decimals="0" id="id_888902_4E988BCD-90FE-4BF8-A71C-8F24A73B8EF0_3_600009"> 57615816 </dei:EntityPublicFloat> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_1007_1000002"> 7929000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0" unitRef="iso4217_USD_per_shares" decimals="1" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_1001_2"> 4.5 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2001_43"> 2975000 </us-gaap:CashAndCashEquivalentsAtCarryingValue> | |||||||||||||||||||||
| <us-gaap:StandardProductWarrantyAccrual contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_2001_0"> 2235000 </us-gaap:StandardProductWarrantyAccrual> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_1001_2"> 3650000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0_505872x500724" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_1005_800002"> -222000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0_505872x502884" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_1003_700002"> -16399000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:SharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0_505872x502884" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_1003_600001"> -1964000 </us-gaap:SharesIssued> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0_505872x503287" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_1006_900002"> -92705000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_1001_500002"> 117255000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:SharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_1001_400001"> 26340000 </us-gaap:SharesIssued> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0_506932x500424" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_3001_1"> 421000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0_506932x502651" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_3002_1"> 110000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20091231_0_506932x533644" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_3003_1"> 30177000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_1003_5"> 2301000 </us-gaap:ProductWarrantyAccrualClassifiedCurrent> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_3007_1000012"> -3047000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_3001_7"> 3.60 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:ProductWarrantyAccrualNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_1003_4"> 424000 </us-gaap:ProductWarrantyAccrualNoncurrent> | |||||||||||||||||||||
| <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1003_43"> 1694000 </us-gaap:CashAndCashEquivalentsAtCarryingValue> | |||||||||||||||||||||
| <us-gaap:StandardProductWarrantyAccrual contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_1003_0"> 2725000 </us-gaap:StandardProductWarrantyAccrual> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_3001_7"> 4130000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0_505872x500724" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_3005_800012"> -324000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0_505872x502884" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_3003_700012"> -16399000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:SharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0_505872x502884" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_3003_600011"> -1964000 </us-gaap:SharesIssued> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0_505872x503287" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_3006_900012"> -104726000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_3001_500012"> 118402000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:SharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_3001_400011"> 26565000 </us-gaap:SharesIssued> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0_506932x500424" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2007_1"> 311000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0_506932x502651" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2008_1"> 110000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20101231_0_506932x533644" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2009_1"> 34250000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_6"> 1808000 </us-gaap:PrepaidExpenseAndOtherAssetsCurrent> | |||||||||||||||||||||
| <us-gaap:Goodwill contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_10"> 2926000 </us-gaap:Goodwill> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_2_7"> 8312000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_13"> 145000 </us-gaap:DeferredTaxAssetsNet> | |||||||||||||||||||||
| <us-gaap:AccruedInsuranceCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_2_5"> 433000 </us-gaap:AccruedInsuranceCurrent> | |||||||||||||||||||||
| <us-gaap:StandardProductWarrantyAccrualCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_2_2"> 2218000 </us-gaap:StandardProductWarrantyAccrualCurrent> | |||||||||||||||||||||
| <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_1002_5"> 2218000 </us-gaap:ProductWarrantyAccrualClassifiedCurrent> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_12"> 33784000 </us-gaap:DeferredTaxAssetsValuationAllowance> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_18"> -586000 </us-gaap:DeferredTaxAssetsLiabilitiesNet> | |||||||||||||||||||||
| <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_12"> 187000 </us-gaap:OtherAssetsNoncurrent> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_44"> 12569000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1004_11"> 212000 </us-gaap:FiniteLivedIntangibleAssetsNet> | |||||||||||||||||||||
| <us-gaap:CommitmentsAndContingencies contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_26"/> | |||||||||||||||||||||
| <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_2FE2429E-177C-4BFF-B373-4B11C0ABC701_1002_0"> 2600000 </us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized> | |||||||||||||||||||||
| <us-gaap:DeferredIncomeTaxLiabilities contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_17"> 731000 </us-gaap:DeferredIncomeTaxLiabilities> | |||||||||||||||||||||
| <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_2_7"> 203000 </us-gaap:OtherAccruedLiabilitiesCurrent> | |||||||||||||||||||||
| <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_35"> 50000000 </us-gaap:CommonStockSharesAuthorized> | |||||||||||||||||||||
| <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_2_1"> 1928000 </us-gaap:EmployeeRelatedLiabilitiesCurrent> | |||||||||||||||||||||
| <us-gaap:TreasuryStockShares contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_43"> 1964000 </us-gaap:TreasuryStockShares> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsStateTaxes contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_4"> 41000 </us-gaap:DeferredTaxAssetsStateTaxes> | |||||||||||||||||||||
| <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_37"> 30538000 </us-gaap:CommonStockSharesOutstanding> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsOtherComprehensiveLoss contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_8"> 144000 </us-gaap:DeferredTaxAssetsOtherComprehensiveLoss> | |||||||||||||||||||||
| <us-gaap:AccruedProfessionalFeesCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_2_4"> 669000 </us-gaap:AccruedProfessionalFeesCurrent> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_3"> 1959000 </us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost> | |||||||||||||||||||||
| <us-gaap:InventoryWorkInProcess contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_A1F388A3-30E0-4F96-B05A-D16C600319C5_2_2"> 2538000 </us-gaap:InventoryWorkInProcess> | |||||||||||||||||||||
| <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_44D25F89-7883-4544-BBFF-27B705E17ED3_2_0"> 399000 </us-gaap:AllowanceForDoubtfulAccountsReceivable> | |||||||||||||||||||||
| <us-gaap:OtherReceivablesNetCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_7D32EEDF-9F90-4271-9C50-6DE66940FC8C_2_3"> 287000 </us-gaap:OtherReceivablesNetCurrent> | |||||||||||||||||||||
| <us-gaap:Liabilities contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_25"> 17238000 </us-gaap:Liabilities> | |||||||||||||||||||||
| <us-gaap:AccountsPayableCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_17"> 7804000 </us-gaap:AccountsPayableCurrent> | |||||||||||||||||||||
| <us-gaap:UnrecognizedTaxBenefits contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B1B3EDE9-2A6E-4ADC-903B-159DF5974014_1001_1"> 1066000 </us-gaap:UnrecognizedTaxBenefits> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_10"> 26075000 </us-gaap:DeferredTaxAssetsOperatingLossCarryforwards> | |||||||||||||||||||||
| <us-gaap:DeferredRevenueCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_20"> 2136000 </us-gaap:DeferredRevenueCurrent> | |||||||||||||||||||||
| <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_24"> 337000 </us-gaap:OtherLiabilitiesNoncurrent> | |||||||||||||||||||||
| <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_30"> 1000000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
| <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_2_3"> 526000 </us-gaap:SalesAndExciseTaxPayableCurrent> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_5"> 1322000 </us-gaap:DeferredTaxAssetsTaxCreditCarryforwards> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsNetNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_11"> 8000 </us-gaap:DeferredTaxAssetsNetNoncurrent> | |||||||||||||||||||||
| <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_40"> -109212000 </us-gaap:RetainedEarningsAccumulatedDeficit> | |||||||||||||||||||||
| <us-gaap:Assets contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_13"> 29807000 </us-gaap:Assets> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_7001_12"> 3.75 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:InventoryValuationReserves contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_426E3BAF-FCC7-40FA-9EE6-92214BFD6C68_1002_0"> 2300000 </us-gaap:InventoryValuationReserves> | |||||||||||||||||||||
| <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_22"> 594000 </us-gaap:DeferredTaxLiabilitiesNoncurrent> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_1"> 2450000 </us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves> | |||||||||||||||||||||
| <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_3"> 8899000 </us-gaap:AccountsReceivableNetCurrent> | |||||||||||||||||||||
| <us-gaap:InventoryNet contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_5"> 11312000 </us-gaap:InventoryNet> | |||||||||||||||||||||
| <us-gaap:ExtendedProductWarrantyAccrual contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EF27FC57-8841-4BF4-A47C-C0FC73EEAE8E_1002_0"> 1056000 </us-gaap:ExtendedProductWarrantyAccrual> | |||||||||||||||||||||
| <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD_per_shares" decimals="3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_29"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare> | |||||||||||||||||||||
| <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_45"> 29807000 </us-gaap:LiabilitiesAndStockholdersEquity> | |||||||||||||||||||||
| <us-gaap:TreasuryStockValue contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_42"> 16399000 </us-gaap:TreasuryStockValue> | |||||||||||||||||||||
| <us-gaap:CustomerDepositsCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_19"> 165000 </us-gaap:CustomerDepositsCurrent> | |||||||||||||||||||||
| <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_2"> 3307000 </us-gaap:CashAndCashEquivalentsAtCarryingValue> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1004_8"> 2576000 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
| <us-gaap:CommonStockSharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_36"> 32502000 </us-gaap:CommonStockSharesIssued> | |||||||||||||||||||||
| <us-gaap:StandardProductWarrantyAccrual contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_1002_0"> 2218000 </us-gaap:StandardProductWarrantyAccrual> | |||||||||||||||||||||
| <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_9"> 212000 </us-gaap:IntangibleAssetsNetExcludingGoodwill> | |||||||||||||||||||||
| <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_39"> -360000 </us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax> | |||||||||||||||||||||
| <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_18"> 6177000 </us-gaap:AccruedLiabilitiesCurrent> | |||||||||||||||||||||
| <us-gaap:InventoryRawMaterials contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_A1F388A3-30E0-4F96-B05A-D16C600319C5_2_1"> 4280000 </us-gaap:InventoryRawMaterials> | |||||||||||||||||||||
| <us-gaap:GoodwillGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_9D215F03-32D0-40AE-A557-828365C1BCDB_1001_4"> 2926000 </us-gaap:GoodwillGross> | |||||||||||||||||||||
| <us-gaap:LiabilitiesCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_21"> 16282000 </us-gaap:LiabilitiesCurrent> | |||||||||||||||||||||
| <us-gaap:DeferredRevenue contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2C798CF1-CC91-4A7C-B290-A2216171490A_2_3"> 2161000 </us-gaap:DeferredRevenue> | |||||||||||||||||||||
| <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_4"> 289000 </us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent> | |||||||||||||||||||||
| <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_A1F388A3-30E0-4F96-B05A-D16C600319C5_2_3"> 4494000 </us-gaap:InventoryFinishedGoodsNetOfReserves> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_7"> 357000 </us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_7001_12"> 3858000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> | |||||||||||||||||||||
| <us-gaap:CommonStockValue contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_33"> 33000 </us-gaap:CommonStockValue> | |||||||||||||||||||||
| <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD_per_shares" decimals="3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_34"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare> | |||||||||||||||||||||
| <us-gaap:DeferredRevenueNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_23"> 25000 </us-gaap:DeferredRevenueNoncurrent> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1004_9"> 2364000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization> | |||||||||||||||||||||
| <us-gaap:AssetsCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_7"> 25326000 </us-gaap:AssetsCurrent> | |||||||||||||||||||||
| <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_32"> 0 </us-gaap:PreferredStockSharesOutstanding> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_11"> 33929000 </us-gaap:DeferredTaxAssetsGross> | |||||||||||||||||||||
| <us-gaap:PreferredStockSharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_31"> 0 </us-gaap:PreferredStockSharesIssued> | |||||||||||||||||||||
| <us-gaap:PreferredStockValue contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_28"/> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsInventory contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_6"> 906000 </us-gaap:DeferredTaxAssetsInventory> | |||||||||||||||||||||
| <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_2_8"> 7164000 </us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_8"> 1148000 </us-gaap:PropertyPlantAndEquipmentNet> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_0"> 576000 </us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets> | |||||||||||||||||||||
| <us-gaap:AdditionalPaidInCapital contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_38"> 138507000 </us-gaap:AdditionalPaidInCapital> | |||||||||||||||||||||
| <us-gaap:DeferredTaxLiabilitiesOther contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_16"> 101000 </us-gaap:DeferredTaxLiabilitiesOther> | |||||||||||||||||||||
| <biol:DeferredTaxAssetsUnrealizedCurrencyExchangeGain contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_9"> 99000 </biol:DeferredTaxAssetsUnrealizedCurrencyExchangeGain> | |||||||||||||||||||||
| <biol:DeferredTaxLiabilitiesStateTaxes contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_15"/> | |||||||||||||||||||||
| <biol:RoyaltiesReceivables contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_7D32EEDF-9F90-4271-9C50-6DE66940FC8C_2_2"> 29000 </biol:RoyaltiesReceivables> | |||||||||||||||||||||
| <biol:TradeAccountReceivable contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_7D32EEDF-9F90-4271-9C50-6DE66940FC8C_2_1"> 8583000 </biol:TradeAccountReceivable> | |||||||||||||||||||||
| <biol:FinancedInsurancePremiumFinanceCharge contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="pure" decimals="3" id="id_888902_0161E897-52C4-49F8-AEE2-0BAF3CBD600B_1002_3"> 0.025 </biol:FinancedInsurancePremiumFinanceCharge> | |||||||||||||||||||||
| <biol:AccruedSupportServices contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_2_6"> 200000 </biol:AccruedSupportServices> | |||||||||||||||||||||
| <biol:FiniteLivedIntangibleAssetsImpairment contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1004_10"/> | |||||||||||||||||||||
| <biol:UndeliveredElementsTrainingInstallationAndProductAndSupportServices contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2402410B-03CB-45FA-A2E2-5F1F64358FBD_1002_0"> 1105000 </biol:UndeliveredElementsTrainingInstallationAndProductAndSupportServices> | |||||||||||||||||||||
| <biol:StockholdersEquityExcludingTreasuryStock contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_2_41"> 28968000 </biol:StockholdersEquityExcludingTreasuryStock> | |||||||||||||||||||||
| <biol:FinancedInsurancePremiumPayable contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_0161E897-52C4-49F8-AEE2-0BAF3CBD600B_1002_0"> 433000 </biol:FinancedInsurancePremiumPayable> | |||||||||||||||||||||
| <biol:UndeliveredElementsExtendedWarrantyCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2C798CF1-CC91-4A7C-B290-A2216171490A_2_2"> 1056000 </biol:UndeliveredElementsExtendedWarrantyCurrent> | |||||||||||||||||||||
| <biol:UndeliveredElementsExtendedWarrantyNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2C798CF1-CC91-4A7C-B290-A2216171490A_2_5"> 25000 </biol:UndeliveredElementsExtendedWarrantyNoncurrent> | |||||||||||||||||||||
| <biol:DeferredTaxAssetsExcludedFromValuationAllowance contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_5C188876-3C84-440B-BB82-D1B711A6FDE1_1002_1"> 8000 </biol:DeferredTaxAssetsExcludedFromValuationAllowance> | |||||||||||||||||||||
| <biol:DeferredTaxLiabilitiesCapitalizedIntangibleAssets contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_2_14"> 630000 </biol:DeferredTaxLiabilitiesCapitalizedIntangibleAssets> | |||||||||||||||||||||
| <us-gaap:EntityWideDisclosureOnGeographicAreasLongLivedAssetsInForeignCountries contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_501891x531305" unitRef="iso4217_USD" decimals="0" id="id_888902_0D85C440-D571-4441-A8AC-9F6FD13D5D8A_1002_0"> 542000 </us-gaap:EntityWideDisclosureOnGeographicAreasLongLivedAssetsInForeignCountries> | |||||||||||||||||||||
| <biol:NumberOfStockOptionsWithAcceleratedVesting contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_504051x652048" unitRef="shares" decimals="0" id="id_888902_616FB663-6E84-42CA-98EA-755D44DFF527_2002_0"> 95833 </biol:NumberOfStockOptionsWithAcceleratedVesting> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_505872x500724" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_5005_800029"> -360000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_505872x502884" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_5003_700029"> -16399000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:SharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_505872x502884" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_5003_600028"> -1964000 </us-gaap:SharesIssued> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_505872x503287" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_5006_900029"> -109212000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_5001_500029"> 138540000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:SharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_5001_400028"> 32502000 </us-gaap:SharesIssued> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_506932x500424" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2004_1"> 289000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_506932x502651" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2005_1"> 110000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_506932x533644" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2006_1"> 33784000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x498304" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_1002_3"> 957000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x500372" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_2002_5"> 1036000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x503469" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_3002_6"> 26000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x510947" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_4002_2"> 317000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x512000" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_5002_1"> 247000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x513379" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_6002_4"> 5729000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x501065" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1001_11"> 212000 </us-gaap:FiniteLivedIntangibleAssetsNet> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x501065" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1001_8"> 1914000 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x501065" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1001_9"> 1702000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization> | |||||||||||||||||||||
| <biol:FiniteLivedIntangibleAssetsImpairment contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x501065" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1001_10"/> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x502477" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1003_8"> 593000 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x502477" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1003_9"> 593000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization> | |||||||||||||||||||||
| <biol:FiniteLivedIntangibleAssetsImpairment contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x502477" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1003_10"/> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x512398" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1002_11"/> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x512398" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1002_8"> 69000 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x512398" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1002_9"> 69000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization> | |||||||||||||||||||||
| <biol:FiniteLivedIntangibleAssetsImpairment contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x512398" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_1002_10"/> | |||||||||||||||||||||
| <us-gaap:CommonStockSharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20111231_0_623961x532774" unitRef="shares" decimals="-5" id="id_888902_492443DC-7271-4452-901B-B2431A2A73D1_2001_0"> 2200000 </us-gaap:CommonStockSharesIssued> | |||||||||||||||||||||
| <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_6"> 1552000 </us-gaap:PrepaidExpenseAndOtherAssetsCurrent> | |||||||||||||||||||||
| <us-gaap:Goodwill contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_10"> 2926000 </us-gaap:Goodwill> | |||||||||||||||||||||
| <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_6CB3BE36-A9DF-4AB8-B8A3-7A507ABAB1A9_1_0"> 683000 </us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_1_7"> 8027000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_13"> 175000 </us-gaap:DeferredTaxAssetsNet> | |||||||||||||||||||||
| <us-gaap:LinesOfCreditCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_16"> 1637000 </us-gaap:LinesOfCreditCurrent> | |||||||||||||||||||||
| <us-gaap:AccruedInsuranceCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_1_5"> 751000 </us-gaap:AccruedInsuranceCurrent> | |||||||||||||||||||||
| <us-gaap:StandardProductWarrantyAccrualCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_1_2"> 1699000 </us-gaap:StandardProductWarrantyAccrualCurrent> | |||||||||||||||||||||
| <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_1001_5"> 1699000 </us-gaap:ProductWarrantyAccrualClassifiedCurrent> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_5C188876-3C84-440B-BB82-D1B711A6FDE1_1001_0"> 33341000 </us-gaap:DeferredTaxAssetsValuationAllowance> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_18"> -647000 </us-gaap:DeferredTaxAssetsLiabilitiesNet> | |||||||||||||||||||||
| <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_12"> 305000 </us-gaap:OtherAssetsNoncurrent> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_30C896F2-69F9-4E43-9EC0-0A47E4A7E272_1001_3"> 62000 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_11001_18"> 2314000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_44"> 11794000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2004_7"> 300000 </us-gaap:FiniteLivedIntangibleAssetsNet> | |||||||||||||||||||||
| <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_6CB3BE36-A9DF-4AB8-B8A3-7A507ABAB1A9_1_3"/> | |||||||||||||||||||||
| <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_2052E80D-0040-49B4-8977-4A5321E0705A_4001_7"> 19000 </us-gaap:InterestPayableCurrentAndNoncurrent> | |||||||||||||||||||||
| <us-gaap:CommitmentsAndContingencies contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_26"/> | |||||||||||||||||||||
| <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_2FE2429E-177C-4BFF-B373-4B11C0ABC701_1001_0"> 1900000 </us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized> | |||||||||||||||||||||
| <us-gaap:DeferredIncomeTaxLiabilities contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_17"> 822000 </us-gaap:DeferredIncomeTaxLiabilities> | |||||||||||||||||||||
| <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_1_7"> 226000 </us-gaap:OtherAccruedLiabilitiesCurrent> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2009_4"> 3.48 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_1001_3"> 195000 </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_2"> 328000 </us-gaap:DeferredTaxAssetsDeferredIncome> | |||||||||||||||||||||
| <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_35"> 50000000 </us-gaap:CommonStockSharesAuthorized> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2009_3"> 3860000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> | |||||||||||||||||||||
| <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_1_1"> 2326000 </us-gaap:EmployeeRelatedLiabilitiesCurrent> | |||||||||||||||||||||
| <us-gaap:TreasuryStockShares contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_43"> 1964000 </us-gaap:TreasuryStockShares> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2009_6"> 2314000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsStateTaxes contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_4"> 45000 </us-gaap:DeferredTaxAssetsStateTaxes> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_11001_18"> 4.02 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_1001_2"> 199000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue> | |||||||||||||||||||||
| <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_37"> 31284000 </us-gaap:CommonStockSharesOutstanding> | |||||||||||||||||||||
| <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_470B0B28-7659-46D3-A4E2-20D5F2E8738E_1001_0"> 91000 </us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate> | |||||||||||||||||||||
| <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_FB2FE48B-80B6-47C5-B35F-57E6C2D7F7AF_1_0"> 9700000 </us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityAmountOutstanding contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_43607B9E-D86B-4584-B9DE-397F911DD2AB_1001_3"> 1600000 </us-gaap:LineOfCreditFacilityAmountOutstanding> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsOtherComprehensiveLoss contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_8"> 127000 </us-gaap:DeferredTaxAssetsOtherComprehensiveLoss> | |||||||||||||||||||||
| <us-gaap:AccruedProfessionalFeesCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_1_4"> 502000 </us-gaap:AccruedProfessionalFeesCurrent> | |||||||||||||||||||||
| <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_6CB3BE36-A9DF-4AB8-B8A3-7A507ABAB1A9_1_2"> 192000 </us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_3"> 2348000 </us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost> | |||||||||||||||||||||
| <us-gaap:InventoryWorkInProcess contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_A1F388A3-30E0-4F96-B05A-D16C600319C5_1_2"> 1949000 </us-gaap:InventoryWorkInProcess> | |||||||||||||||||||||
| <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_6CB3BE36-A9DF-4AB8-B8A3-7A507ABAB1A9_1_1"> 618000 </us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears> | |||||||||||||||||||||
| <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_44D25F89-7883-4544-BBFF-27B705E17ED3_1_0"> 414000 </us-gaap:AllowanceForDoubtfulAccountsReceivable> | |||||||||||||||||||||
| <us-gaap:OtherReceivablesNetCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_7D32EEDF-9F90-4271-9C50-6DE66940FC8C_1_3"> 179000 </us-gaap:OtherReceivablesNetCurrent> | |||||||||||||||||||||
| <us-gaap:Liabilities contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_25"> 20179000 </us-gaap:Liabilities> | |||||||||||||||||||||
| <us-gaap:AccountsPayableCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_17"> 7663000 </us-gaap:AccountsPayableCurrent> | |||||||||||||||||||||
| <us-gaap:UnrecognizedTaxBenefits contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B1B3EDE9-2A6E-4ADC-903B-159DF5974014_3001_4"> 1226000 </us-gaap:UnrecognizedTaxBenefits> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_10"> 25746000 </us-gaap:DeferredTaxAssetsOperatingLossCarryforwards> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_30C896F2-69F9-4E43-9EC0-0A47E4A7E272_1001_1"> 118000 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths> | |||||||||||||||||||||
| <us-gaap:DeferredRevenueCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_20"> 3226000 </us-gaap:DeferredRevenueCurrent> | |||||||||||||||||||||
| <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_24"> 138000 </us-gaap:OtherLiabilitiesNoncurrent> | |||||||||||||||||||||
| <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_30"> 1000000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
| <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_837D3322-65DE-41B6-A4A2-F4E76E002C18_1_3"> 763000 </us-gaap:SalesAndExciseTaxPayableCurrent> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_5"> 1167000 </us-gaap:DeferredTaxAssetsTaxCreditCarryforwards> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsNetNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_11"> 16000 </us-gaap:DeferredTaxAssetsNetNoncurrent> | |||||||||||||||||||||
| <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_40"> -112268000 </us-gaap:RetainedEarningsAccumulatedDeficit> | |||||||||||||||||||||
| <us-gaap:Assets contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_13"> 31973000 </us-gaap:Assets> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_11001_17"> 3.48 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_18ACFD68-E0ED-4C53-9B2D-D9ECD439E461_1001_2"> 8000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity> | |||||||||||||||||||||
| <us-gaap:InventoryValuationReserves contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_426E3BAF-FCC7-40FA-9EE6-92214BFD6C68_1001_0"> 1900000 </us-gaap:InventoryValuationReserves> | |||||||||||||||||||||
| <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_22"> 663000 </us-gaap:DeferredTaxLiabilitiesNoncurrent> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_1"> 2082000 </us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves> | |||||||||||||||||||||
| <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_3"> 11680000 </us-gaap:AccountsReceivableNetCurrent> | |||||||||||||||||||||
| <us-gaap:InventoryNet contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_5"> 11142000 </us-gaap:InventoryNet> | |||||||||||||||||||||
| <us-gaap:ExtendedProductWarrantyAccrual contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EF27FC57-8841-4BF4-A47C-C0FC73EEAE8E_1001_0"> 1506000 </us-gaap:ExtendedProductWarrantyAccrual> | |||||||||||||||||||||
| <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_29"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare> | |||||||||||||||||||||
| <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_45"> 31973000 </us-gaap:LiabilitiesAndStockholdersEquity> | |||||||||||||||||||||
| <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_470B0B28-7659-46D3-A4E2-20D5F2E8738E_1001_2"> 29000 </us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued> | |||||||||||||||||||||
| <us-gaap:TreasuryStockValue contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_42"> 16399000 </us-gaap:TreasuryStockValue> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_5CB263AF-C4E1-4AA8-BAC5-BB6364A61622_1001_3"> 6400000 </us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity> | |||||||||||||||||||||
| <us-gaap:CustomerDepositsCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_19"> 582000 </us-gaap:CustomerDepositsCurrent> | |||||||||||||||||||||
| <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_2"> 2543000 </us-gaap:CashAndCashEquivalentsAtCarryingValue> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2004_4"> 2800000 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
| <us-gaap:CommonStockSharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_36"> 33248000 </us-gaap:CommonStockSharesIssued> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_E0472D81-9381-41D6-8B9F-C1F85FCC62EC_2001_1"> 42800000 </us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal> | |||||||||||||||||||||
| <us-gaap:StandardProductWarrantyAccrual contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_1001_3"> 1699000 </us-gaap:StandardProductWarrantyAccrual> | |||||||||||||||||||||
| <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_9"> 300000 </us-gaap:IntangibleAssetsNetExcludingGoodwill> | |||||||||||||||||||||
| <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_6CB3BE36-A9DF-4AB8-B8A3-7A507ABAB1A9_1_4"/> | |||||||||||||||||||||
| <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_39"> -320000 </us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax> | |||||||||||||||||||||
| <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_18"> 6267000 </us-gaap:AccruedLiabilitiesCurrent> | |||||||||||||||||||||
| <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_470B0B28-7659-46D3-A4E2-20D5F2E8738E_1001_1"> 18000 </us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued> | |||||||||||||||||||||
| <us-gaap:InventoryRawMaterials contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_A1F388A3-30E0-4F96-B05A-D16C600319C5_1_1"> 4017000 </us-gaap:InventoryRawMaterials> | |||||||||||||||||||||
| <us-gaap:GoodwillGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_9D215F03-32D0-40AE-A557-828365C1BCDB_3001_2"> 2926000 </us-gaap:GoodwillGross> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_30C896F2-69F9-4E43-9EC0-0A47E4A7E272_1001_4"> 51000 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_30C896F2-69F9-4E43-9EC0-0A47E4A7E272_1001_2"> 69000 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo> | |||||||||||||||||||||
| <us-gaap:LiabilitiesCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_21"> 19375000 </us-gaap:LiabilitiesCurrent> | |||||||||||||||||||||
| <us-gaap:DeferredRevenue contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2C798CF1-CC91-4A7C-B290-A2216171490A_1_3"> 3229000 </us-gaap:DeferredRevenue> | |||||||||||||||||||||
| <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_4"> 304000 </us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent> | |||||||||||||||||||||
| <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_A1F388A3-30E0-4F96-B05A-D16C600319C5_1_3"> 5176000 </us-gaap:InventoryFinishedGoodsNetOfReserves> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_7"> 240000 </us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_11001_17"> 3860000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> | |||||||||||||||||||||
| <us-gaap:CommonStockValue contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_33"> 34000 </us-gaap:CommonStockValue> | |||||||||||||||||||||
| <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_34"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare> | |||||||||||||||||||||
| <us-gaap:DeferredRevenueNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_23"> 3000 </us-gaap:DeferredRevenueNoncurrent> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2004_5"> 2500000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization> | |||||||||||||||||||||
| <us-gaap:AssetsCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_7"> 26917000 </us-gaap:AssetsCurrent> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_E0472D81-9381-41D6-8B9F-C1F85FCC62EC_2001_0"> 67000000 </us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic> | |||||||||||||||||||||
| <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_32"> 0 </us-gaap:PreferredStockSharesOutstanding> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_11"> 33516000 </us-gaap:DeferredTaxAssetsGross> | |||||||||||||||||||||
| <us-gaap:PreferredStockSharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="shares" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_31"> 0 </us-gaap:PreferredStockSharesIssued> | |||||||||||||||||||||
| <us-gaap:PreferredStockValue contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_28"/> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsInventory contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_6"> 868000 </us-gaap:DeferredTaxAssetsInventory> | |||||||||||||||||||||
| <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_6CB3BE36-A9DF-4AB8-B8A3-7A507ABAB1A9_1_5"> 1493000 </us-gaap:OperatingLeasesFutureMinimumPaymentsDue> | |||||||||||||||||||||
| <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_1_8"> 6518000 </us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_8"> 1509000 </us-gaap:PropertyPlantAndEquipmentNet> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_0"> 405000 </us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets> | |||||||||||||||||||||
| <us-gaap:AdditionalPaidInCapital contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_38"> 140747000 </us-gaap:AdditionalPaidInCapital> | |||||||||||||||||||||
| <us-gaap:DeferredTaxLiabilitiesOther contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_16"> 119000 </us-gaap:DeferredTaxLiabilitiesOther> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2009_7"> 4.02 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> | |||||||||||||||||||||
| <biol:WorkingCapital contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_5CB263AF-C4E1-4AA8-BAC5-BB6364A61622_1001_0"> 7500000 </biol:WorkingCapital> | |||||||||||||||||||||
| <biol:DeferredTaxAssetsValuationAllowancePercentage contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="pure" decimals="2" id="id_888902_8F582FED-65AC-4884-BFC2-2B6EF144544D_1001_0"> 1.00 </biol:DeferredTaxAssetsValuationAllowancePercentage> | |||||||||||||||||||||
| <biol:DeferredTaxAssetsUnrealizedCurrencyExchangeGain contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_9"> 160000 </biol:DeferredTaxAssetsUnrealizedCurrencyExchangeGain> | |||||||||||||||||||||
| <biol:DeferredTaxLiabilitiesStateTaxes contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_15"/> | |||||||||||||||||||||
| <biol:RoyaltiesReceivables contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_7D32EEDF-9F90-4271-9C50-6DE66940FC8C_1_2"> 45000 </biol:RoyaltiesReceivables> | |||||||||||||||||||||
| <biol:TradeAccountReceivable contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_7D32EEDF-9F90-4271-9C50-6DE66940FC8C_1_1"> 11456000 </biol:TradeAccountReceivable> | |||||||||||||||||||||
| <biol:FinancedInsurancePremiumFinanceCharge contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="pure" decimals="3" id="id_888902_0161E897-52C4-49F8-AEE2-0BAF3CBD600B_1001_3"> 0.030 </biol:FinancedInsurancePremiumFinanceCharge> | |||||||||||||||||||||
| <biol:FiniteLivedIntangibleAssetsImpairment contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2004_6"/> | |||||||||||||||||||||
| <biol:UndeliveredElementsTrainingInstallationAndProductAndSupportServices contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2402410B-03CB-45FA-A2E2-5F1F64358FBD_1001_0"> 1723000 </biol:UndeliveredElementsTrainingInstallationAndProductAndSupportServices> | |||||||||||||||||||||
| <biol:StockholdersEquityExcludingTreasuryStock contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_C64428A3-0F61-4BF9-AEFE-A933124CE7E8_1_41"> 28193000 </biol:StockholdersEquityExcludingTreasuryStock> | |||||||||||||||||||||
| <biol:FinancedInsurancePremiumPayable contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_0161E897-52C4-49F8-AEE2-0BAF3CBD600B_1001_0"> 379000 </biol:FinancedInsurancePremiumPayable> | |||||||||||||||||||||
| <biol:UndeliveredElementsExtendedWarrantyCurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2C798CF1-CC91-4A7C-B290-A2216171490A_1_2"> 1506000 </biol:UndeliveredElementsExtendedWarrantyCurrent> | |||||||||||||||||||||
| <biol:UndeliveredElementsExtendedWarrantyNoncurrent contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2C798CF1-CC91-4A7C-B290-A2216171490A_1_5"> 3000 </biol:UndeliveredElementsExtendedWarrantyNoncurrent> | |||||||||||||||||||||
| <biol:DeferredTaxAssetsExcludedFromValuationAllowance contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_5C188876-3C84-440B-BB82-D1B711A6FDE1_1001_1"> 16000 </biol:DeferredTaxAssetsExcludedFromValuationAllowance> | |||||||||||||||||||||
| <biol:DeferredTaxLiabilitiesCapitalizedIntangibleAssets contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B08921ED-8D31-46C0-9848-01FABB1AC8A0_1_14"> 703000 </biol:DeferredTaxLiabilitiesCapitalizedIntangibleAssets> | |||||||||||||||||||||
| <biol:UnrecognizedTaxBenefitsImpactAdditionalPaidInCapitalIfRealized contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_13CA9E60-756F-4695-950A-21890BF81FFE_1001_1"> 1500000 </biol:UnrecognizedTaxBenefitsImpactAdditionalPaidInCapitalIfRealized> | |||||||||||||||||||||
| <biol:ChangeInControlEmployeeSeverance contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_9243C6E7-53CA-47EB-95B1-D34C6DBDDED7_1001_0"> 714000 </biol:ChangeInControlEmployeeSeverance> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityAmountOutstanding contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_501572x498232" unitRef="iso4217_USD" decimals="-5" id="id_888902_BC9E0ADC-B0CE-4F16-9F04-921B1E0A1306_2001_2"> 1600000 </us-gaap:LineOfCreditFacilityAmountOutstanding> | |||||||||||||||||||||
| <us-gaap:LongLivedAssetsHeldForSaleGainLossOnSale contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_501891x497675_510903x511397" unitRef="iso4217_USD" decimals="0" id="id_888902_25C32206-C119-4393-8649-46DE850C6709_1002_2"> 3000 </us-gaap:LongLivedAssetsHeldForSaleGainLossOnSale> | |||||||||||||||||||||
| <us-gaap:EntityWideDisclosureOnGeographicAreasLongLivedAssetsInForeignCountries contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_501891x531305" unitRef="iso4217_USD" decimals="0" id="id_888902_0D85C440-D571-4441-A8AC-9F6FD13D5D8A_1001_0"> 412000 </us-gaap:EntityWideDisclosureOnGeographicAreasLongLivedAssetsInForeignCountries> | |||||||||||||||||||||
| <us-gaap:FairValueAssumptionsExercisePrice contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_503845x508355" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_3E8BAF06-B992-41B0-B401-A4EECA8BA525_2001_0"> 2.83 </us-gaap:FairValueAssumptionsExercisePrice> | |||||||||||||||||||||
| <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x514053" unitRef="shares" decimals="INF" id="id_888902_557BE04E-FDF1-453B-97BD-9E93A62464FD_2001_0"> 1000000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537828" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2001_4"> 1.43 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537828" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2001_3"> 456000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537828" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2001_6"> 379000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537828" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2001_7"> 1.35 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537829" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2002_4"> 2.28 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537829" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2002_3"> 2175000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537829" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2002_6"> 917000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537829" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2002_7"> 2.08 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537830" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2003_4"> 3.20 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537830" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2003_3"> 159000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537830" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2003_6"> 75000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537830" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2003_7"> 3.20 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537831" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2004_4"> 4.25 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537831" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2004_3"> 268000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537831" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2004_6"> 232000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537831" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2004_7"> 4.15 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537832" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2005_4"> 5.44 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537832" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2005_3"> 373000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537832" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2005_6"> 288000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537832" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2005_7"> 5.45 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537833" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2006_4"> 7.49 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537833" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2006_3"> 225000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537833" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2006_6"> 219000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537833" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2006_7"> 7.53 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537834" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2007_4"> 11.34 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537834" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2007_3"> 150000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537834" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2007_6"> 150000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537834" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2007_7"> 11.34 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537835" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2008_4"> 14.14 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537835" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2008_3"> 54000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537835" unitRef="shares" decimals="INF" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2008_6"> 54000 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537835" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2008_7"> 14.14 </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_505872x500724" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_7005_800045"> -320000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_505872x502884" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_7003_700045"> -16399000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:SharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_505872x502884" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_7003_600044"> -1964000 </us-gaap:SharesIssued> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_505872x503287" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_7006_900045"> -112268000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:StockholdersEquity contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_7001_500045"> 140781000 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
| <us-gaap:SharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_7001_400044"> 33248000 </us-gaap:SharesIssued> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_506932x500424" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2001_4"> 304000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_506932x502651" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2002_4"> 110000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesBalance contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_506932x533644" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2003_4"> 33341000 </us-gaap:ValuationAllowancesAndReservesBalance> | |||||||||||||||||||||
| <us-gaap:DebtInstrumentBasisSpreadOnVariableRate contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_507611x652001" unitRef="pure" decimals="4" id="id_888902_2052E80D-0040-49B4-8977-4A5321E0705A_5001_1"> 0.0425 </us-gaap:DebtInstrumentBasisSpreadOnVariableRate> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityAmountOutstanding contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_507611x652001" unitRef="iso4217_USD" decimals="-5" id="id_888902_43607B9E-D86B-4584-B9DE-397F911DD2AB_2001_5"> 1600000 </us-gaap:LineOfCreditFacilityAmountOutstanding> | |||||||||||||||||||||
| <biol:LiborFloorRateApplicableToVariableRates contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_507611x652001" unitRef="pure" decimals="4" id="id_888902_2052E80D-0040-49B4-8977-4A5321E0705A_5001_3"> 0.0100 </biol:LiborFloorRateApplicableToVariableRates> | |||||||||||||||||||||
| <us-gaap:DebtInstrumentBasisSpreadOnVariableRate contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_507611x652129" unitRef="pure" decimals="4" id="id_888902_2052E80D-0040-49B4-8977-4A5321E0705A_6001_0"> 0.0525 </us-gaap:DebtInstrumentBasisSpreadOnVariableRate> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityAmountOutstanding contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_507611x652129" unitRef="iso4217_USD" decimals="-6" id="id_888902_43607B9E-D86B-4584-B9DE-397F911DD2AB_3001_4"> 0 </us-gaap:LineOfCreditFacilityAmountOutstanding> | |||||||||||||||||||||
| <biol:LiborFloorRateApplicableToVariableRates contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_507611x652129" unitRef="pure" decimals="4" id="id_888902_2052E80D-0040-49B4-8977-4A5321E0705A_6001_2"> 0.0100 </biol:LiborFloorRateApplicableToVariableRates> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_508454x652096" unitRef="shares" decimals="INF" id="id_888902_3D8FFD85-E025-4F17-85E4-38CBCF282A6B_1001_3"> 592000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_508454x652096" unitRef="shares" decimals="INF" id="id_888902_3D8FFD85-E025-4F17-85E4-38CBCF282A6B_1001_0"> 6950000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_508454x652096" unitRef="shares" decimals="INF" id="id_888902_3D8FFD85-E025-4F17-85E4-38CBCF282A6B_1001_2"> 3860000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercised contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_508454x652096" unitRef="shares" decimals="0" id="id_888902_3D8FFD85-E025-4F17-85E4-38CBCF282A6B_1001_1"> 2498000 </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercised> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_508681x532680" unitRef="iso4217_USD" decimals="0" id="id_888902_E0472D81-9381-41D6-8B9F-C1F85FCC62EC_3001_5"> 319000 </us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch> | |||||||||||||||||||||
| <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_508681x532681" unitRef="iso4217_USD" decimals="0" id="id_888902_E0472D81-9381-41D6-8B9F-C1F85FCC62EC_4001_3"> 786000 </us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x498304" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_1001_3"> 1193000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x500372" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_2001_5"> 1046000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x503469" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_3001_6"> 132000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x510947" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_4001_2"> 246000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x512000" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_5001_1"> 191000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x513379" unitRef="iso4217_USD" decimals="-3" id="id_888902_6BFF5A17-3743-425E-8C7C-E18D69A92748_6001_4"> 5219000 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x501065" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2001_7"> 81000 </us-gaap:FiniteLivedIntangibleAssetsNet> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x501065" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2001_4"> 1914000 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x501065" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2001_5"> 1833000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization> | |||||||||||||||||||||
| <biol:FiniteLivedIntangibleAssetsImpairment contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x501065" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2001_6"/> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x502477" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2003_7"> 219000 </us-gaap:FiniteLivedIntangibleAssetsNet> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x502477" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2003_4"> 817000 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x502477" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2003_5"> 598000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization> | |||||||||||||||||||||
| <biol:FiniteLivedIntangibleAssetsImpairment contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x502477" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2003_6"/> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x512398" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2002_7"/> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x512398" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2002_4"> 69000 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x512398" unitRef="iso4217_USD" decimals="-3" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2002_5"> 69000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization> | |||||||||||||||||||||
| <biol:FiniteLivedIntangibleAssetsImpairment contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x512398" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_2002_6"/> | |||||||||||||||||||||
| <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_513696x537356" unitRef="shares" decimals="INF" id="id_888902_557BE04E-FDF1-453B-97BD-9E93A62464FD_3001_1"> 500000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
| <us-gaap:SharePrice contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_623961x624861" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_387698F4-28CC-4DD4-B8AB-4392D7A7974B_2002_2"> 5.60 </us-gaap:SharePrice> | |||||||||||||||||||||
| <us-gaap:CommonStockSharesIssued contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_623961x624861" unitRef="shares" decimals="INF" id="id_888902_387698F4-28CC-4DD4-B8AB-4392D7A7974B_2002_1"> 320000 </us-gaap:CommonStockSharesIssued> | |||||||||||||||||||||
| <biol:PreferredStockPurchaseRightRedemptionPricePerRight contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_642484x693936" unitRef="iso4217_USD_per_Right" decimals="3" id="id_888902_AECA8B8F-9D1D-47A9-99BA-B9A456E3F11D_4001_5"> 0.001 </biol:PreferredStockPurchaseRightRedemptionPricePerRight> | |||||||||||||||||||||
| <biol:ClassOfWarrantOrRightOriginalExercisePriceOfWarrantsOrRights contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_642484x693936_681893x634572" unitRef="iso4217_USD_per_Right" decimals="2" id="id_888902_AECA8B8F-9D1D-47A9-99BA-B9A456E3F11D_5001_2"> 30.00 </biol:ClassOfWarrantOrRightOriginalExercisePriceOfWarrantsOrRights> | |||||||||||||||||||||
| <us-gaap:FairValueAssumptionsExercisePrice contextRef="eol_PE753-----1210-K0003_STD_0_20121231_0_652146x532799" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_3E8BAF06-B992-41B0-B401-A4EECA8BA525_3001_1"> 2.00 </us-gaap:FairValueAssumptionsExercisePrice> | |||||||||||||||||||||
| <us-gaap:RepaymentsOfLinesOfCredit contextRef="eol_PE753-----1210-K0003_STD_28_20110228_0_507199x693142" unitRef="iso4217_USD" decimals="-5" id="id_888902_BDE164F8-C0E0-47A8-90F9-E5EBE015A789_1001_1"> 2600000 </us-gaap:RepaymentsOfLinesOfCredit> | |||||||||||||||||||||
| <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="eol_PE753-----1210-K0003_STD_28_20130228_0_501819x545944_506663x511390" id="id_888902_B8D282B8-C59E-4A21-BB37-EE5C6C48E425_1001_2"> 2013-03-15 </us-gaap:DividendsPayableDateOfRecordDayMonthAndYear> | |||||||||||||||||||||
| <biol:SpecialStockDividendsIntended contextRef="eol_PE753-----1210-K0003_STD_28_20130228_0_501819x545944_506663x511390" unitRef="pure" decimals="2" id="id_888902_B8D282B8-C59E-4A21-BB37-EE5C6C48E425_1001_0"> 0.02 </biol:SpecialStockDividendsIntended> | |||||||||||||||||||||
| <biol:SpecialStockDividendsDeclared contextRef="eol_PE753-----1210-K0003_STD_28_20130228_0_501819x545944_506663x511390" unitRef="pure" decimals="3" id="id_888902_B8D282B8-C59E-4A21-BB37-EE5C6C48E425_1001_1"> 0.005 </biol:SpecialStockDividendsDeclared> | |||||||||||||||||||||
| <biol:SpecialStockDividendsIntended contextRef="eol_PE753-----1210-K0003_STD_28_20130228_0_506663x511390" unitRef="pure" decimals="2" id="id_888902_03316352-E7D4-40BC-94D7-2A5E1F0E8A3B_1_0"> 0.02 </biol:SpecialStockDividendsIntended> | |||||||||||||||||||||
| <biol:NumberOfWarrantsExercised contextRef="eol_PE753-----1210-K0003_STD_28_20130228_0_506663x511390_507199x551171" unitRef="shares" decimals="INF" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_2003_9"> 60000 </biol:NumberOfWarrantsExercised> | |||||||||||||||||||||
| <biol:NumberRevolvingCreditFacilityAgreements contextRef="eol_PE753-----1210-K0003_STD_30_20120524_0_501572x498232_507199x551171" unitRef="Agreement" decimals="0" id="id_888902_BC9E0ADC-B0CE-4F16-9F04-921B1E0A1306_1002_1"> 2 </biol:NumberRevolvingCreditFacilityAgreements> | |||||||||||||||||||||
| <biol:ExercisePriceOfWarrantsReduced contextRef="eol_PE753-----1210-K0003_STD_30_20120524_0_507199x551171" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_32424B1C-8809-4A3E-980D-6A4A8893E592_1001_2"> 2.00 </biol:ExercisePriceOfWarrantsReduced> | |||||||||||||||||||||
| <biol:IrWarrantsIssuedToPurchaseCommonStockPricePerShare contextRef="eol_PE753-----1210-K0003_STD_30_20100930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_C34BC229-9A2F-4C6E-8FAB-6B3A2F3172C8_1_1"> 0.74 </biol:IrWarrantsIssuedToPurchaseCommonStockPricePerShare> | |||||||||||||||||||||
| <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE753-----1210-K0003_STD_30_20110630_0_623961x652398" unitRef="iso4217_USD" decimals="-6" id="id_888902_C4D52BFF-0BD6-404C-A757-93A5546AA52C_1001_5"> 9000000 </us-gaap:ProceedsFromIssuanceOfCommonStock> | |||||||||||||||||||||
| <biol:ServiceFeesPaid contextRef="eol_PE753-----1210-K0003_STD_30_20110630_0_623961x652398" unitRef="iso4217_USD" decimals="0" id="id_888902_C4D52BFF-0BD6-404C-A757-93A5546AA52C_1001_8"> 451000 </biol:ServiceFeesPaid> | |||||||||||||||||||||
| <biol:ProceedsFromSaleOfCommonStockNetOfIssuanceCosts contextRef="eol_PE753-----1210-K0003_STD_30_20110630_0_623961x652398" unitRef="iso4217_USD" decimals="-5" id="id_888902_C4D52BFF-0BD6-404C-A757-93A5546AA52C_1001_7"> 8400000 </biol:ProceedsFromSaleOfCommonStockNetOfIssuanceCosts> | |||||||||||||||||||||
| <biol:ReimbursedExpense contextRef="eol_PE753-----1210-K0003_STD_30_20110630_0_623961x652398" unitRef="iso4217_USD" decimals="0" id="id_888902_C4D52BFF-0BD6-404C-A757-93A5546AA52C_1001_9"> 50000 </biol:ReimbursedExpense> | |||||||||||||||||||||
| <biol:TransactionIssuanceCosts contextRef="eol_PE753-----1210-K0003_STD_30_20110630_0_623961x652398" unitRef="iso4217_USD" decimals="0" id="id_888902_C4D52BFF-0BD6-404C-A757-93A5546AA52C_1001_6"> 622000 </biol:TransactionIssuanceCosts> | |||||||||||||||||||||
| <us-gaap:LeaseAndRentalExpense contextRef="eol_PE753-----1210-K0003_STD_31_20060131_0" unitRef="iso4217_USD" decimals="0" id="id_888902_AE5CFA81-851C-4239-A747-6355570D033C_1_2"> 38692 </us-gaap:LeaseAndRentalExpense> | |||||||||||||||||||||
| <biol:LeaseTerm contextRef="eol_PE753-----1210-K0003_STD_31_20060131_0" id="id_888902_AE5CFA81-851C-4239-A747-6355570D033C_1_0"> P5Y </biol:LeaseTerm> | |||||||||||||||||||||
| <us-gaap:NotesIssued1 contextRef="eol_PE753-----1210-K0003_STD_31_20100531_0_507199x693142" unitRef="iso4217_USD" decimals="-6" id="id_888902_E50077F7-D8A8-4D5E-BCB7-314CF1B9FC5E_1001_1"> 3000000 </us-gaap:NotesIssued1> | |||||||||||||||||||||
| <biol:ExercisePriceOfWarrantsReduced contextRef="eol_PE753-----1210-K0003_STD_31_20100531_0_507199x693142" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_E50077F7-D8A8-4D5E-BCB7-314CF1B9FC5E_1001_5"> 0.84 </biol:ExercisePriceOfWarrantsReduced> | |||||||||||||||||||||
| <biol:PeriodForExtendedLease contextRef="eol_PE753-----1210-K0003_STD_31_20090924_0" id="id_888902_AE5CFA81-851C-4239-A747-6355570D033C_2_3"> April 20, 2015 </biol:PeriodForExtendedLease> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE753-----1210-K0003_STD_31_20111231_0_504051x652048" id="id_888902_616FB663-6E84-42CA-98EA-755D44DFF527_1002_2"> P4Y </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE753-----1210-K0003_STD_31_20111231_0_504051x652048" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_616FB663-6E84-42CA-98EA-755D44DFF527_1002_1"> 2.58 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue> | |||||||||||||||||||||
| <biol:PenaltiesRate contextRef="eol_PE753-----1210-K0003_STD_33_20110802_0_504957x514053_623961x652398" unitRef="pure" decimals="3" id="id_888902_B762C515-633E-4552-863B-767CE4852DD0_1001_0"> 0.030 </biol:PenaltiesRate> | |||||||||||||||||||||
| <biol:RepurchaseOfWarrantsDuringPeriodValue contextRef="eol_PE753-----1210-K0003_STD_33_20110802_0_623961x652398" unitRef="iso4217_USD" decimals="0" id="id_888902_8E3524CA-C5C1-4A7A-BF35-61346633AA56_1001_1"> 99900 </biol:RepurchaseOfWarrantsDuringPeriodValue> | |||||||||||||||||||||
| <biol:RepurchaseOfWarrantsDuringPeriodShares contextRef="eol_PE753-----1210-K0003_STD_33_20110802_0_623961x652398" unitRef="shares" decimals="INF" id="id_888902_8E3524CA-C5C1-4A7A-BF35-61346633AA56_1001_0"> 90000 </biol:RepurchaseOfWarrantsDuringPeriodShares> | |||||||||||||||||||||
| <biol:WarrantExpense contextRef="eol_PE753-----1210-K0003_STD_33_20110802_0_623961x652398" unitRef="iso4217_USD" decimals="0" id="id_888902_8E3524CA-C5C1-4A7A-BF35-61346633AA56_1001_3"> 30000 </biol:WarrantExpense> | |||||||||||||||||||||
| <biol:WarrantsRepurchaseAverageCostPerShare contextRef="eol_PE753-----1210-K0003_STD_33_20110802_0_623961x652398" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_8E3524CA-C5C1-4A7A-BF35-61346633AA56_1001_2"> 1.11 </biol:WarrantsRepurchaseAverageCostPerShare> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="4" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_3_3"> 0.0194 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_3_2"> 111000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue> | |||||||||||||||||||||
| <us-gaap:OperatingIncomeLoss contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_14"> -11495000 </us-gaap:OperatingIncomeLoss> | |||||||||||||||||||||
| <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_13"> -87000 </us-gaap:OtherNoncashIncomeExpense> | |||||||||||||||||||||
| <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_3_1"/> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_3"> 0.064 </us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4007_1000008"> 115000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued> | |||||||||||||||||||||
| <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_33"> 300000 </us-gaap:RepaymentsOfLongTermDebt> | |||||||||||||||||||||
| <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_3_1"> 3126000 </us-gaap:StandardProductWarrantyAccrualWarrantiesIssued> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_8"> 0.008 </us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4007_1000005"> 727000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue> | |||||||||||||||||||||
| <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_24"> -12123000 </us-gaap:ComprehensiveIncomeNetOfTax> | |||||||||||||||||||||
| <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_3_4"> -18000 </us-gaap:CurrentIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_4"> -0.013 </us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther> | |||||||||||||||||||||
| <us-gaap:AssetImpairmentCharges contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_5"> 35000 </us-gaap:AssetImpairmentCharges> | |||||||||||||||||||||
| <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_3"> 1070000 </us-gaap:DepreciationDepletionAndAmortization> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensation contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_11"> 727000 </us-gaap:ShareBasedCompensation> | |||||||||||||||||||||
| <us-gaap:EarningsPerShareDiluted contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_27"> -0.46 </us-gaap:EarningsPerShareDiluted> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_4001_6"> 3.91 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_21"> -773000 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities> | |||||||||||||||||||||
| <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_3_6"> 55000 </us-gaap:DeferredFederalIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:ProvisionForDoubtfulAccounts contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_6"> -80000 </us-gaap:ProvisionForDoubtfulAccounts> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_4001_5"> 225000 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_6"> -0.006 </us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch> | |||||||||||||||||||||
| <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_3_1"> -19000 </us-gaap:CurrentFederalTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_11"> 0.005 </us-gaap:EffectiveIncomeTaxRateContinuingOperations> | |||||||||||||||||||||
| <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_39"> 199000 </us-gaap:ProceedsFromStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_23"> -3812000 </us-gaap:NetCashProvidedByUsedInOperatingActivities> | |||||||||||||||||||||
| <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_28"> -237000 </us-gaap:NetCashProvidedByUsedInInvestingActivities> | |||||||||||||||||||||
| <us-gaap:InvestmentIncomeInterest contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_16"> 3000 </us-gaap:InvestmentIncomeInterest> | |||||||||||||||||||||
| <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_34"> 85000 </us-gaap:PaymentsOfDebtIssuanceCosts> | |||||||||||||||||||||
| <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_3_7"> 16000 </us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_22"> -1016000 </us-gaap:IncreaseDecreaseInDeferredRevenue> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInCustomerDeposits contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_20"> 5877000 </us-gaap:IncreaseDecreaseInCustomerDeposits> | |||||||||||||||||||||
| <us-gaap:ProductWarrantyExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_3_2"> 2636000 </us-gaap:ProductWarrantyExpense> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_4001_5"> 0.89 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_10"> 70000 </us-gaap:AmortizationOfFinancingCosts> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_5"> -0.069 </us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes> | |||||||||||||||||||||
| <us-gaap:InterestExpenseOther contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_0161E897-52C4-49F8-AEE2-0BAF3CBD600B_3_2"> 5000 </us-gaap:InterestExpenseOther> | |||||||||||||||||||||
| <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_25"> 237000 </us-gaap:PaymentsToAcquirePropertyPlantAndEquipment> | |||||||||||||||||||||
| <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_42"> -1281000 </us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease> | |||||||||||||||||||||
| <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_10"> 6557000 </us-gaap:GeneralAndAdministrativeExpense> | |||||||||||||||||||||
| <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_32"> 3000000 </us-gaap:ProceedsFromIssuanceOfLongTermDebt> | |||||||||||||||||||||
| <us-gaap:AdvertisingExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_47F0FA0A-7512-4CA2-8B84-6375BAABFD90_3_0"> 610000 </us-gaap:AdvertisingExpense> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_19"> -173000 </us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets> | |||||||||||||||||||||
| <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="shares" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_30"> 26250000 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> | |||||||||||||||||||||
| <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_9"> 37000 </us-gaap:AmortizationOfFinancingCostsAndDiscounts> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4007_1000004"> 199000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:SalesRevenueNet contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F5DDECB5-1E3B-4851-A5D4-8558DD026906_3_2"> 26225000 </us-gaap:SalesRevenueNet> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_17"> -978000 </us-gaap:IncreaseDecreaseInAccountsReceivable> | |||||||||||||||||||||
| <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4007_1000010"> -102000 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax> | |||||||||||||||||||||
| <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_19"> -11963000 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments> | |||||||||||||||||||||
| <us-gaap:SellingAndMarketingExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_9"> 9938000 </us-gaap:SellingAndMarketingExpense> | |||||||||||||||||||||
| <us-gaap:EarningsPerShareBasic contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_26"> -0.46 </us-gaap:EarningsPerShareBasic> | |||||||||||||||||||||
| <us-gaap:LicensesRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_5631A702-427C-4C22-AFF5-8DA3A3E32B3B_3_0"> 145000 </us-gaap:LicensesRevenue> | |||||||||||||||||||||
| <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_11"> 3790000 </us-gaap:ResearchAndDevelopmentExpense> | |||||||||||||||||||||
| <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_40"> 2814000 </us-gaap:NetCashProvidedByUsedInFinancingActivities> | |||||||||||||||||||||
| <us-gaap:CostOfRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_6"> 17400000 </us-gaap:CostOfRevenue> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_4001_6"> 1386000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_7"> 0.001 </us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential> | |||||||||||||||||||||
| <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_12"> 35000 </us-gaap:ImpairmentOfLongLivedAssetsHeldForUse> | |||||||||||||||||||||
| <us-gaap:OperatingExpenses contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_13"> 20320000 </us-gaap:OperatingExpenses> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="2" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_3_1"> 0.91 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate> | |||||||||||||||||||||
| <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="shares" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_29"> 26250000 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_18"> -874000 </us-gaap:IncreaseDecreaseInInventories> | |||||||||||||||||||||
| <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_3_2"> 4000 </us-gaap:CurrentStateAndLocalTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="INF" id="id_888902_6711DCBB-37C7-42E3-A924-5E588642E2BC_3_600000"> 849000.0 </us-gaap:OperatingLeasesRentExpenseNet> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_0"> -0.340 </us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_1"> 0.304 </us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance> | |||||||||||||||||||||
| <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_3_3"> -3000 </us-gaap:CurrentForeignTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:Depreciation contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_46904EA1-BF3D-4007-BAC7-D0B631B35705_3_0"> 940000 </us-gaap:Depreciation> | |||||||||||||||||||||
| <us-gaap:IncomeTaxesPaidNet contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_47"> -96000 </us-gaap:IncomeTaxesPaidNet> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_9"> 0.038 </us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost> | |||||||||||||||||||||
| <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_4"> -55000 </us-gaap:GainLossOnSaleOfPropertyPlantEquipment> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_1813445F-7B13-4B49-8C60-F0A3C90E693C_3_0"> 727000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:GrossProfit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_7"> 8825000 </us-gaap:GrossProfit> | |||||||||||||||||||||
| <us-gaap:InterestPaid contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_46"> 236000 </us-gaap:InterestPaid> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_2"> 0.027 </us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes> | |||||||||||||||||||||
| <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_14"> 76000 </us-gaap:DeferredIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="shares" decimals="INF" id="id_888902_7CD2608E-9850-4846-9ECE-9AAEFD5BF1C8_3_0"> 4282000 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> | |||||||||||||||||||||
| <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_3_8"> 5000 </us-gaap:DeferredForeignIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:NetIncomeLoss contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4007_1000009"> -12021000 </us-gaap:NetIncomeLoss> | |||||||||||||||||||||
| <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_18"> -468000 </us-gaap:NonoperatingIncomeExpense> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4007_1000007"> 87000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition> | |||||||||||||||||||||
| <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_15"> -110000 </us-gaap:ForeignCurrencyTransactionGainLossBeforeTax> | |||||||||||||||||||||
| <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_3_10"> 58000 </us-gaap:IncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_41"> -46000 </us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents> | |||||||||||||||||||||
| <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_30C896F2-69F9-4E43-9EC0-0A47E4A7E272_3_0"> 130000 </us-gaap:AmortizationOfIntangibleAssets> | |||||||||||||||||||||
| <us-gaap:InterestExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_17"> 361000 </us-gaap:InterestExpense> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_3_3"> 1.09 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue> | |||||||||||||||||||||
| <biol:TotalDeferredIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_3_9"> 76000 </biol:TotalDeferredIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <biol:EffectiveIncomeTaxRateReconciliationOtherReconcilingItems contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_3_10"> -0.009 </biol:EffectiveIncomeTaxRateReconciliationOtherReconcilingItems> | |||||||||||||||||||||
| <biol:OtherEquityInstrumentsCompensation contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_3_12"> 19000 </biol:OtherEquityInstrumentsCompensation> | |||||||||||||||||||||
| <biol:LicenseFeesAndRoyaltyRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_2"> 1645000 </biol:LicenseFeesAndRoyaltyRevenue> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_3_2"> 0.00 </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend> | |||||||||||||||||||||
| <biol:NoIndividualCountryOtherThanUnitedStatesRepresentsMoreThanTenPercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" id="id_888902_F6551FB0-5793-4D0A-BCDD-92EC7113145F_3_0"> No individual international country represented more than 10% of net revenue </biol:NoIndividualCountryOtherThanUnitedStatesRepresentsMoreThanTenPercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermOne contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_3_0"> P4Y6M15D </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermOne> | |||||||||||||||||||||
| <biol:ProductsAndServicesRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_0"> 24580000 </biol:ProductsAndServicesRevenue> | |||||||||||||||||||||
| <biol:ShareBasedCompensationNetImpactOnEarningPerShareDiluted contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_1813445F-7B13-4B49-8C60-F0A3C90E693C_3_1"> -0.03 </biol:ShareBasedCompensationNetImpactOnEarningPerShareDiluted> | |||||||||||||||||||||
| <biol:PercentageOfSalesConcentrationToOneCustomer contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="2" id="id_888902_F2A94BE9-307B-412C-9F16-7877D048A40A_3_0"> 0.38 </biol:PercentageOfSalesConcentrationToOneCustomer> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodFairValue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_3_4"> 713000 </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodFairValue> | |||||||||||||||||||||
| <biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4007_1000006"> 19000 </biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments> | |||||||||||||||||||||
| <biol:SalesToCustomersLocatedWithinUnitedStates contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="2" id="id_888902_A4E9705E-B209-41B7-A974-72655DFC36E9_3_0"> 0.64 </biol:SalesToCustomersLocatedWithinUnitedStates> | |||||||||||||||||||||
| <biol:SalesToCustomersLocatedOutsideOfUnitedStates contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="pure" decimals="2" id="id_888902_A4E9705E-B209-41B7-A974-72655DFC36E9_3_1"> 0.36 </biol:SalesToCustomersLocatedOutsideOfUnitedStates> | |||||||||||||||||||||
| <biol:CostOfRevenuePriorToNonrecurringEvent contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_3_4"> 17400000 </biol:CostOfRevenuePriorToNonrecurringEvent> | |||||||||||||||||||||
| <us-gaap:SalesRevenueNet contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_501891x498006" unitRef="iso4217_USD" decimals="-3" id="id_888902_F5DDECB5-1E3B-4851-A5D4-8558DD026906_1003_0"> 16900000 </us-gaap:SalesRevenueNet> | |||||||||||||||||||||
| <us-gaap:SalesRevenueNet contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_501891x505266" unitRef="iso4217_USD" decimals="-3" id="id_888902_F5DDECB5-1E3B-4851-A5D4-8558DD026906_2003_1"> 9325000 </us-gaap:SalesRevenueNet> | |||||||||||||||||||||
| <us-gaap:InterestExpenseBorrowings contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_503845x610237" unitRef="iso4217_USD" decimals="0" id="id_888902_F8F3014D-6BF9-431F-8D0C-A0458EF2DB4B_1002_0"> 345000 </us-gaap:InterestExpenseBorrowings> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_504296x510320" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_1003_2"> 407000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_504296x549651" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_2003_1"> 193000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_504296x555087" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_3003_0"> 41000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_504296x595048" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_4003_3"> 86000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x500724" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4005_800010"> -102000 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax> | |||||||||||||||||||||
| <us-gaap:NetIncomeLoss contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x503287" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4006_900009"> -12021000 </us-gaap:NetIncomeLoss> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4001_500008"> 115000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4001_500005"> 727000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4001_400003"> 225000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4001_500004"> 199000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4001_500007"> 87000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition> | |||||||||||||||||||||
| <biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_4001_500006"> 19000 </biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_506932x500424" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_7_2"> -80000 </us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_506932x500424" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_7_3"> 30000 </us-gaap:ValuationAllowancesAndReservesDeductions> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_506932x502651" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_8_2"/> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_506932x502651" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_8_3"/> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_506932x533644" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_9_2"> 4073000 </us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_506932x533644" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_9_3"/> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x549700" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_1003_4"> 0.16 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x651997" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_2003_1"> 0.30 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x652137" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_3003_0"> 0.32 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x652157" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_4003_3"> 0.00 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x693138" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_5003_5"> 0.06 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x694007" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_6003_2"> 0.16 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_584109x517783" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_5001_3"> 1.77 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_584109x517783" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_5001_3"> 434000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_584109x517784" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_6001_4"> 2.00 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_584109x517784" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_6001_4"> 1657000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod> | |||||||||||||||||||||
| <biol:PercentageOfSalesConcentrationToOneCustomer contextRef="eol_PE753-----1210-K0003_STD_365_20101231_0_652106x652160" unitRef="pure" decimals="2" id="id_888902_46E3080C-9291-48CC-BA34-5B0094D808B2_1003_0"> 0.38 </biol:PercentageOfSalesConcentrationToOneCustomer> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="4" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_2_3"> 0.0153 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_2_2"> 1328000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue> | |||||||||||||||||||||
| <us-gaap:OperatingIncomeLoss contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_14"> -4004000 </us-gaap:OperatingIncomeLoss> | |||||||||||||||||||||
| <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_13"> -250000 </us-gaap:OtherNoncashIncomeExpense> | |||||||||||||||||||||
| <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_2_1"/> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_3"> 0.202 </us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther> | |||||||||||||||||||||
| <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_33"> 2700000 </us-gaap:RepaymentsOfLongTermDebt> | |||||||||||||||||||||
| <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_2_1"> 1586000 </us-gaap:StandardProductWarrantyAccrualWarrantiesIssued> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_8"> 0.038 </us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6007_1000015"> 1528000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue> | |||||||||||||||||||||
| <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_24"> -4522000 </us-gaap:ComprehensiveIncomeNetOfTax> | |||||||||||||||||||||
| <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_2_4"> 36000 </us-gaap:CurrentIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_4"> -0.023 </us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther> | |||||||||||||||||||||
| <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_3"> 695000 </us-gaap:DepreciationDepletionAndAmortization> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensation contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_11"> 1528000 </us-gaap:ShareBasedCompensation> | |||||||||||||||||||||
| <us-gaap:EarningsPerShareDiluted contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_27"> -0.15 </us-gaap:EarningsPerShareDiluted> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_8001_11"> 4.92 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:SalesReturnsAndAllowancesGoods contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_3319AA15-B1D9-479C-AF03-F11267154D8A_2_0"> 110000 </us-gaap:SalesReturnsAndAllowancesGoods> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_21"> 4230000 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities> | |||||||||||||||||||||
| <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_2_6"> 66000 </us-gaap:DeferredFederalIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:ProvisionForDoubtfulAccounts contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_6"> 74000 </us-gaap:ProvisionForDoubtfulAccounts> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_8001_10"> 657000 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_6"> -0.030 </us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch> | |||||||||||||||||||||
| <us-gaap:StockRepurchasedDuringPeriodValue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6007_1000021"> 268000 </us-gaap:StockRepurchasedDuringPeriodValue> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_11"> 0.022 </us-gaap:EffectiveIncomeTaxRateContinuingOperations> | |||||||||||||||||||||
| <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_39"> 1244000 </us-gaap:ProceedsFromStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_23"> -13320000 </us-gaap:NetCashProvidedByUsedInOperatingActivities> | |||||||||||||||||||||
| <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_28"> -428000 </us-gaap:NetCashProvidedByUsedInInvestingActivities> | |||||||||||||||||||||
| <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_2_7"> -16000 </us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_22"> 79000 </us-gaap:IncreaseDecreaseInDeferredRevenue> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInCustomerDeposits contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_20"> -5711000 </us-gaap:IncreaseDecreaseInCustomerDeposits> | |||||||||||||||||||||
| <us-gaap:ProductWarrantyExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_2_2"> 2093000 </us-gaap:ProductWarrantyExpense> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_8001_10"> 2.08 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_10"> 99000 </us-gaap:AmortizationOfFinancingCosts> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_5"> 0.181 </us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes> | |||||||||||||||||||||
| <us-gaap:InterestExpenseOther contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_0161E897-52C4-49F8-AEE2-0BAF3CBD600B_2_2"> 5000 </us-gaap:InterestExpenseOther> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6007_1000019"> 17223000 </us-gaap:StockIssuedDuringPeriodValueNewIssues> | |||||||||||||||||||||
| <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_25"> 428000 </us-gaap:PaymentsToAcquirePropertyPlantAndEquipment> | |||||||||||||||||||||
| <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_42"> 1613000 </us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease> | |||||||||||||||||||||
| <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_10"> 7936000 </us-gaap:GeneralAndAdministrativeExpense> | |||||||||||||||||||||
| <us-gaap:InventoryWriteDown contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_7"> 392000 </us-gaap:InventoryWriteDown> | |||||||||||||||||||||
| <us-gaap:AdvertisingExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_47F0FA0A-7512-4CA2-8B84-6375BAABFD90_2_0"> 444000 </us-gaap:AdvertisingExpense> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_19"> 552000 </us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets> | |||||||||||||||||||||
| <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="shares" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_30"> 29907000 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> | |||||||||||||||||||||
| <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_9"> 78000 </us-gaap:AmortizationOfFinancingCostsAndDiscounts> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6007_1000014"> 1244000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:SalesRevenueNet contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F5DDECB5-1E3B-4851-A5D4-8558DD026906_2_2"> 48858000 </us-gaap:SalesRevenueNet> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_17"> 5642000 </us-gaap:IncreaseDecreaseInAccountsReceivable> | |||||||||||||||||||||
| <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6007_1000027"> -36000 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax> | |||||||||||||||||||||
| <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_35"> 18000 </us-gaap:ProceedsFromWarrantExercises> | |||||||||||||||||||||
| <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_19"> -4397000 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments> | |||||||||||||||||||||
| <us-gaap:SellingAndMarketingExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_9"> 13075000 </us-gaap:SellingAndMarketingExpense> | |||||||||||||||||||||
| <us-gaap:EarningsPerShareBasic contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_26"> -0.15 </us-gaap:EarningsPerShareBasic> | |||||||||||||||||||||
| <us-gaap:LicensesRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_5631A702-427C-4C22-AFF5-8DA3A3E32B3B_2_0"> 64000 </us-gaap:LicensesRevenue> | |||||||||||||||||||||
| <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_11"> 4311000 </us-gaap:ResearchAndDevelopmentExpense> | |||||||||||||||||||||
| <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_40"> 15387000 </us-gaap:NetCashProvidedByUsedInFinancingActivities> | |||||||||||||||||||||
| <us-gaap:CostOfRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_6"> 27540000 </us-gaap:CostOfRevenue> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_8001_11"> 766000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod> | |||||||||||||||||||||
| <us-gaap:PaymentsForRepurchaseOfWarrants contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_36"> 130000 </us-gaap:PaymentsForRepurchaseOfWarrants> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_7"> -0.002 </us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential> | |||||||||||||||||||||
| <us-gaap:OperatingExpenses contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_13"> 25322000 </us-gaap:OperatingExpenses> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="2" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_2_1"> 1.05 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate> | |||||||||||||||||||||
| <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="shares" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_29"> 29907000 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_18"> 4716000 </us-gaap:IncreaseDecreaseInInventories> | |||||||||||||||||||||
| <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_2_2"> 16000 </us-gaap:CurrentStateAndLocalTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_6711DCBB-37C7-42E3-A924-5E588642E2BC_2_500000"> 1000000 </us-gaap:OperatingLeasesRentExpenseNet> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_0"> -0.340 </us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_1"> -0.023 </us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance> | |||||||||||||||||||||
| <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_2_3"> 20000 </us-gaap:CurrentForeignTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:Depreciation contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_46904EA1-BF3D-4007-BAC7-D0B631B35705_2_0"> 565000 </us-gaap:Depreciation> | |||||||||||||||||||||
| <us-gaap:IncomeTaxesPaidNet contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_47"> 44000 </us-gaap:IncomeTaxesPaidNet> | |||||||||||||||||||||
| <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_4"> -36000 </us-gaap:GainLossOnSaleOfPropertyPlantEquipment> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_1813445F-7B13-4B49-8C60-F0A3C90E693C_2_0"> 1528000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:GrossProfit contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_7"> 21318000 </us-gaap:GrossProfit> | |||||||||||||||||||||
| <us-gaap:InterestPaid contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_46"> 80000 </us-gaap:InterestPaid> | |||||||||||||||||||||
| <us-gaap:ConcentrationRiskCustomer contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" id="id_888902_44101FD8-6AA5-4745-9590-83D3E9A50500_2_0"> Less than 10% </us-gaap:ConcentrationRiskCustomer> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_2"> 0.020 </us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightExpenseOrRevenueRecognized contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" id="id_888902_C34BC229-9A2F-4C6E-8FAB-6B3A2F3172C8_3_2"> 273000 </us-gaap:ClassOfWarrantOrRightExpenseOrRevenueRecognized> | |||||||||||||||||||||
| <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_14"> 53000 </us-gaap:DeferredIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_888902_7CD2608E-9850-4846-9ECE-9AAEFD5BF1C8_2_0"> 4626000 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> | |||||||||||||||||||||
| <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_2_8"> 3000 </us-gaap:DeferredForeignIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:NetIncomeLoss contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6007_1000026"> -4486000 </us-gaap:NetIncomeLoss> | |||||||||||||||||||||
| <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_18"> -393000 </us-gaap:NonoperatingIncomeExpense> | |||||||||||||||||||||
| <us-gaap:CommonStockDividendsShares contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_2_1"> 1165715 </us-gaap:CommonStockDividendsShares> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6007_1000017"> 250000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition> | |||||||||||||||||||||
| <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_15"> -88000 </us-gaap:ForeignCurrencyTransactionGainLossBeforeTax> | |||||||||||||||||||||
| <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_2_10"> 89000 </us-gaap:IncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_41"> -26000 </us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents> | |||||||||||||||||||||
| <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_30C896F2-69F9-4E43-9EC0-0A47E4A7E272_2_0"> 130000 </us-gaap:AmortizationOfIntangibleAssets> | |||||||||||||||||||||
| <us-gaap:InterestExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_17"> 305000 </us-gaap:InterestExpense> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_2_3"> 2.97 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue> | |||||||||||||||||||||
| <biol:TotalDeferredIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_2_9"> 53000 </biol:TotalDeferredIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <biol:EffectiveIncomeTaxRateReconciliationOtherReconcilingItems contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_2_10"> -0.001 </biol:EffectiveIncomeTaxRateReconciliationOtherReconcilingItems> | |||||||||||||||||||||
| <biol:ProceedsFromSaleOfCommonStockNetOfIssuanceCosts contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_37"> 17223000 </biol:ProceedsFromSaleOfCommonStockNetOfIssuanceCosts> | |||||||||||||||||||||
| <biol:StockIssuedDuringPeriodValueWarrantsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6007_1000024"> 18000 </biol:StockIssuedDuringPeriodValueWarrantsExercised> | |||||||||||||||||||||
| <biol:AdjustmentsToAdditionalPaidInCapitalWarrantRepurchased contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6007_1000022"> 130000 </biol:AdjustmentsToAdditionalPaidInCapitalWarrantRepurchased> | |||||||||||||||||||||
| <biol:OtherEquityInstrumentsCompensation contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_12"> 273000 </biol:OtherEquityInstrumentsCompensation> | |||||||||||||||||||||
| <biol:LicenseFeesAndRoyaltyRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_2"> 439000 </biol:LicenseFeesAndRoyaltyRevenue> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_2_2"> 0.00 </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend> | |||||||||||||||||||||
| <biol:NoIndividualCountryOtherThanUnitedStatesRepresentsMoreThanTenPercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" id="id_888902_F6551FB0-5793-4D0A-BCDD-92EC7113145F_2_0"> No individual international country represented more than 10% of net revenue </biol:NoIndividualCountryOtherThanUnitedStatesRepresentsMoreThanTenPercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermOne contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_2_0"> P4Y1M24D </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermOne> | |||||||||||||||||||||
| <biol:ProductsAndServicesRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_0"> 48419000 </biol:ProductsAndServicesRevenue> | |||||||||||||||||||||
| <biol:ShareBasedCompensationNetImpactOnEarningPerShareDiluted contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_1813445F-7B13-4B49-8C60-F0A3C90E693C_2_1"> -0.05 </biol:ShareBasedCompensationNetImpactOnEarningPerShareDiluted> | |||||||||||||||||||||
| <biol:PaymentsOfStockRepurchaseCosts contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_2_38"> 268000 </biol:PaymentsOfStockRepurchaseCosts> | |||||||||||||||||||||
| <biol:PercentageOfSalesConcentrationToOneCustomer contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="2" id="id_888902_F2A94BE9-307B-412C-9F16-7877D048A40A_2_0"> 0.19 </biol:PercentageOfSalesConcentrationToOneCustomer> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodFairValue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_2_4"> 1259000 </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodFairValue> | |||||||||||||||||||||
| <biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6007_1000016"> 273000 </biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments> | |||||||||||||||||||||
| <biol:SalesToCustomersLocatedWithinUnitedStates contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="2" id="id_888902_A4E9705E-B209-41B7-A974-72655DFC36E9_2_0"> 0.67 </biol:SalesToCustomersLocatedWithinUnitedStates> | |||||||||||||||||||||
| <biol:SalesToCustomersLocatedOutsideOfUnitedStates contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="pure" decimals="2" id="id_888902_A4E9705E-B209-41B7-A974-72655DFC36E9_2_1"> 0.33 </biol:SalesToCustomersLocatedOutsideOfUnitedStates> | |||||||||||||||||||||
| <biol:CostOfRevenuePriorToNonrecurringEvent contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_2_4"> 27540000 </biol:CostOfRevenuePriorToNonrecurringEvent> | |||||||||||||||||||||
| <us-gaap:SalesRevenueNet contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_501891x498006" unitRef="iso4217_USD" decimals="-3" id="id_888902_F5DDECB5-1E3B-4851-A5D4-8558DD026906_1002_0"> 32782000 </us-gaap:SalesRevenueNet> | |||||||||||||||||||||
| <us-gaap:SalesRevenueNet contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_501891x505266" unitRef="iso4217_USD" decimals="-3" id="id_888902_F5DDECB5-1E3B-4851-A5D4-8558DD026906_2002_1"> 16076000 </us-gaap:SalesRevenueNet> | |||||||||||||||||||||
| <us-gaap:TreasuryStockAcquiredAverageCostPerShare contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_502360x564264" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_F8984708-319D-4BC9-B04D-FBC67D0ED533_1003_2"> 2.68 </us-gaap:TreasuryStockAcquiredAverageCostPerShare> | |||||||||||||||||||||
| <us-gaap:StockRepurchasedDuringPeriodShares contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_502360x564264" unitRef="shares" decimals="INF" id="id_888902_F8984708-319D-4BC9-B04D-FBC67D0ED533_1003_1"> 100500 </us-gaap:StockRepurchasedDuringPeriodShares> | |||||||||||||||||||||
| <us-gaap:InterestExpenseBorrowings contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_503845x610237" unitRef="iso4217_USD" decimals="0" id="id_888902_F8F3014D-6BF9-431F-8D0C-A0458EF2DB4B_1001_0"> 293000 </us-gaap:InterestExpenseBorrowings> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_504296x510320" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_1002_2"> 751000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_504296x549651" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_2002_1"> 463000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_504296x555087" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_3002_0"> 175000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_504296x595048" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_4002_3"> 139000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x500724" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6005_800027"> -36000 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax> | |||||||||||||||||||||
| <us-gaap:NetIncomeLoss contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x503287" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6006_900026"> -4486000 </us-gaap:NetIncomeLoss> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_500015"> 1528000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue> | |||||||||||||||||||||
| <us-gaap:StockDividendsShares contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_400025"> 1166000 </us-gaap:StockDividendsShares> | |||||||||||||||||||||
| <us-gaap:StockRepurchasedDuringPeriodValue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_500021"> 268000 </us-gaap:StockRepurchasedDuringPeriodValue> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_500019"> 17223000 </us-gaap:StockIssuedDuringPeriodValueNewIssues> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_400013"> 628000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_500014"> 1244000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:StockRepurchasedDuringPeriodShares contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_400020"> 100000 </us-gaap:StockRepurchasedDuringPeriodShares> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_500017"> 250000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_400018"> 4117000 </us-gaap:StockIssuedDuringPeriodSharesNewIssues> | |||||||||||||||||||||
| <biol:StockIssuedDuringPeriodValueWarrantsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_500024"> 18000 </biol:StockIssuedDuringPeriodValueWarrantsExercised> | |||||||||||||||||||||
| <biol:AdjustmentsToAdditionalPaidInCapitalWarrantRepurchased contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_500022"> 130000 </biol:AdjustmentsToAdditionalPaidInCapitalWarrantRepurchased> | |||||||||||||||||||||
| <biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_500016"> 273000 </biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments> | |||||||||||||||||||||
| <biol:StockIssuedDuringPeriodSharesPurchaseWarrantsExercised contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_6001_400023"> 126000 </biol:StockIssuedDuringPeriodSharesPurchaseWarrantsExercised> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_506932x500424" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_4_2"> 74000 </us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_506932x500424" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_4_3"> 96000 </us-gaap:ValuationAllowancesAndReservesDeductions> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_506932x502651" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_5_2"/> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_506932x502651" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_5_3"/> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_506932x533644" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_6_2"> -466000 </us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_506932x533644" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_6_3"/> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x549700" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_1002_4"> 0.09 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x651997" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_2002_1"> 0.19 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x652137" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_3002_0"> 0.60 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x652157" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_4002_3"> 0.00 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x693138" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_5002_5"> 0.01 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x694007" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_6002_2"> 0.11 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_584109x517783" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_9001_8"> 4.11 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_584109x517783" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_9001_8"> 1151000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod> | |||||||||||||||||||||
| <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_623961x532774" unitRef="iso4217_USD" decimals="-5" id="id_888902_492443DC-7271-4452-901B-B2431A2A73D1_1001_1"> 7500000 </us-gaap:ProceedsFromIssuanceOfCommonStock> | |||||||||||||||||||||
| <biol:ProceedsFromSaleOfCommonStockNetOfIssuanceCosts contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_623961x532774" unitRef="iso4217_USD" decimals="-5" id="id_888902_492443DC-7271-4452-901B-B2431A2A73D1_1001_2"> 7200000 </biol:ProceedsFromSaleOfCommonStockNetOfIssuanceCosts> | |||||||||||||||||||||
| <biol:PercentageOfSalesConcentrationToOneCustomer contextRef="eol_PE753-----1210-K0003_STD_365_20111231_0_652106x652160" unitRef="pure" decimals="2" id="id_888902_46E3080C-9291-48CC-BA34-5B0094D808B2_1002_0"> 0.19 </biol:PercentageOfSalesConcentrationToOneCustomer> | |||||||||||||||||||||
| <dei:TradingSymbol contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_4E988BCD-90FE-4BF8-A71C-8F24A73B8EF0_1_400000"> BIOL </dei:TradingSymbol> | |||||||||||||||||||||
| <dei:EntityRegistrantName contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_4E988BCD-90FE-4BF8-A71C-8F24A73B8EF0_1_400001"> BIOLASE, INC </dei:EntityRegistrantName> | |||||||||||||||||||||
| <dei:EntityCurrentReportingStatus contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_4E988BCD-90FE-4BF8-A71C-8F24A73B8EF0_1_400005"> Yes </dei:EntityCurrentReportingStatus> | |||||||||||||||||||||
| <dei:AmendmentFlag contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_EFC5B6BE-B88D-4B75-859D-921D0989AD4A_1_1"> false </dei:AmendmentFlag> | |||||||||||||||||||||
| <dei:EntityFilerCategory contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_4E988BCD-90FE-4BF8-A71C-8F24A73B8EF0_1_400007"> Accelerated Filer </dei:EntityFilerCategory> | |||||||||||||||||||||
| <dei:DocumentFiscalPeriodFocus contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_EFC5B6BE-B88D-4B75-859D-921D0989AD4A_1_4"> FY </dei:DocumentFiscalPeriodFocus> | |||||||||||||||||||||
| <dei:EntityVoluntaryFilers contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_4E988BCD-90FE-4BF8-A71C-8F24A73B8EF0_1_400006"> No </dei:EntityVoluntaryFilers> | |||||||||||||||||||||
| <dei:DocumentFiscalYearFocus contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_EFC5B6BE-B88D-4B75-859D-921D0989AD4A_1_3"> 2012 </dei:DocumentFiscalYearFocus> | |||||||||||||||||||||
| <dei:DocumentType contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_EFC5B6BE-B88D-4B75-859D-921D0989AD4A_1_0"> 10-K </dei:DocumentType> | |||||||||||||||||||||
| <dei:DocumentPeriodEndDate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_EFC5B6BE-B88D-4B75-859D-921D0989AD4A_1_2"> 2012-12-31 </dei:DocumentPeriodEndDate> | |||||||||||||||||||||
| <dei:EntityCentralIndexKey contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_4E988BCD-90FE-4BF8-A71C-8F24A73B8EF0_1_400002"> 0000811240 </dei:EntityCentralIndexKey> | |||||||||||||||||||||
| <dei:EntityWellKnownSeasonedIssuer contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_4E988BCD-90FE-4BF8-A71C-8F24A73B8EF0_1_400004"> No </dei:EntityWellKnownSeasonedIssuer> | |||||||||||||||||||||
| <dei:CurrentFiscalYearEndDate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_4E988BCD-90FE-4BF8-A71C-8F24A73B8EF0_1_400003"> --12-31 </dei:CurrentFiscalYearEndDate> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="4" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_1_3"> 0.0077 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate> | |||||||||||||||||||||
| <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_87E3623E-5A86-4A25-A940-F0D6C8DE3C02_1_0"> <div> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The provision for income taxes differs from the amount that would result from applying the federal statutory rate as follows for the years ended December 31:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="78%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Statutory regular federal income tax rate</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(34.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(34.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(34.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Change in valuation allowance</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(13.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2.3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30.4</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tax return to prior year provision adjustments</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.7</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Expiration of federal net operating losses</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">28.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.4</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Reduction of net operating loss attributes</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3.7</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2.3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1.3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">State tax benefit (net of federal benefit)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">18.1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(6.9</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Research credits</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.6</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign amounts with no tax benefit</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.6</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Non-deductible expenses</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.8</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.8</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Stock option expenses with no tax benefit</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.8</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.6</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.9</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.9</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock> | |||||||||||||||||||||
| <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_D1C6D0DF-E3DD-4917-A300-CE239350DAAB_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 8 — STOCKHOLDERS’ EQUITY</b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Preferred Stock</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Board of Directors, without further stockholder authorization, may issue from time to time up to 1,000,000 shares of the Company’s preferred stock. Of the 1,000,000 shares of preferred stock, 500,000 shares are designated as Series B Junior Participating Cumulative Preferred Stock. As of December 31, 2012 and 2011, none of the preferred stock was outstanding.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company has a stockholder rights plan under which one preferred stock purchase right was distributed on January 11, 1999 with respect to each share of common stock outstanding at the close of business on December 31, 1998. The rights provide, among other things, that in the event any person becomes the beneficial owner of 15% or more of the Company’s common stock while the rights are outstanding, each right will be exercisable to purchase shares of common stock having a market value equal to two times the then current exercise price of a right (initially $30.00). The rights also provide that, if on or after the occurrence of such event, the Company merges with any other corporation or 50% or more of its assets or earning power are sold, each right will be exercisable to purchase common stock of the acquiring corporation having a market value equal to two times the then current exercise price of such stock. The rights are subject to redemption at $0.001 per right at any time prior to the first date upon which they become exercisable to purchase common shares. The rights had an original expiration date of December 31, 2008, which was amended further extending the term to December 31, 2018.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Common Stock</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">At December 31, 2012, the Company had 33,248,000 shares of common stock issued with 31,284,000 shares outstanding. The Company currently has 50,000,000 shares of common stock authorized for issuance and 1,964,000 shares of common stock in its treasury.</font></p> <p style="MARGIN-TOP: 18px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Offering Agreement, Shelf Registration, and Securities Purchase Agreement</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On December 23, 2010, the Company entered into a Controlled Equity Offering Agreement (the “Offering Agreement”) with Ascendiant, as sales agent. In accordance with the terms of the Offering Agreement, the Company was able to issue and sell up to 3,000,000 shares of its common stock under the 2010 Shelf Registration Statement with a fee of 3.75% of the gross proceeds in a series of transactions over time as the Company directed in privately negotiated transactions and/or any other method permitted by law, including sales deemed to be an “at the market” offering as defined in Rule 415 under the Securities Act of 1993. “At the market” sales include sales made directly on the NASDAQ Capital Market, the existing trading market for the Company’s common stock, or sales made to or through a market maker other than on an exchange.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">During the year ended December 31, 2011, the Company sold approximately 2.2 million shares of common stock with gross proceeds of approximately $7.5 million and net proceeds of approximately $7.2 million, net of commissions and direct costs, through the Offering Agreement with Ascendiant.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On April 7, 2011, the Company entered into an agreement with Rodman & Renshaw, LLC (“Rodman & Renshaw”), pursuant to which Rodman & Renshaw arranged for the sale of shares of its common stock in a registered direct placement (the “April 2011 Registered Direct Placement”) pursuant to the 2010 Shelf Registration Statement with a fee of 4.5% of the aggregate gross proceeds. In addition, on April 7, 2011, the Company and certain institutional investors entered into a securities purchase agreement arranged by Rodman & Renshaw, pursuant to which the Company sold in an aggregate of 320,000 shares of the Company’s common stock in the April 2011 Registered Direct Placement with a purchase price of $5.60 per share for gross proceeds of approximately $1.8 million. The net proceeds to the Company from the April 2011 Registered Direct Placement totaled approximately $1.7 million. The costs associated with the April 2011 Registered Direct Placement of approximately $124,000 were paid in April 2011 upon the closing of the transaction. The shares of common stock sold in connection with the April 2011 Registered Direct Placement were issued pursuant to a prospectus supplement dated April 11, 2011 to the 2010 Shelf Registration Statement, which was filed with the SEC.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The transactions described above exhausted the securities available for sale under the Company’s 2010 Shelf Registration Statement.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In June 2011, the Company entered into a securities purchase agreement (the “June 2011 Securities Purchase Agreement”) with certain institutional investors (the “June 2011 Purchasers”) under which the Company sold an aggregate of 1,625,947 shares of the Company’s common stock at a price of $5.55 per share, together with five-year warrants to purchase 812,974 shares of its common stock having an exercise price of $6.50 per share (the “June 2011 Warrants”). The June 2011 Warrants were not exercisable for six months following their issuance. Gross proceeds from the offering totaled approximately $9 million, and net proceeds to the Company, after commissions and other offering expenses of approximately $622,000, totaled approximately $8.4 million. The Company used the proceeds for working capital and general corporate purposes. In connection with the June 2011 Securities Purchase Agreement, the Company entered into an agreement with Rodman & Renshaw in which Rodman & Renshaw agreed to act as the Company’s exclusive placement agent for the offering and the Company paid Rodman & Renshaw fees totaling approximately $451,000, and reimbursed expenses of $50,000. The commissions and expenses paid to Rodman and Renshaw were included in the offering expenses.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The common stock and the June 2011 Warrants were offered and sold, and the common stock issuable upon exercise of the June 2011 Warrants were offered, pursuant to exemptions from registration set forth in section 4(2) of the 1933 Act and Rule 506 of Regulation D promulgated under the 1933 Act. As such, the common stock, the June 2011 Warrants, and the common stock issuable upon exercise of the June 2011 Warrants was not permitted to be re-offered or resold absent either registration under the 1933 Act or the availability of an exemption from the registration requirements.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The June 2011 Securities Purchase Agreement was subject to a registration rights agreement whereby the Company would have incurred penalties of up to 3.0% of the offering proceeds if it was unable to file a registration statement by July 19, 2011. The Company filed a registration statement on Form S-3 with the SEC to register the Registerable Securities (File No. 333-175664) on July 19, 2011 which was declared effective by the SEC on August 25, 2011, thereby satisfying the registration rights agreement.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On August 2, 2011, the Company repurchased 90,000 of the June 2011 Warrants for $99,900, or $1.11 per underlying share, plus expenses of $30,000.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Additional Warrants</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On November 8, 2012, the Company issued warrants to purchase up to 50,000 shares of the Company’s common stock to an investor relations consultant, at a price per share of $2.50. The warrants vest and become exercisable only if the Company’s common stock closing price on NASDAQ reaches or exceeds $7.00 by November 7, 2013. The warrant expires November 7, 2015. As of December 31, 2012, no stock-based compensation has been recognized. The Company will reassess whether achievement of the contingent exercise provision is probable on a quarterly basis and recognize stock-based compensation when it is probable that the market performance requirement will be achieved.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In May 2012, the Company issued warrants to purchase up to 80,000 shares of the Company’s common stock to Comerica Bank at a price per share of $2.83, which was subsequently reduced to $2.00. See <i>Note 5 — Lines of Credit and Other Borrowings</i> for further discussion.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">During September 2010, the Company issued warrants (the “IR Warrants”) to purchase an aggregate of 50,000 shares of common stock at a price per share of $0.74 to three service providers who provide investor relations services. Pursuant to the agreement, the service providers were also entitled to a second tranche of IR Warrants to purchase an aggregate of 50,000 shares of common stock at a price per share of $0.74. The IR Warrants were fully exercised during the year ended December 31, 2012. In connection with the issuance of the IR Warrants, the Company recognized expenses of approximately $23,000 and $273,000 for the years ended December 31, 2012 and 2011, respectively.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In May 2010, the Company granted warrants to purchase an aggregate of 101,694 shares of its common stock to MidCap Financial, LLC, and Silicon Valley Bank at a price per share of $1.77, which was subsequently reduced to $0.84. See <i>Note 5 — Lines of Credit and Other Borrowings</i> for further discussion.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Stock Options</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December 31, 2012, a total of 6,950,000 shares have been authorized for issuance under the Company’s 2002 Stock Incentive Plan, of which 2,498,000 shares have been issued for options which have been exercised, 3,860,000 shares have been reserved for options that are outstanding, and 592,000 shares are available for the granting of additional options.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Stock options may be granted as incentive or nonqualified options; however, no incentive stock options have been granted to date. The exercise price of options is at least equal to the market price of the stock as of the date of grant. Options may vest over various periods but typically vest on a quarterly basis over three years. Options expire after five years, ten years or within a specified time from termination of employment, if earlier. The Company issues new shares of common stock upon the exercise of stock options. The following table summarizes option activity:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="46%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Shares</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Exercise Price</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Per Share</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted Average<br /> Remaining<br /> Contractual Term<br /> (Years)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Aggregate Intrinsic<br /> Value(1)</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Options outstanding, January 1, 2010</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,650,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">434,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.77</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at above fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,657,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(225,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Forfeited, cancelled, or expired</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,386,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.91</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Options outstanding, December 31, 2010</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,130,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.60</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,151,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.11</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at above fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(657,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.08</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Forfeited, cancelled, or expired</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(766,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.92</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Options outstanding, December 31, 2011</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,858,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.75</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">614,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.80</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at above fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">568,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(214,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.12</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Forfeited, cancelled, or expired</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(966,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.63</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Options outstanding, December 31, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,860,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.48</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.96</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">199,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Options exercisable, December 31, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,314,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.02</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.86</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">195,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vested options</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vested options expired during the twelve months ended December 31, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">208,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.84</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <!-- End Table Body --></table> <p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(1)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The intrinsic value calculation does not include negative values. This can occur when the fair market value on the reporting date is less than the exercise price of a grant.</font></td> </tr> </table> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table summarizes additional information for those options that are outstanding and exercisable as of December 31, 2012:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <!-- Begin Table Head --> <tr> <td width="48%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Options Outstanding</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Exercisable</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 84pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Range of Exercise Prices</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>of Shares</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Exercise Price</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Remaining<br /> Life (Years)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>of Shares</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Exercise Price</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 0.72 — $1.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">456,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.43</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">379,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.35</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 2.00 — $2.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,175,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.28</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.91</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">917,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.08</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 3.00 — $3.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">159,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.20</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.20</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 4.00 — $4.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">268,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.25</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">232,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 5.00 — $5.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">373,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.22</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">288,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.45</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 6.00 — $9.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">225,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7.49</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.12</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">219,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7.53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 10.00 — $13.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">150,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11.34</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.31</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">150,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11.34</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 14.00 — $18.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">54,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">14.14</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.43</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">54,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">14.14</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,860,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.48</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.96</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,314,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.02</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Cash proceeds, along with fair value disclosures related to grants, exercises, and vesting options, are as follows for the years ended December 31 (in thousands, except per share amounts):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <!-- Begin Table Head --> <tr> <td width="74%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Twelve Months Ended</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Proceeds from stock options exercised</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">455</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,244</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">199</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tax benefit related to stock options exercised(1)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">N/A</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">N/A</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">N/A</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intrinsic value of stock options exercised(2)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">91</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,328</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">111</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted-average fair value of options granted</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.39</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.97</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total fair value of shares vested during the year</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,737</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,259</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">713</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <!-- End Table Body --></table> <p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(1)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Excess tax benefits received related to stock option exercises are presented as financing cash inflows. Currently the Company does not receive a tax benefit related to the exercise of stock options due to its net operating losses.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(2)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The intrinsic value of stock options exercised is the amount by which the market price of the stock on the date of exercise exceeded the market price of the stock on the date of grant.</font></td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On May 7, 2012, the Board granted a non-qualified stock option to purchase 65,000 shares of the Company’s common stock to a consultant, at a price per share of $2.55, the closing market price of the Company’s common stock on the grant date. The option fully vests and becomes exercisable upon the achievement of certain specified performance conditions, as defined in the consulting agreement with this consultant, and the option expires five years from the grant date. As of December 31, 2012, no stock-based compensation has been recognized. The Company will reassess whether achievement of the performance conditions is probable on a quarterly basis and recognize stock-based compensation when it is probable that the performance conditions will be achieved.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On March 2, 2012, the Company’s Board of Directors (the “Board”) accelerated the vesting period for options to purchase 95,833 shares of common stock held by Federico Pignatelli, the Company’s Chief Executive Officer (“CEO”). The options were originally granted in December 2011 at $2.58 per share with monthly vesting over four years. The Board accelerated the vesting period to March 2, 2012, in part due to the CEO’s continued commitment to maintain his annual salary of one dollar for the year ending December 31, 2012. Accelerating the vesting period of the common stock options resulted in the Company recognizing unamortized compensation cost of approximately $183,000 in March 2012. The transaction did not result in any additional compensation cost primarily as the effects of the decrease in the expected term and volatility offset the effects of the difference between the stock price and the option price on the date the vesting of the common stock options were modified.</font></p> </div> </us-gaap:StockholdersEquityNoteDisclosureTextBlock> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_1_2"> 91000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue> | |||||||||||||||||||||
| <us-gaap:OperatingIncomeLoss contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_14"> -2531000 </us-gaap:OperatingIncomeLoss> | |||||||||||||||||||||
| <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_13"> -250000 </us-gaap:OtherNoncashIncomeExpense> | |||||||||||||||||||||
| <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_1_1"/> | |||||||||||||||||||||
| <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_BF980339-C1D9-4D1A-8D1F-8D6803CD03FF_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Revenue Recognition</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company’s products were sold exclusively through HSIC in North America from September 2006 through August 2010. Effective August 30, 2010, the Company’s products were sold domestically both directly to customers through its direct sales force and through non-exclusive distributors. Sales are recorded upon shipment and payment is generally due within 90 days or less. Internationally, the Company sells products through independent distributors, including HSIC. Revenue is recorded based on four basic criteria that must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred and title and the risks and rewards of ownership have been transferred to the customer or services have been rendered; (3) the price is fixed or determinable; and (4) collectability is reasonably assured. Revenue is recorded for all sales upon shipment assuming all other revenue recognition criteria are met.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Sales of the Company’s laser systems include separate deliverables consisting of the product, disposables used with the laser systems, installation, and training. For these sales, effective January 1, 2011, the Company applies the relative selling price method, which requires that arrangement consideration be allocated at the inception of an arrangement to all deliverables using the relative selling price method. This requires the Company to use (estimated) selling prices of each of the deliverables in the total arrangement. The sum of those prices is then compared to the arrangement, and any difference is applied to the separate deliverable ratably. This method also establishes a selling price hierarchy for determining the selling price of a deliverable, which includes: (1) vendor-specific objective evidence (“VSOE”) if available, (2) third-party evidence if vendor-specific objective evidence is not available, and (3) estimated selling price if neither vendor-specific nor third-party evidence is available. VSOE is determined based on the value the Company sells the undelivered element to a customer as a stand-alone product. Revenue attributable to the undelivered elements is included in deferred revenue when the product is shipped and is recognized when the related service is performed. Disposables not shipped at time of sale and installation services are typically shipped or installed within 30 days. Training is included in deferred revenue when the product is shipped and is recognized when the related service is performed or upon expiration of time offered under the agreement, typically within six months from date of sale. The adoption of the relative selling price method does not significantly change the value of revenue recognized. Deferred revenue attributable to undelivered elements, which primarily consists of training, totaled $1.7 million and $1.1 million as of December 31, 2012 and 2011, respectively.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Key judgments of the Company’s revenue recognition include the collectability of payment from the customer, the satisfaction of all elements of the arrangement having been delivered, and that no additional customer credits and discounts are needed. The Company evaluates the customer’s credit worthiness prior to the shipment of the product. Based on the assessment of the credit information available, the Company may determine the credit risk is higher than normally acceptable, and will either decline the purchase or defer the revenue until payment is reasonably assured. Future obligations required at the time of sale may also cause the Company to defer the revenue until the obligation is satisfied.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Although all sales are final, the Company accepts returns of products in certain, limited circumstances and records a provision for sales returns based on historical experience concurrent with the recognition of revenue. The sales returns allowance is recorded as a reduction of accounts receivable and revenue. As of December 31, 2012 and 2011, $110,000 and $110,000, respectively, was recorded as a reduction of accounts receivable for sales returns.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Extended warranty contracts, which are sold to non-distributor customers, are recorded as revenue on a straight-line basis over the period of the contracts, which is typically one year. Included in deferred revenue for each of the years ended December 31, 2012 and 2011, was $1.5 million and $1.1 million, respectively, for extended warranty contracts. This is inclusive of an extended service contract commitment assumed as part of a settlement, of which $3,000 will not be recognized as revenue until 2014 and beyond.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">For sales transactions involving used laser trade-ins, the Company records the purchased trade-ins as inventory at the fair value of the asset surrendered with the offset to accounts receivable. In determining the estimated fair value of used laser trade-ins, Management makes an assessment of usable parts, key components, and consider the ultimate resale value of the certified pre-owned (or “CPO”) laser with applicable margins. The Company sells these CPO laser trade-ins as refurbished lasers following its laser system revenue recognition policy. Trade-in rights are not established nor negotiated with customers during the initial sales transaction of the original lasers. Trade-in rights are promotional events used at Management’s discretion to encourage existing laser customers to purchase new lasers by offering perceived discounts in exchange for customers trading in original lasers. A customer is not required to trade-in a laser nor is the Company required to accept a trade-in, however, the promotional value offered in exchange for the trade-in laser is not offered without a laser trade-in. The transaction is treated as a monetary transaction as each sale transaction involving a customer trade-in includes significant boot of greater than 25% of the fair value of the exchange. As a monetary transaction, the sale is recognized following the Company’s laser system revenue recognition policy. There have been no sales transactions in which the cash consideration was less than 25% of the total transaction value.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company recognizes revenue for royalties under licensing agreements for our patented technology when the product using our technology is sold. The Company estimates and recognizes the amount earned based on historical performance and current knowledge about the business operations of our licensees. Historically, the Company’s estimates have generally been consistent with amounts reported by the licensees. Licensing revenue related to exclusive licensing arrangements is recognized concurrent with the related exclusivity period and totaled $0, $64,000, and $145,000 for the years ended December 31, 2012, 2011, and 2010, respectively.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">From time to time, the Company may offer sales incentives and promotions on its products. The cost of sales incentives are recorded at the date at which the related revenue is recognized as a reduction in revenue, increase in cost of goods sold or as a selling expense, as applicable, or later, in the case of incentives offered after the initial sale has occurred.</font></p> </div> </us-gaap:RevenueRecognitionPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_1_3"> 0.282 </us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther> | |||||||||||||||||||||
| <us-gaap:InventoryPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_CBCA348C-BC16-4EA0-9A2C-ADC82173B92B_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Inventory</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company values inventory at the lower of cost, determined using the first-in, first-out method, or market. The carrying value of inventory is evaluated periodically for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The allowance is adjusted based on such evaluation, with a corresponding provision included in cost of revenue. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and our allocation of fixed production overhead is based on the normal capacity of our production facilities.</font></p> </div> </us-gaap:InventoryPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9007_1000038"> 142000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_C7111786-A380-480C-9255-F005F97FA1AD_2001_3"> P3Y10M10D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1> | |||||||||||||||||||||
| <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_1_1"> 1705000 </us-gaap:StandardProductWarrantyAccrualWarrantiesIssued> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_1_8"> 0.061 </us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9007_1000033"> 1600000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue> | |||||||||||||||||||||
| <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_24"> -3016000 </us-gaap:ComprehensiveIncomeNetOfTax> | |||||||||||||||||||||
| <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_1_4"> 50000 </us-gaap:CurrentIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityCommitmentFeeAmount contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_18ACFD68-E0ED-4C53-9B2D-D9ECD439E461_1_0"> 120000 </us-gaap:LineOfCreditFacilityCommitmentFeeAmount> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_00273638-FEF5-476D-8BA0-07C5A7FEDCB9_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Property, Plant and Equipment</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Property, plant and equipment is stated at acquisition cost less accumulated depreciation. Maintenance and repairs are expensed as incurred. Upon sale or disposition of assets, any gain or loss is included in the consolidated statements of operations.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The cost of property, plant and equipment is depreciated using the straight-line method over the following estimated useful lives of the respective assets, except for leasehold improvements, which are depreciated over the lesser of the estimated useful lives of the respective assets or the related lease terms.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="86%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Building</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Leasehold improvements</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3 to 5 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Equipment and computers</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3 to 5 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Furniture and fixtures</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Depreciation expense for the years ended December 31, 2012, 2011, and 2010 totaled approximately $377,000, $565,000, and $940,000, respectively.</font></p> </div> </us-gaap:PropertyPlantAndEquipmentPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_DE2889BF-7C55-4B80-93A5-3E7E1C749CA4_1_0"> <div> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Cash and Cash Equivalents</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company considers all highly liquid investments with maturities of three months or less when purchased, as cash equivalents. Generally, any excess cash is invested in money market funds. Cash equivalents are carried at cost, which approximates fair market value.</font></p> </div> </us-gaap:CashAndCashEquivalentsPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_1_4"> -0.037 </us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther> | |||||||||||||||||||||
| <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_3"> 513000 </us-gaap:DepreciationDepletionAndAmortization> | |||||||||||||||||||||
| <us-gaap:ProceedsFromLinesOfCredit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_30"> 16600000 </us-gaap:ProceedsFromLinesOfCredit> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensation contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_11"> 1600000 </us-gaap:ShareBasedCompensation> | |||||||||||||||||||||
| <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_383728D1-222F-48A4-9259-900F46E4A70F_1_0"> <div> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Net revenue by geographic location based on the location of customers was as follows (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="70%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Years Ended December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">United States</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,524</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">32,782</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,900</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">International</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,832</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,076</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,325</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">57,356</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">48,858</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26,225</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock> | |||||||||||||||||||||
| <us-gaap:EarningsPerShareDiluted contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_27"> -0.10 </us-gaap:EarningsPerShareDiluted> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_13001_16"> 3.63 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:LiquidityDisclosureTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_7C13E31E-1DD2-494F-ACE2-97E231A34229_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Liquidity and Management’s Plans</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Although the Company generated $1.9 million of cash from operations during the quarter ended December 31, 2012, the Company has suffered recurring losses from operations and has not generated cash from operations for the three years ended December 31, 2012. In order for the Company to continue operations and discharge its liabilities and commitments in the normal course of business, the Company must sell its products directly to end-users and through distributors; establish profitable operations through increased sales and reduced operating expenses; and potentially raise additional funds, principally through the additional sales of securities or debt financings to meet its working capital needs.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company intends to increase sales by increasing its product offerings, expanding its direct sales force and its distributor relationships both domestically and internationally. Accordingly, the Company has taken steps during Fiscal 2012 to improve its financial condition and ultimately improve its financial results, including increasing its product offerings with the launch of the new Epic diode laser system, for which the Company received the CE Mark in late September 2012 and FDA clearance in October 2012, executing a definitive five-year agreement with Copenhagen-based 3Shape Corporation (“3Shape”), making the Company a distributor of 3Shape’s TRIOS intra-oral CAD/CAM scanning technologies for digital impression-taking solutions in the U.S. and Canada, expanding our direct sales force and certain distributor relationships, and establishing two revolving credit facilities to meet quarterly working capital needs.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Management anticipates that the cash generated from operations and the borrowings available under the lines of credit with Comerica Bank will be sufficient to fund the working capital requirements of the Company for 2013.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">At December 31, 2012, the Company had approximately $7.5 million in working capital. The Company’s principal sources of liquidity at December 31, 2012 consisted of approximately $2.5 million in cash and cash equivalents, $11.7 million of net accounts receivable, and $6.4 million of available borrowings under two revolving credit facility agreements.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On May 24, 2012, the Company entered into two revolving credit facility agreements with Comerica Bank which provide for borrowings of up to $8.0 million. The Company had approximately $1.6 million of borrowings outstanding under these lines of credit as of December 31, 2012. See <i>Note 5 — Lines of Credit and Other Borrowings</i> for additional information.</font></p> </div> </us-gaap:LiquidityDisclosureTextBlock> | |||||||||||||||||||||
| <us-gaap:SalesReturnsAndAllowancesGoods contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_3319AA15-B1D9-479C-AF03-F11267154D8A_1_0"> 110000 </us-gaap:SalesReturnsAndAllowancesGoods> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_21"> -347000 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities> | |||||||||||||||||||||
| <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_B58E3232-D625-40E5-8961-FAD1B1C2A6AF_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Newly Adopted Accounting Standards</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In September 2011, the FASB issued guidance for the impairment testing of goodwill. The guidance permits an entity to first assess qualitative factors to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. This guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The Company adopted this guidance effective January 1, 2012. The adoption did not have a material impact on the Company’s consolidated financial statements.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In June 2011, the FASB updated the accounting guidance relating to presentation of comprehensive income. This guidance requires companies to present total comprehensive income, the components of net income, and the components of other comprehensive income (“OCI”) either in a single continuous statement of comprehensive income or in two, but consecutive, statements. Additionally, companies are required to present on the face of the consolidated financial statements the reclassification adjustments that are reclassified from OCI to net income, where the components of net income and the components of OCI are presented. This guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2011, and requires retrospective application to all periods presented. The Company adopted this guidance effective January 1, 2012 and elected to present a single continuous statement of comprehensive loss. The adoption did not have a material impact on the Company’s consolidated financial statements.</font></p> </div> </us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_4EA0ECF6-DEFB-4211-8A8A-A01ACBB0BA48_1_0"> <div> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The components of the deferred income tax assets and liabilities as of December 31 (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="77%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalized intangible assets for tax purposes</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">405</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">576</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Reserves not currently deductible</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,082</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,450</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deferred revenue</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">328</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Stock options</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,348</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,959</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">State Taxes</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">45</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Income tax credits</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,167</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,322</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Inventory</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">868</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">906</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Property and equipment</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">240</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">357</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other comprehensive income</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">127</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">144</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Unrealized gain on foreign currency</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">160</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">99</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net operating losses</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">25,746</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26,075</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total deferred tax assets</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,516</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,929</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Valuation allowance</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(33,341</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(33,784</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Net deferred tax assets</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">175</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">145</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalized intangible assets</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(703</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(630</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">State tax</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(119</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(101</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total deferred tax liabilities</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(822</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(731</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net deferred tax liabilities</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(647</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(586</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock> | |||||||||||||||||||||
| <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_1_6"> 57000 </us-gaap:DeferredFederalIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:ProvisionForDoubtfulAccounts contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_6"> 241000 </us-gaap:ProvisionForDoubtfulAccounts> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_13001_15"> 214000 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_CA046A0C-52A8-46E3-B7FE-A860802D6CD7_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 3 — SUPPLEMENTARY BALANCE SHEET INFORMATION</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="81%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 153pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>ACCOUNTS RECEIVABLE (in thousands):</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Components of accounts receivable, net of allowances, are as follows:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Trade</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,456</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,583</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Royalties</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">45</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">179</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">287</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total receivables, net</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,680</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,899</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Accounts receivable is net of allowances for doubtful accounts and sales returns totaling approximately $414,000 and $399,000 at December 31, 2012 and 2011, respectively.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 122pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>INVENTORY, NET (in thousands):</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Components of inventory, net of allowances, are as follows:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Raw materials</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,280</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Work-in-process</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,949</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,538</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Finished goods</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,176</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,494</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Inventory, net</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,142</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,312</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Inventory is net of a provision for excess and obsolete inventory totaling approximately $1.9 million and $2.3 million at December 31, 2012 and 2011, respectively.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="79%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 219pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>PROPERTY, PLANT AND EQUIPMENT, NET (in thousands):</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Components of property, plant and equipment, net of depreciation, are as follows:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">191</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">247</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Building</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">246</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">317</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Leasehold improvements</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,193</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">957</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Equipment and computers</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,219</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,729</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Furniture and fixtures</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,046</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,036</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Construction in progress</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">132</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,027</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,312</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accumulated depreciation and amortization</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(6,518</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(7,164</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Property, plant and equipment, net</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,509</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,148</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On August 21, 2012, pursuant to a Sale and Purchase Agreement entered on June 12, 2012, the Company sold the smaller of two buildings and a portion of the land parcel of its two-building property in Floss, Germany. The purchase price of approximately $136,000 was reduced by transaction costs, resulting in net proceeds of approximately $124,000. As of December 31, 2012, the Company recorded a realized gain on the sale of these assets of approximately $3,000. The Company also undertook an appraisal of the remaining land and building at the Floss property and determined that no impairment charge was necessary.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="82%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 144pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>ACCRUED LIABILITIES (in thousands):</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Components of accrued liabilities are as follows:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Payroll and benefits</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,326</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,928</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Warranty accrual, current portion</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,699</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sales tax</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">763</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">526</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accrued professional services</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">502</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">669</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accrued insurance premium</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">751</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">433</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accrued support services</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">200</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">226</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">203</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accrued liabilities</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,267</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,177</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="81%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 138pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>DEFERRED REVENUE (in thousands):</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Components of deferred revenue are as follows:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Undelivered elements (training, installation, product and support services)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,723</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,105</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Extended warranty contracts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,506</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,056</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total Deferred Revenue</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,229</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,161</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Less Long-Term amounts:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Extended warranty contracts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(25</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total Deferred Revenue — Long Term</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(25</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total Deferred Revenue — Current</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,226</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,136</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On May 20, 2010, the Company entered into a license agreement (the “2010 P&G Agreement”), with Procter and Gamble Company (“P&G”), which replaced an existing license agreement between the Company and P&G (the “2006 P&G Agreement”). Pursuant to the 2010 P&G Agreement, the Company agreed to continue granting P&G an exclusive license to certain of the Company’s patents to enable P&G to develop products aimed at the consumer market and P&G agreed to pay royalties based on sales of products developed with such intellectual property. On June 28, 2011, the Company entered into an amendment to the 2010 P&G Agreement (the “2011 P&G Amendment”) which extended the effective period for the 2010 P&G Agreement from December 31, 2010 through June 30, 2011, and resulted in the Company recognizing the previously deferred $375,000 of revenue as royalty revenue during the quarter ended June 30, 2011.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The 2011 P&G Amendment also provided that effective January 1, 2011, P&G’s exclusive license to the Company’s patents converted to a non-exclusive license unless P&G paid the Company a license payment in the amount of $187,500 by the end of the third quarter of 2011, and at the end of each quarter thereafter, throughout the term of the 2010 P&G Agreement. As a result of P&G not making any payments to the Company in the third and fourth quarters of the year ended December 31, 2011, their license converted to a non-exclusive license. The Company is currently engaged in an active collaboration with P&G to commercialize a consumer product utilizing its patents.</font></p> </div> </us-gaap:SupplementalBalanceSheetDisclosuresTextBlock> | |||||||||||||||||||||
| <us-gaap:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_7A64106C-7EE1-4830-B76D-14EF85E66D25_1_0"> <div> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>BIOLASE, INC.</b></font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>Schedule II — Consolidated Valuation and Qualifying Accounts and Reserves</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>For the Years Ended December 31, 2012, 2011 and 2010</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>(in thousands)</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="57%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Balance at</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Beginning</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>of Year</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Charges</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>(Reversals) to Cost<br /> or Expenses</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Deductions</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Balance at</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>End of Year</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Year Ended December 31, 2012:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for doubtful accounts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">289</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">241</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(226</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">304</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for sales returns</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for tax valuation</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,784</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(443</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,341</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Year Ended December 31, 2011:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for doubtful accounts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">311</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">74</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(96</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">289</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for sales returns</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for tax valuation</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">34,250</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(466</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,784</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Year Ended December 31, 2010:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for doubtful accounts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">421</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(80</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(30</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">311</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for sales returns</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for tax valuation</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30,177</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,073</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">34,250</font></td> </tr> </table> </div> </us-gaap:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock> | |||||||||||||||||||||
| <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_DA76D37C-BBB8-427A-93FF-50793F4F149F_1_0"> <div> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table summarizes additional information for those options that are outstanding and exercisable as of December 31, 2012:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="48%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Options Outstanding</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Exercisable</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 84pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Range of Exercise Prices</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>of Shares</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Exercise Price</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Remaining<br /> Life (Years)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>of Shares</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Exercise Price</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 0.72 — $1.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">456,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.43</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">379,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.35</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 2.00 — $2.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,175,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.28</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.91</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">917,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.08</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 3.00 — $3.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">159,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.20</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.20</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 4.00 — $4.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">268,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.25</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">232,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 5.00 — $5.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">373,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.22</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">288,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.45</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 6.00 — $9.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">225,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7.49</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.12</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">219,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7.53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 10.00 — $13.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">150,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11.34</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.31</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">150,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11.34</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">$ 14.00 — $18.99</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">54,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">14.14</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.43</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">54,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">14.14</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,860,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.48</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.96</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,314,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.02</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_13001_20"> 208000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod> | |||||||||||||||||||||
| <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_5AB57EE4-D6E6-4C84-B8A2-443A13D5C358_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Concentration of credit risk, interest rate risk and foreign currency exchange rate risk</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Financial instruments which potentially expose the Company to a concentration of credit risk consist principally of cash and cash equivalents, restricted cash, and trade accounts receivable. The Company invests its cash and cash equivalents and restricted cash with established commercial banks. At times, balances may exceed federally insured limits. To minimize the risk associated with trade accounts receivable, management performs ongoing credit evaluations of customers’ financial condition and maintains relationships with the Company’s customers which allow management to monitor current changes in business operations respond as needed. The Company does not, generally, require customers to provide collateral before it sells them products; however is has required certain distributors to make prepayments for significant purchases of products. For the years ended December 31, 2012, 2011, and 2010, sales to Henry Schein, Inc. (“HSIC”) worldwide accounted for approximately 3%, 19%, and 38%, respectively, of our net sales.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Substantially all of the Company’s revenue is denominated in U.S. dollars, including sales to international distributors. Only a small portion of its revenue and expenses is denominated in foreign currencies, principally the Euro and Indian Rupee. The Company’s foreign currency expenditures primarily consist of the cost of maintaining offices, including the facilities, consulting services and employee-related costs. To date, the Company has not entered into any hedging contracts. Future fluctuations in the value of the U.S. dollar may, however, affect the price competitiveness of the Company’s products outside the United States.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Management’s primary objective in managing the Company’s cash balances has been preservation of principal and maintenance of liquidity to meet the Company’s operating needs. Most of the Company’s excess cash balances are invested in money market accounts in which there is minimal interest rate risk. An increase in the LIBOR rate associated with the Company’s lines of credit would increase the interest expense the Company must pay. The Company’s risk associated with fluctuation in interest expense is limited to its outstanding lines of credit balances. The Company does not use interest rate derivative instruments to manage exposure to interest rate changes.</font></p> </div> </us-gaap:ConcentrationRiskCreditRisk> | |||||||||||||||||||||
| <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_C4D635DB-E55B-4373-A7AF-844E33171BC4_1_0"> <div> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table presents the current and deferred provision (benefit) for income taxes for the years ended December 31 (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="78%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Current:</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Federal</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(19</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">State</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">18</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">32</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(18</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Deferred:</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Federal</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">57</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">66</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">55</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">State</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(16</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(8</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">61</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">76</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">111</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">58</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock> | |||||||||||||||||||||
| <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_B1B3EDE9-2A6E-4ADC-903B-159DF5974014_5001_3"/> | |||||||||||||||||||||
| <us-gaap:StockRepurchasedDuringPeriodValue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9007_1000037"> 235000 </us-gaap:StockRepurchasedDuringPeriodValue> | |||||||||||||||||||||
| <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_49"> 200000 </us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_1_11"> 0.039 </us-gaap:EffectiveIncomeTaxRateContinuingOperations> | |||||||||||||||||||||
| <us-gaap:ShortTermDebtDescription contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_0161E897-52C4-49F8-AEE2-0BAF3CBD600B_1_1"> Nine </us-gaap:ShortTermDebtDescription> | |||||||||||||||||||||
| <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_26"> 124000 </us-gaap:ProceedsFromSaleOfProductiveAssets> | |||||||||||||||||||||
| <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_D3236007-3BA1-4AC8-9159-6BA4230280A4_1_0"> <div> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company discloses material loss contingencies deemed to be reasonably possible and accrues for loss contingencies when, in consultation with its legal advisors, management concludes that a loss is probable and reasonably estimable. The ability to predict the ultimate outcome of such matters involves judgments, estimates, and inherent uncertainties. The actual outcome of such matters could differ materially from management’s estimates.</font></p> </div> </us-gaap:CommitmentsAndContingenciesPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_39"> 455000 </us-gaap:ProceedsFromStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_23"> -1664000 </us-gaap:NetCashProvidedByUsedInOperatingActivities> | |||||||||||||||||||||
| <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_28"> -698000 </us-gaap:NetCashProvidedByUsedInInvestingActivities> | |||||||||||||||||||||
| <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_34"> 304000 </us-gaap:PaymentsOfDebtIssuanceCosts> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_58075942-1647-4A62-8EB2-11F879C04FA9_1_0"> <div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="79%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 219pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>PROPERTY, PLANT AND EQUIPMENT, NET (in thousands):</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Components of property, plant and equipment, net of depreciation, are as follows:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">191</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">247</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Building</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">246</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">317</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Leasehold improvements</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,193</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">957</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Equipment and computers</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,219</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,729</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Furniture and fixtures</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,046</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,036</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Construction in progress</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">132</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,027</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,312</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accumulated depreciation and amortization</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(6,518</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(7,164</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Property, plant and equipment, net</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,509</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,148</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:PropertyPlantAndEquipmentTextBlock> | |||||||||||||||||||||
| <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_1_7"> 12000 </us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_22"> 1068000 </us-gaap:IncreaseDecreaseInDeferredRevenue> | |||||||||||||||||||||
| <us-gaap:StandardProductWarrantyPolicy contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_E494D4D3-98E0-4F46-856F-0C7ABCAA6125_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Provision for Warranty Expense</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company provides warranties against defects in materials and workmanship of its laser systems for specified periods of time. Waterlase systems sold domestically are covered by the Company’s warranty for a period of one year while the Company’s Diode systems warranty period is for two years from date of sale by the Company or the distributor to the end-user. Waterlase systems sold internationally are generally covered by the Company’s warranty for a period of sixteen months while its Diode systems warranty period is up to twenty eight months from date of sale to the international distributor. Estimated warranty expenses are recorded as an accrued liability with a corresponding provision to cost of revenue. This estimate is recognized concurrent with the recognition of revenue on the sale to the distributor or end-user. Warranty expenses expected to be incurred after one year from the time of sale to the distributor are classified as a long term warranty accrual. The Company’s overall accrual is based on its historical experience and Management’s expectation of future conditions, taking into consideration the location and type of customer and the type of laser, which directly correlate to the materials and components under warranty, the duration of the warranty period, and the logistical costs to service the warranty. Additional factors that may impact the Company’s warranty accrual include changes in the quality of materials, leadership and training of the production and services departments, knowledge of the lasers and workmanship, training of customers, and adherence to the warranty policies. Additionally, an increase in warranty claims or in the costs associated with servicing those claims would likely result in an increase in the accrual and a decrease in gross profit. The Company does not offer warranties on imaging products which are covered by the manufacturer’s warranties.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Changes in the initial product warranty accrual and the expenses incurred under our initial and extended warranties for the years ended December 31 were as follows (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="69%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Years Ended December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Initial warranty accrual, beginning balance</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,725</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,235</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Provision for estimated warranty cost</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,705</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,586</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,126</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Warranty expenditures</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,224</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,093</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,636</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Initial warranty accrual, ending balance</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,699</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,725</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total warranty accrual, long term</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">424</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total warranty accrual, current portion</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,699</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,301</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:StandardProductWarrantyPolicy> | |||||||||||||||||||||
| <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_059E62AA-8857-4641-8F7E-4CCC7034115B_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Goodwill and Other Intangible Assets</i></b></font></p> <p style="PADDING-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Goodwill and other intangible assets with indefinite lives are not subject to amortization but are evaluated for impairment annually or whenever events or changes in circumstances indicate that the asset might be impaired. The Company operates in one operating segment and has one operating unit; therefore goodwill is tested for impairment at the consolidated level against the fair value of the Company. The fair value of a reporting unit refers to the amount at which the unit as a whole could be bought or sold in a current transaction between willing parties. Quoted market prices in active markets are the best evidence of fair value and are used as the basis for measurement, if available. Management assesses potential impairment on an annual basis on June 30</font><font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">th</sup></font> <font style="FONT-FAMILY: Times New Roman" size="2">and compares the Company’s market capitalization to its carrying amount, including goodwill. A significant decrease in the Company’s stock price could indicate a material impairment of goodwill which, after further analysis, could result in a material charge to operations. If goodwill is considered impaired, the impairment loss to be recognized is measured by the amount by which the carrying amount of the goodwill exceeds the implied fair value of that goodwill. Inherent in the Company’s fair value determinations are certain judgments and estimates, including projections of future cash flows, the discount rate reflecting the inherent risk in future cash flows, the interpretation of current economic indicators and market valuations, and strategic plans with regards to operations. A change in these underlying assumptions could cause a change in the results of the tests, which could cause the fair value of the reporting unit to be less than its respective carrying amount.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Costs incurred to acquire and successfully defend patents, and costs incurred to acquire trademarks and trade names are capitalized. Costs related to the internal development of technologies that are ultimately patented are expensed as incurred. Intangible assets, except those determined to have an indefinite life, are amortized using the straight-line method over management’s best estimate of the pattern of economic benefit over the estimated useful life of the assets. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.</font></p> </div> </us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInCustomerDeposits contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_20"> 417000 </us-gaap:IncreaseDecreaseInCustomerDeposits> | |||||||||||||||||||||
| <us-gaap:ProductWarrantyExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_2608449F-F8FC-4C41-BFEA-B25C65B35F3C_1_2"> 2224000 </us-gaap:ProductWarrantyExpense> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_13001_15"> 2.12 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:RepaymentsOfLinesOfCredit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_31"> 14963000 </us-gaap:RepaymentsOfLinesOfCredit> | |||||||||||||||||||||
| <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_10"> 91000 </us-gaap:AmortizationOfFinancingCosts> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_1_5"> 0.041 </us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes> | |||||||||||||||||||||
| <us-gaap:InterestExpenseOther contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_0161E897-52C4-49F8-AEE2-0BAF3CBD600B_1_2"> 5000 </us-gaap:InterestExpenseOther> | |||||||||||||||||||||
| <us-gaap:NumberOfOperatingSegments contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="Segment" decimals="INF" id="id_888902_717B0963-A1A6-4ADF-914D-6BDD0CEDC06F_1_0"> 1 </us-gaap:NumberOfOperatingSegments> | |||||||||||||||||||||
| <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_25"> 808000 </us-gaap:PaymentsToAcquirePropertyPlantAndEquipment> | |||||||||||||||||||||
| <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_CEBA5A83-CB9E-465D-8B7B-F3B80DD48E5E_1_0"> <div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 122pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>INVENTORY, NET (in thousands):</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Components of inventory, net of allowances, are as follows:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Raw materials</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,280</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Work-in-process</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,949</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,538</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Finished goods</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,176</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,494</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Inventory, net</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,142</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,312</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfInventoryCurrentTableTextBlock> | |||||||||||||||||||||
| <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_42"> -764000 </us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease> | |||||||||||||||||||||
| <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_10"> 8075000 </us-gaap:GeneralAndAdministrativeExpense> | |||||||||||||||||||||
| <us-gaap:InventoryWriteDown contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_7"> 330000 </us-gaap:InventoryWriteDown> | |||||||||||||||||||||
| <us-gaap:ReceivablesPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_1F355527-A1DC-4A5A-A112-BAD5B0994913_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Accounts Receivable</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in its existing accounts receivable. The Company evaluates its allowance for doubtful accounts based upon its knowledge of customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis which incorporates input from sales, service, and finance personnel. The review process evaluates all account balances with amounts outstanding more than 90 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. The allowance for doubtful accounts is adjusted based on such evaluation, with a corresponding provision included in general and administrative expenses. Account balances are charged off against the allowance when it is probable the receivable will not be recovered. The Company does not have any off-balance-sheet credit exposure related to its customers.</font></p> </div> </us-gaap:ReceivablesPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_14A9F8B7-8F4D-450C-868F-5FB958197AFE_1_0"> <div> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table summarizes the activity related to the Company’s unrecognized tax benefits during the year ended December 31, 2012 (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <!-- Begin Table Head --> <tr> <td width="90%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance at January 1, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,066</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Additions for tax positions related to the prior year</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">160</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Lapse of statute of limitations</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance at December 31, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,226</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> </table> </div> </us-gaap:SummaryOfIncomeTaxContingenciesTextBlock> | |||||||||||||||||||||
| <us-gaap:AdvertisingExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_47F0FA0A-7512-4CA2-8B84-6375BAABFD90_1_0"> 907000 </us-gaap:AdvertisingExpense> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_19"> -450000 </us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets> | |||||||||||||||||||||
| <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_9B2F5F66-327A-461F-BADB-8E276AA1A873_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 12 — SUBSEQUENT EVENT</b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Stock Dividend</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In February 2013, the Board of Directors announced a 2% annual stock dividend policy for 2013 and declared a one-half percent stock dividend (the “March Stock Dividend”) payable March 29, 2013 to stockholders of record on March 15, 2013. The Company expects to record the effects of the March Stock Dividend in the first quarter ending March 31, 2013.</font></p> </div> </us-gaap:SubsequentEventsTextBlock> | |||||||||||||||||||||
| <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_2FE2429E-177C-4BFF-B373-4B11C0ABC701_1_1"> P1Y2M12D </us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1> | |||||||||||||||||||||
| <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="shares" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_30"> 31308000 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> | |||||||||||||||||||||
| <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_E34A193C-A882-41EC-91B8-952346E9EB7D_1_0"> <div> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table summarizes option activity:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="46%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Shares</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Exercise Price</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Per Share</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted Average<br /> Remaining<br /> Contractual Term<br /> (Years)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Aggregate Intrinsic<br /> Value(1)</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Options outstanding, January 1, 2010</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,650,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">434,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.77</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at above fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,657,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(225,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Forfeited, cancelled, or expired</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,386,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.91</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Options outstanding, December 31, 2010</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,130,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.60</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,151,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.11</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at above fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(657,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.08</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Forfeited, cancelled, or expired</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(766,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.92</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Options outstanding, December 31, 2011</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,858,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.75</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">614,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.80</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted at above fair market value</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">568,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(214,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.12</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Forfeited, cancelled, or expired</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(966,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.63</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Options outstanding, December 31, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,860,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.48</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.96</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">199,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Options exercisable, December 31, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,314,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.02</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.86</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">195,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vested options</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vested options expired during the twelve months ended December 31, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">208,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.84</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> </table> <p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(1)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The intrinsic value calculation does not include negative values. This can occur when the fair market value on the reporting date is less than the exercise price of a grant.</font></td> </tr> </table> </div> </us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9007_1000031"> 455000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_80EA5128-FFE5-4A43-8CE9-2DFDD13187F0_1_0"> <div> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 4 — INTANGIBLE ASSETS AND GOODWILL</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company conducted its annual two-step impairment test of intangible assets and goodwill as of June 30, 2012 and determined that there was no impairment. The Company also tests its intangible assets and goodwill between the annual impairment test if events occur or circumstances change that would more likely than not reduce the fair value of the Company or its assets below their carrying amounts. No events have occurred that would trigger further impairment testing of the Company’s intangible assets and goodwill during the years ended December 31, 2012 and 2011.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Amortization expense for the years ended December 31, 2012, 2011, and 2010, totaled $136,000, $130,000, and $130,000, respectively. Estimated intangible asset amortization expense, based on existing intangible assets, for the years ending December 31, 2013, 2014, 2015, and 2016, is $118,000, $69,000, $62,000, and $51,000, respectively.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table presents the details of the Company’s intangible assets, related accumulated amortization and goodwill (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="38%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>As of December 31, 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>As of December 31, 2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gross</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Accumulated<br /> Amortization</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Impairment</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Net</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gross</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Accumulated<br /> Amortization</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Impairment</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Net</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Patents (4-10 years)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,914</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,833</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">81</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,914</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,702</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">212</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Trademarks (6 years)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">69</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(69</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">69</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(69</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other (4 to 6 years)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">817</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(598</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">219</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">593</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(593</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,800</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,500</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">300</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,576</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,364</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">212</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Goodwill (Indefinite life)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,926</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,926</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,926</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,926</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In December 2012, the Company capitalized approximately $224,000 related to intangible assets acquired from its former distributor in India. These assets primarily include a non-compete agreement and customer and luminary lists. Of the total capitalized balance, $200,000 was a noncash investment whereby the Company reduced the accounts receivable from its former distributor in exchange for these assets. The Company is amortizing these assets on a straight-line basis over the expected useful life of four years and has recognized amortization expense of approximately $5,000 related to these intangible assets during the year ended December 31, 2012.</font></p> </div> </us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock> | |||||||||||||||||||||
| <us-gaap:SalesRevenueNet contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F5DDECB5-1E3B-4851-A5D4-8558DD026906_1_2"> 57356000 </us-gaap:SalesRevenueNet> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_9_5"> P3Y11M16D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_17"> 3222000 </us-gaap:IncreaseDecreaseInAccountsReceivable> | |||||||||||||||||||||
| <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9007_1000043"> 40000 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax> | |||||||||||||||||||||
| <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_35"> 6000 </us-gaap:ProceedsFromWarrantExercises> | |||||||||||||||||||||
| <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_828E99C8-4E30-480A-A4BD-6E5109D229CD_1_0"> <div> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The stock option fair values were estimated using the Black-Scholes option-pricing model with the following assumptions:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="75%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Expected term (years)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.70</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.54</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Volatility</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">97</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">105</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">91</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Annual dividend per share</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Risk-free interest rate</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.77</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.94</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> </table> </div> </us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock> | |||||||||||||||||||||
| <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_19"> -2945000 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments> | |||||||||||||||||||||
| <us-gaap:SellingAndMarketingExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_9"> 16250000 </us-gaap:SellingAndMarketingExpense> | |||||||||||||||||||||
| <us-gaap:EarningsPerShareBasic contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_26"> -0.10 </us-gaap:EarningsPerShareBasic> | |||||||||||||||||||||
| <us-gaap:LicensesRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_5631A702-427C-4C22-AFF5-8DA3A3E32B3B_1_0"> 0 </us-gaap:LicensesRevenue> | |||||||||||||||||||||
| <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_11"> 4684000 </us-gaap:ResearchAndDevelopmentExpense> | |||||||||||||||||||||
| <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_40"> 1559000 </us-gaap:NetCashProvidedByUsedInFinancingActivities> | |||||||||||||||||||||
| <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_6B2C78B3-9937-4C34-927A-6198DCC06F51_1_0"> <div> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Changes in the initial product warranty accrual and the expenses incurred under our initial and extended warranties for the years ended December 31 were as follows (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="69%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Years Ended December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Initial warranty accrual, beginning balance</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,725</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,235</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Provision for estimated warranty cost</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,705</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,586</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,126</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Warranty expenditures</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,224</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,093</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,636</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Initial warranty accrual, ending balance</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,699</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,725</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total warranty accrual, long term</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">424</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total warranty accrual, current portion</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,699</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,301</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock> | |||||||||||||||||||||
| <us-gaap:CostOfRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_6"> 30878000 </us-gaap:CostOfRevenue> | |||||||||||||||||||||
| <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_D2C4068C-5DE1-4157-ADE8-64369C12FE1A_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Income Taxes</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Differences between accounting for income taxes for financial statement purposes and accounting for tax return purposes are stated as deferred tax assets or deferred tax liabilities in the accompanying consolidated financial statements. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities. The Company establishes a valuation allowance when it is more likely than not that the deferred tax assets will not be realized.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On January 1, 2007, the Company adopted the interpretations issued by the Financial Accounting Standards Board (“FASB”) which establishes a single model to address accounting for uncertain tax positions. The interpretations clarify the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements and also provides guidance on de-recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.</font></p> </div> </us-gaap:IncomeTaxPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_15"> 19000 </us-gaap:IncreaseDecreaseInInterestPayableNet> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_13001_16"> 966000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_1_7"> -0.006 </us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential> | |||||||||||||||||||||
| <us-gaap:OperatingExpenses contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_13"> 29009000 </us-gaap:OperatingExpenses> | |||||||||||||||||||||
| <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_9F8EE8D4-4FAB-4E28-9D14-B3B7C3AE9F2B_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Other Comprehensive (Loss) Income</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Other comprehensive (loss) income encompasses the change in equity from transactions and other events and circumstances from non-owner sources and is included as a component of stockholders’ equity (deficit) but is excluded from net (loss) income. Accumulated other comprehensive gain (loss) consists of the effects of foreign currency translation adjustments and unrealized gains or losses on marketable securities classified as available for sale.</font></p> </div> </us-gaap:ComprehensiveIncomePolicyPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_1_1"> 0.97 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate> | |||||||||||||||||||||
| <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="shares" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_29"> 31308000 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> | |||||||||||||||||||||
| <us-gaap:IncomeTaxDisclosureTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_C3357C4E-2B17-4D9E-A610-5E250B04E13A_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 6 — INCOME TAXES</b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table presents the current and deferred provision (benefit) for income taxes for the years ended December 31 (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <!-- Begin Table Head --> <tr> <td width="78%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Current:</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Federal</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(19</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">State</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">18</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">32</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(18</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Deferred:</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Federal</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">57</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">66</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">55</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">State</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(16</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(8</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">61</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">76</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">111</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">58</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The provision for income taxes differs from the amount that would result from applying the federal statutory rate as follows for the years ended December 31:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <!-- Begin Table Head --> <tr> <td width="78%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Statutory regular federal income tax rate</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(34.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(34.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(34.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Change in valuation allowance</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(13.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2.3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30.4</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tax return to prior year provision adjustments</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.7</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Expiration of federal net operating losses</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">28.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.4</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Reduction of net operating loss attributes</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3.7</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2.3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1.3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">State tax benefit (net of federal benefit)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">18.1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(6.9</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Research credits</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.6</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign amounts with no tax benefit</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.6</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Non-deductible expenses</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.8</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.8</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Stock option expenses with no tax benefit</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.8</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.6</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.9</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)% </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.9</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The components of the deferred income tax assets and liabilities as of December 31 (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <!-- Begin Table Head --> <tr> <td width="77%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalized intangible assets for tax purposes</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">405</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">576</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Reserves not currently deductible</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,082</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,450</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deferred revenue</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">328</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Stock options</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,348</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,959</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">State Taxes</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">45</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Income tax credits</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,167</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,322</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Inventory</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">868</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">906</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Property and equipment</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">240</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">357</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other comprehensive income</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">127</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">144</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Unrealized gain on foreign currency</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">160</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">99</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net operating losses</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">25,746</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26,075</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total deferred tax assets</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,516</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,929</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Valuation allowance</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(33,341</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(33,784</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Net deferred tax assets</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">175</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">145</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalized intangible assets</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(703</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(630</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">State tax</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(119</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(101</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total deferred tax liabilities</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(822</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(731</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net deferred tax liabilities</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(647</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(586</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Based upon the Company’s operating losses incurred for the three years ended December 31, 2012, and the available evidence, the Company has established a valuation allowance against its net deferred tax assets in the amount of $33.3 million as of December 31, 2012, excluding a portion of the foreign operations totaling $16,000 and $8,000 at December 31, 2012 and 2011, respectively. Management considered factors such as the Company’s earnings history, future projected earnings and tax planning strategies. If sufficient evidence of the Company’s ability to generate sufficient future taxable income tax benefits becomes apparent, the valuation allowance may be reduced, thereby resulting in tax benefits in the statement of operations and additional paid-in-capital. Management evaluates the potential realization of the Company’s deferred tax assets and assesses the need for reducing the valuation allowance periodically.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December 31, 2012, the Company had net operating loss (“NOL”) carryforwards for federal and state purposes of approximately $67.0 million and $42.8 million, respectively, which begin to expire in 2013. The utilization of NOL and credit carryforwards may be limited under the provisions of the Internal Revenue Code (“IRC”) Section 382 and similar state provisions. IRC Section 382 generally imposes an annual limitation on the amount of NOL carryforwards that may be used to offset taxable income where a corporation has undergone significant changes in stock ownership. During the year ended December 31, 2006, the Company completed an analysis to determine the potential applicability of any annual limitations imposed by IRC Section 382. Based on the analysis, management determined that there was no significant IRC Section 382 limitation. As of December 31, 2012, the Company had research and development tax credit carryforwards for federal and state purposes of approximately $786,000 and $319,000, respectively, which will begin to expire in 2018 for federal purposes and will carryforward indefinitely for state purposes. An updated analysis may be required at the time the Company begins utilizing any of its net operating losses to determine if there is an IRC Section 382 limitation.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In addition to the NOL carryforwards included in the deferred tax asset and liability schedule are excess tax deductions relating to stock options that have not been realized. When the benefit of the NOLs containing these excess tax deductions are realized, the benefit will not affect earnings, but rather additional paid-in-capital. As of December 31, 2012, the cumulative unrealized excess tax deductions amounted to approximately $6.4 million. These amounts have been excluded from the Company’s NOL carryforwards. To the extent that such excess tax deductions are realized in the future by virtue of reducing income taxes payable, the Company would expect additional paid-in-capital to increase by approximately $1.5 million. The Company follows the appropriate ordering rules to determine when such NOLs have been realized.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Recently enacted tax laws may also affect the tax provision on the Company’s financial statements. The state of California passed a new law which mandates the use of a single sales factor apportionment formula for tax years beginning on or after January 1, 2013. As a result, the state deferred tax assets will be revalued during the year ending December 31, 2013 in order to account for the change in the tax law. As of December 31, 2012, there was a 100% valuation allowance against the state deferred tax asset.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table summarizes the activity related to the Company’s unrecognized tax benefits during the year ended December 31, 2012 (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <!-- Begin Table Head --> <tr> <td width="90%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance at January 1, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,066</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Additions for tax positions related to the prior year</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">160</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Lapse of statute of limitations</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance at December 31, 2012</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,226</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Included in the payable at December 31, 2012, are $91,000 of tax positions, which if recognized, would increase the Company’s annual effective tax rate. As of December 31, 2012, the Company has recorded a liability for potential penalties and interest of $18,000 and $29,000, respectively. The Company does not expect its unrecognized tax benefits to change significantly over the next 12 months.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The federal and state NOL and credit carryforwards per the income tax returns filed in prior years included uncertain tax positions taken and are larger than the NOL and credit carryforwards recognized for financial statement purposes.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company files U.S., state and foreign income tax returns in jurisdictions with varying statutes of limitations. The 2007 through 2011 tax years generally remain subject to examination by federal and most state tax authorities. In foreign jurisdictions, the 2005 through 2011 tax years remain subject to examination by their respective tax authorities.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">U.S. income taxes or withholding taxes were provided for all the distributed earnings for the Company’s foreign subsidiaries as of December 31, 2012. There were no undistributed earnings from foreign subsidiaries as of December 31, 2012. The Company intends to reinvest any earnings until such time a decision is made to liquidate the foreign operations.</font></p> </div> </us-gaap:IncomeTaxDisclosureTextBlock> | |||||||||||||||||||||
| <us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_18"> 160000 </us-gaap:IncreaseDecreaseInInventories> | |||||||||||||||||||||
| <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_1_2"> 18000 </us-gaap:CurrentStateAndLocalTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_888902_6711DCBB-37C7-42E3-A924-5E588642E2BC_1_400000"> 789000.0 </us-gaap:OperatingLeasesRentExpenseNet> | |||||||||||||||||||||
| <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_8DB401B5-7861-471A-B03C-AE8860F50A14_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Restricted Cash</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company maintains bank accounts under deposit account control agreements with Comerica Bank, to be held for repayment of lines of credit and accrued interest expense or disbursement to its operating bank account, pursuant to the terms of two revolving credit facility agreements with Comerica Bank. At December 31, 2012, there were no restricted cash amounts.</font></p> </div> </us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_1_0"> -0.340 </us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate> | |||||||||||||||||||||
| <us-gaap:ConsolidationPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_11F5CC7E-B78F-4E90-92BE-34D823333F6F_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Basis of Presentation</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The consolidated financial statements include the accounts of BIOLASE, Inc. and its wholly-owned subsidiaries. The Company has eliminated all material intercompany transactions and balances in the accompanying consolidated financial statements. Certain amounts for prior years have been reclassified to conform to the current year presentation.</font></p> </div> </us-gaap:ConsolidationPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:DeferredRevenueByArrangementDisclosureTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_83024391-3AF6-4541-BA9E-A4593CFB3EA8_1_0"> <div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="81%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 138pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>DEFERRED REVENUE (in thousands):</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Components of deferred revenue are as follows:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Undelivered elements (training, installation, product and support services)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,723</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,105</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Extended warranty contracts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,506</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,056</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total Deferred Revenue</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,229</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,161</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Less Long-Term amounts:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Extended warranty contracts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(25</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total Deferred Revenue — Long Term</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(25</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total Deferred Revenue — Current</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,226</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,136</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:DeferredRevenueByArrangementDisclosureTextBlock> | |||||||||||||||||||||
| <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_12392F7B-6ABB-405A-A2C9-FC16D6F8C802_1_0"> <div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="82%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 144pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>ACCRUED LIABILITIES (in thousands):</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Components of accrued liabilities are as follows:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Payroll and benefits</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,326</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,928</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Warranty accrual, current portion</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,699</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sales tax</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">763</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">526</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accrued professional services</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">502</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">669</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accrued insurance premium</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">751</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">433</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accrued support services</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">200</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">226</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">203</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accrued liabilities</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,267</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,177</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_C7111786-A380-480C-9255-F005F97FA1AD_2001_2"> P3Y11M16D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_1_1"> -0.130 </us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance> | |||||||||||||||||||||
| <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_1_3"> 32000 </us-gaap:CurrentForeignTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:Depreciation contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_46904EA1-BF3D-4007-BAC7-D0B631B35705_1_0"> 377000 </us-gaap:Depreciation> | |||||||||||||||||||||
| <us-gaap:IncomeTaxesPaidNet contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_47"> 62000 </us-gaap:IncomeTaxesPaidNet> | |||||||||||||||||||||
| <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_4"> -15000 </us-gaap:GainLossOnSaleOfPropertyPlantEquipment> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_1813445F-7B13-4B49-8C60-F0A3C90E693C_1_0"> 1600000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:GrossProfit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_7"> 26478000 </us-gaap:GrossProfit> | |||||||||||||||||||||
| <us-gaap:ShippingAndHandlingCostPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_98DB3A0A-6B85-4EEA-AD0E-0449D5C3F6EA_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Shipping and Handling Costs and Revenues</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Shipping and handling costs are expensed as incurred and are recorded as a component of cost of revenue. Charges to customers for shipping and handling are included as a component of revenue.</font></p> </div> </us-gaap:ShippingAndHandlingCostPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:DebtDisclosureTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_9BC8C620-D766-47EA-AE5F-873DB674DD66_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 5 — LINES OF CREDIT AND OTHER BORROWINGS</b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Lines of Credit</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On May 24, 2012, the Company entered into two revolving credit facility agreements with Comerica Bank (the “Credit Agreements”), as amended on August 6, 2012 (“Amendment No. 1”), which provide for borrowings against certain domestic accounts receivable and inventory, as set forth in the $4.0 million revolving credit facility agreement (the “Domestic Revolver”), and borrowings against certain export related accounts receivable and inventory, as set forth in the $4.0 million revolving credit facility agreement (the “Ex-Im Revolver”), for a combined aggregate commitment of borrowings up to $8.0 million. The lines of credit mature on May 1, 2014, at which date any remaining borrowings and accrued interest under the lines of credit become due and payable. As of December 31, 2012, the Company had outstanding borrowings totaling approximately $1.6 million, which included $0 under the Domestic Revolver and $1.6 million under the Ex-Im Revolver.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Lockbox arrangements under the revolving bank facilities provide that substantially all of the income generated is deposited directly into lockbox accounts and then swept into cash management accounts for the benefit of Comerica Bank. Cash is disbursed from Comerica Bank to the Company only after payment of the applicable debt service and principal. At December 31, 2012, there were no restricted cash amounts. The Company’s obligations are generally secured by substantially all of the Company’s assets now owned or hereinafter acquired.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Credit Agreements require the Company to maintain compliance with certain financial and non-financial covenants, as defined therein. If a default occurs, Comerica Bank may declare the amounts outstanding under the Credit Agreements immediately due and payable. As of December 31, 2012, the Company was in compliance with these covenants.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The interest rates on the outstanding principal balance of the credit facilities bear interest at annual percentage rates equal to the daily adjusting LIBOR rate, plus spreads of 5.25% for the Domestic Revolver and 4.25% for the Ex-Im Revolver. The daily adjusting LIBOR rate is subject to a floor of 1.00% per annum. The Company is also required to pay an unused commitment fee of 0.25% based on a portion of the undrawn lines of credit, payable quarterly in arrears. During the year ended December 31, 2012, the Company incurred $232,000 of interest expense associated with the credit facilities, of which approximately $19,000 was payable at December 31, 2012. Included in interest expense during the year ended December 31, 2012 is $91,000 of amortization of deferred debt issuance costs and $43,000 of amortization of the discount on lines of credit.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Pursuant to the Credit Agreements, the Company paid both the first and second annual $120,000 commitment fees, each being one and one-half percent of the aggregate $8.0 million commitment, totaling $240,000. The commitment fees and the legal costs associated with acquiring the credit facilities were capitalized and are being amortized on a straight-line basis as interest expense over the term of the Credit Agreements.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">As additional consideration for the lines of credit, the Company also issued warrants to Comerica Bank (the “Comerica Warrants”) to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $2.83 per share. The Comerica Warrants vest in four equal quarterly tranches beginning on May 24, 2012 and are exercisable once vested. The Comerica Warrants may be exercised with a cash payment from Comerica Bank, or, in lieu of a cash payment, Comerica Bank may convert the warrants into a number of shares, in whole or in part. In February 2013, Comerica Bank exercised 60,000 of the 80,000 warrants pursuant to the Notice of Exercise resulting in a net issuance of 30,515 shares of common stock. These remaining warrants to purchase 20,000 shares of common stock have an expiration date of May 24, 2017. The fair value of the Comerica Warrants was estimated using the Black-Scholes option-pricing model with the following assumptions: expected term of 5.00 years; volatility of 99.55%; annual dividend per share of $0.00; and risk-free interest rate of 0.77%; and resulted in an estimated fair value of $135,000 which was recorded as equity and resulted in a discount to the credit facilities at issuance. The discount is being amortized on a straight-line basis to interest expense over the term of the Credit Agreements.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In connection with Amendment No. 1, the Company reduced the exercise price of the Comerica Warrants from $2.83 to $2.00 per share. The fair value of the re-priced Comerica Warrants was estimated using the Black-Scholes option-pricing model with the following assumptions: expected term of 4.80 years; volatility of 100.37%; annual dividend per share of $0.00; and risk-free interest rate of 0.65%. The modification to the Comerica Warrants resulted in an incremental expense of $7,000 which was added to the discount and is being amortized on a straight-line basis over the remaining term of the Credit Agreements.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Loan and Security Agreement</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In May 2010, the Company entered into the Loan and Security Agreement with MidCap Financial, LLC (subsequently assigned to MidCap Funding III, LLC) and Silicon Valley Bank. In connection with the Loan and Security Agreement, the Company issued two secured promissory notes in an aggregate principal amount of $3 million, at 14.25%, secured by the Company’s assets, and warrants to purchase up to an aggregate of 101,694 shares of Common Stock at an exercise price of $1.77 per share, which was subsequently reduced to $0.84 per share, with an expiration date of May 26, 2015.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">During February 2011, the Company repaid approximately $2.6 million in principal and MidCap Funding III, LLC and Silicon Valley Bank performed a cashless exercise of all of their warrants, which resulted in the combined issuance of 78,172 shares of unregistered stock.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">During the years ended December 31, 2011 and 2010, the Company incurred $293,000 and $345,000, respectively, of interest expense, including amortization of debt issuance costs and discounts, associated with the Loan and Security Agreement.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Other Borrowings</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company finances a portion of its annual insurance premiums which it pays in installments over nine months. As of December 31, 2012 and 2011, $379,000 at an annual interest rate of 3.0% and $433,000 at an annual interest rate of 2.5%, respectively, were outstanding under this arrangement. The Company incurred interest expense associated with the financed insurance premiums of approximately $5,000 during each of the years ended December 31, 2012, 2011, and 2010.</font></p> </div> </us-gaap:DebtDisclosureTextBlock> | |||||||||||||||||||||
| <us-gaap:OperatingLossCarryforwardsExpirationDates contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_E0472D81-9381-41D6-8B9F-C1F85FCC62EC_1_2"> 2013 </us-gaap:OperatingLossCarryforwardsExpirationDates> | |||||||||||||||||||||
| <us-gaap:InterestPaid contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_46"> 88000 </us-gaap:InterestPaid> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_A9B053A4-CA9E-49B7-8E1B-637623B69551_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Stock-Based Compensation</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">During the years ended December 31, 2012, 2011, and 2010, the Company recognized compensation cost related to stock options of $1.6 million, $1.5 million, and $727,000, respectively, based on the grant date fair value. The net impact to earnings for the years ended December 31, 2012, 2011, and 2010, was $(0.05), $(0.05) and $(0.03) per diluted share, respectively. The following table summarizes the income statement classification of compensation expense associated with share-based payments (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="75%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Years Ended December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cost of revenue</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">245</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">175</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sales and marketing</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">514</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">463</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">193</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">General and administrative</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">668</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">751</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">407</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Engineering and development</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">173</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">139</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">86</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,600</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,528</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">727</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December 31, 2012 and 2011, the Company had $1.9 million and $2.6 million, respectively, of total unrecognized compensation cost, net of estimated forfeitures, related to unvested share-based compensation arrangements granted under our existing plans. The cost is expected to be recognized over a weighted average period of 1.2 years.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Black-Scholes option valuation model is used in estimating the fair value of traded options. This option pricing model requires the Company to make several assumptions regarding the key variables used to calculate the fair value of its stock options. The risk-free interest rate used is based on the U.S. Treasury yield curve in effect for the expected lives of the options at their dates of grant. Since July 1, 2005, the Company has used a dividend yield of zero as it does not intend to pay cash dividends on its common stock in the foreseeable future. The most critical assumption used in calculating the fair value of stock options is the expected volatility of the Company’s common stock. Management believes that the historic volatility of the Company’s common stock is a reliable indicator of future volatility, and accordingly, a stock volatility factor based on the historical volatility of the Company’s common stock over a period of time is used in approximating the estimated volatility of new stock options. The expected term is estimated by analyzing the Company’s historical share option exercise experience over a five year period. Compensation expense is recognized using the straight-line method for all stock-based awards. Compensation expense is recognized only for those options expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations. Forfeitures are estimated at the time of the grant and revised as necessary in subsequent periods if actual forfeitures differ from those estimates.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The stock option fair values were estimated using the Black-Scholes option-pricing model with the following assumptions:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="75%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Expected term (years)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.70</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.54</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Volatility</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">97</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">105</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">91</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Annual dividend per share</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Risk-free interest rate</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.77</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.94</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> </table> </div> </us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy> | |||||||||||||||||||||
| <us-gaap:ConcentrationRiskCustomer contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_44101FD8-6AA5-4745-9590-83D3E9A50500_1_0"> Less than 10% </us-gaap:ConcentrationRiskCustomer> | |||||||||||||||||||||
| <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_10C64B61-3DDC-45A9-A014-32134E02B4F2_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 7 — COMMITMENTS AND CONTINGENCIES</b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Leases</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In January 2006, the Company entered into a five-year lease for its 57,000 square foot corporate headquarters and manufacturing facility located at 4 Cromwell, Irvine, California, with initial monthly installments of $38,692 and annual adjustments over the lease term. On September 24, 2009, the lease was amended to extend the term through April 20, 2015, adjust the basic rent, and modify provisions to the security deposit. On January 4, 2011, the lease was further amended to defer a portion of the basic rent to future periods. The Company is recognizing rent expense on a straight line basis with the difference between rent expense and the cash paid recorded to deferred rent. These amounts are reflected in the commitments as of December 31, 2011, listed below. The Company also leases certain office equipment and automobiles under various operating lease arrangements.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Future minimum rental commitments under operating lease agreements with non-cancelable terms greater than one year for each of the years ending December 31 are as follows (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"></p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <!-- Begin Table Head --> <tr> <td width="90%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">2013</font></p> </td> <td valign="bottom"></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">683</font></td> <td valign="bottom" nowrap="nowrap"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">2014</font></p> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">618</font></td> <td valign="bottom" nowrap="nowrap"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015</font></p> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">192</font></td> <td valign="bottom" nowrap="nowrap"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Thereafter</font></p> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"></p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"></p> </td> <td></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total future minimum lease obligations</font></p> </td> <td valign="bottom"></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,493</font></td> <td valign="bottom" nowrap="nowrap"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"></p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"></p> </td> <td></td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Rent expense totaled approximately $789,000, $1.0 million, and $849,000 for the years ended December 31, 2012, 2011, and 2010, respectively.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Employee arrangements and other compensation</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Certain members of management are entitled to severance benefits payable upon termination following a change in control, which would approximate $714,000 at December 31, 2012. The Company also has agreements with certain employees to pay bonuses based on targeted performance criteria. No amount was required to be accrued at December 31, 2012.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Purchase Commitments</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company generally purchases components and subassemblies for its products from a limited group of third party suppliers through purchase orders. The Company had $9.7 million of purchase commitments as of December 31, 2012, for which the Company has not received the goods or services and which is expected to be purchased within one year. These purchase commitments were made to secure better pricing and to ensure the Company will have the necessary parts to meet anticipated near term demand. Although open purchase orders are considered enforceable and legally binding, the Company may be able to cancel, reschedule, or adjust requirements prior to supplier fulfillment.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Litigation</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company discloses material loss contingencies deemed to be reasonably possible and accrues for loss contingencies when, in consultation with its legal advisors, management concludes that a loss is probable and reasonably estimable. The ability to predict the ultimate outcome of such matters involves judgments, estimates, and inherent uncertainties. The actual outcome of such matters could differ materially from management’s estimates.</font></p> <p style="MARGIN-TOP: 18px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Intellectual Property Litigation</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On April 24, 2012, CAO Group, Inc. (“CAO”) filed a lawsuit against the Company in the United States District Court for the District of Utah, Central Division, alleging patent infringement of U.S. Patent No. 7,485,116 involving the Company’s ezLase diode laser. On September 12, 2012, CAO filed a First Amended Complaint, which added claims for (1) business disparagement/injurious falsehood and (2) unfair competition. The new claims are based on a press release that the Company issued on or about April 30, 2012, which CAO alleges contain statements that are factually inaccurate and falsities that are disparaging to CAO and its diode product. The First Amended Complaint seeks unspecified damages, punitive damages, injunctive relief, treble damages, costs, interest, and attorneys’ fees. On September 14, 2012, the Company filed an inter partes reexamination request with respect to the asserted patent with the United States Patent and Trademark Office. The Court then entered a stay of the lawsuit pending the request for reexamination, which reexamination request was subsequently granted. Management plans to vigorously defend against the allegations.</font></p> <p style="MARGIN-TOP: 18px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Other Matters</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In the normal course of business, the Company may be subject to other legal proceedings, lawsuits and other claims. Although the ultimate aggregate amount of probable monetary liability or financial impact with respect to these matters is subject to many uncertainties and is therefore not predictable with assurance, the Company’s management believes that any monetary liability or financial impact to the Company from these other matters, individually and in the aggregate, would not be material to the Company’s financial condition, results of operations or cash flows. However, there can be no assurance with respect to such result, and monetary liability or financial impact to the Company from these other matters could differ materially from those projected.</font></p> <!-- xbrl,n --></div> </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock> | |||||||||||||||||||||
| <us-gaap:SegmentReportingDisclosureTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_A9F993D4-4A4B-425D-A875-78860850BA7B_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 9 — SEGMENT INFORMATION</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company currently operates in a single business segment. Management uses one measurement of profitability and does not segregate its business for internal reporting. For the year ended December 31, 2012, sales in the United States accounted for approximately 71% of net revenue and international sales accounted for approximately 29% of net revenue. For the years ended December 31, 2011 and 2010, sales in the United States accounted for approximately 67% and 64% of net revenue and international sales accounted for approximately 33% and 36% of net revenue, respectively.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Net revenue by geographic location based on the location of customers was as follows (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="70%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Years Ended December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">United States</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,524</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">32,782</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,900</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">International</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,832</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,076</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,325</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">57,356</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">48,858</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26,225</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">No individual international country represented more than 10% of net revenue during the years ended December 31, 2012, 2011, and 2010.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Long-lived assets located outside of the United States at our foreign subsidiaries, totaled approximately $412,000 and $542,000 as of December 31, 2012 and 2011, respectively.</font></p> </div> </us-gaap:SegmentReportingDisclosureTextBlock> | |||||||||||||||||||||
| <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_1_2"> 0.162 </us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes> | |||||||||||||||||||||
| <us-gaap:ClassOfWarrantOrRightExpenseOrRevenueRecognized contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_C34BC229-9A2F-4C6E-8FAB-6B3A2F3172C8_2_2"> 23000 </us-gaap:ClassOfWarrantOrRightExpenseOrRevenueRecognized> | |||||||||||||||||||||
| <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_27"> 14000 </us-gaap:PaymentsToAcquireIntangibleAssets> | |||||||||||||||||||||
| <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_14"> 61000 </us-gaap:DeferredIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:AmortizationOfDebtDiscountPremium contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_2052E80D-0040-49B4-8977-4A5321E0705A_1_9"> 43000 </us-gaap:AmortizationOfDebtDiscountPremium> | |||||||||||||||||||||
| <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_B1B3EDE9-2A6E-4ADC-903B-159DF5974014_5001_2"> 160000 </us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions> | |||||||||||||||||||||
| <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_888902_7CD2608E-9850-4846-9ECE-9AAEFD5BF1C8_1_0"> 4713000 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> | |||||||||||||||||||||
| <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_1_8"> -8000 </us-gaap:DeferredForeignIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:PolicyholdersDividendPolicy contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_752929DF-2B54-4E4A-80B6-13A8EE6A3B38_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Stock Dividends</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Board declared special one-half percent stock dividends during each of the quarters of 2012. The stock dividend declared during the quarter ended December 31, 2012 was payable December 28, 2012 to shareholders of record on December 14, 2012, the stock dividend declared during the quarter ended September 30, 2012 was payable September 28, 2012 to shareholders of record on September 14, 2012, the stock dividend declared during the quarter ended June 30, 2012 was payable June 25, 2012 to shareholders of record on June 8, 2012, and the stock dividend declared during the quarter ended March 31, 2012 was payable March 30, 2012 to shareholders of record on March 15, 2012. The Board deems these four stock dividends to be special dividends and there is no assurance, with respect to amount or frequency, that any stock dividend will be declared again in the future. All stock information presented, other than that related to stock options and warrants, has been adjusted to reflect the effects of these stock dividends. The number of shares issued as part of these quarterly stock dividends totaled 634,162 shares. During the year ended December 31, 2011, the Company declared and paid 1% stock dividends in each of the four quarters resulting in the issuance of 1,165,715 shares. The Board of Directors deems these four dividends to be special dividends and there is no assurance, with respect to amount or frequency, that any stock dividend will be declared again in the future. All stock information presented, other than that related to stock options and warrants, has been adjusted to reflect the effects of the stock dividends.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In February 2013, the Board of Directors announced a 2% annual stock dividend policy for 2013 and declared a one-half percent stock dividend (the “March Stock Dividend”) payable March 29, 2013 to stockholders of record on March 15, 2013. The Company expects to record the effects of the March Stock Dividend in the first quarter ending March 31, 2013.</font></p> </div> </us-gaap:PolicyholdersDividendPolicy> | |||||||||||||||||||||
| <us-gaap:NetIncomeLoss contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9007_1000042"> -3056000 </us-gaap:NetIncomeLoss> | |||||||||||||||||||||
| <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_18"> -414000 </us-gaap:NonoperatingIncomeExpense> | |||||||||||||||||||||
| <us-gaap:CommonStockDividendsShares contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_1_1"> 634162 </us-gaap:CommonStockDividendsShares> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9007_1000035"> 250000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition> | |||||||||||||||||||||
| <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_15"> -175000 </us-gaap:ForeignCurrencyTransactionGainLossBeforeTax> | |||||||||||||||||||||
| <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_98C38D1B-916C-4365-A9D9-82F72051CAF9_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Advertising Costs</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Advertising costs are expensed as incurred and totaled approximately $907,000, $444,000, and $610,000 for the years ended December 31, 2012, 2011, and 2010, respectively.</font></p> </div> </us-gaap:AdvertisingCostsPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_B6226642-2029-4C80-933B-A5E1C7851B3B_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Long-Lived Assets</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The carrying values of long-lived assets, including intangible assets subject to amortization, are reviewed when indicators of impairment, such as reductions in demand or significant economic slowdowns, are present. Reviews are performed to determine whether carrying value of an asset is impaired based on comparisons to undiscounted expected future cash flows. If this comparison indicates that there is impairment, the impaired asset is written down to fair value, which is typically calculated using discounted expected future cash flows. Impairment is based on the excess of the carrying amount over the fair value of those assets.</font></p> </div> </us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_EC7C33AB-A4F6-45FF-BFFE-E8F234789DB4_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Foreign Currency Translation and Transactions</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Transactions of the Company’s German, Spanish, Australian, and Indian subsidiaries are denominated in their local currencies. The results of operations and cash flows are translated at average exchange rates during the period, and assets and liabilities are translated at end-of-period exchange rates. Translation gains or losses are shown as a component of accumulated other comprehensive gain (loss) in stockholders’ equity (deficit). Gains and losses resulting from foreign currency transactions, which are denominated in a currency other than the entity’s functional currency, are included in the consolidated statements of operations.</font></p> </div> </us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_741BEFD0-7290-4AFF-A101-740C3021651D_1_0"> <div> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table summarizes the income statement classification of compensation expense associated with share-based payments (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="75%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Years Ended December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cost of revenue</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">245</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">175</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sales and marketing</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">514</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">463</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">193</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">General and administrative</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">668</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">751</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">407</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Engineering and development</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">173</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">139</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">86</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,600</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,528</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">727</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock> | |||||||||||||||||||||
| <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_1_10"> 111000 </us-gaap:IncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_41"> 39000 </us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents> | |||||||||||||||||||||
| <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_E74CABE8-0103-4E59-97C1-82A7294EE3A2_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Cash and Cash Equivalents</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company considers all highly liquid investments with maturities of three months or less when purchased, as cash equivalents. Generally, any excess cash is invested in money market funds. Cash equivalents are carried at cost, which approximates fair market value.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Restricted Cash</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company maintains bank accounts under deposit account control agreements with Comerica Bank, to be held for repayment of lines of credit and accrued interest expense or disbursement to its operating bank account, pursuant to the terms of two revolving credit facility agreements with Comerica Bank. At December 31, 2012, there were no restricted cash amounts.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Accounts Receivable</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in its existing accounts receivable. The Company evaluates its allowance for doubtful accounts based upon its knowledge of customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis which incorporates input from sales, service, and finance personnel. The review process evaluates all account balances with amounts outstanding more than 90 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. The allowance for doubtful accounts is adjusted based on such evaluation, with a corresponding provision included in general and administrative expenses. Account balances are charged off against the allowance when it is probable the receivable will not be recovered. The Company does not have any off-balance-sheet credit exposure related to its customers.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Inventory</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company values inventory at the lower of cost, determined using the first-in, first-out method, or market. The carrying value of inventory is evaluated periodically for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The allowance is adjusted based on such evaluation, with a corresponding provision included in cost of revenue. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and our allocation of fixed production overhead is based on the normal capacity of our production facilities.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Property, Plant and Equipment</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Property, plant and equipment is stated at acquisition cost less accumulated depreciation. Maintenance and repairs are expensed as incurred. Upon sale or disposition of assets, any gain or loss is included in the consolidated statements of operations.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The cost of property, plant and equipment is depreciated using the straight-line method over the following estimated useful lives of the respective assets, except for leasehold improvements, which are depreciated over the lesser of the estimated useful lives of the respective assets or the related lease terms.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="86%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Building</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Leasehold improvements</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3 to 5 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Equipment and computers</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3 to 5 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Furniture and fixtures</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Depreciation expense for the years ended December 31, 2012, 2011, and 2010 totaled approximately $377,000, $565,000, and $940,000, respectively.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Goodwill and Other Intangible Assets</i></b></font></p> <p style="PADDING-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Goodwill and other intangible assets with indefinite lives are not subject to amortization but are evaluated for impairment annually or whenever events or changes in circumstances indicate that the asset might be impaired. The Company operates in one operating segment and has one operating unit; therefore goodwill is tested for impairment at the consolidated level against the fair value of the Company. The fair value of a reporting unit refers to the amount at which the unit as a whole could be bought or sold in a current transaction between willing parties. Quoted market prices in active markets are the best evidence of fair value and are used as the basis for measurement, if available. Management assesses potential impairment on an annual basis on June 30</font><font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">th</sup></font> <font style="FONT-FAMILY: Times New Roman" size="2">and compares the Company’s market capitalization to its carrying amount, including goodwill. A significant decrease in the Company’s stock price could indicate a material impairment of goodwill which, after further analysis, could result in a material charge to operations. If goodwill is considered impaired, the impairment loss to be recognized is measured by the amount by which the carrying amount of the goodwill exceeds the implied fair value of that goodwill. Inherent in the Company’s fair value determinations are certain judgments and estimates, including projections of future cash flows, the discount rate reflecting the inherent risk in future cash flows, the interpretation of current economic indicators and market valuations, and strategic plans with regards to operations. A change in these underlying assumptions could cause a change in the results of the tests, which could cause the fair value of the reporting unit to be less than its respective carrying amount.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Costs incurred to acquire and successfully defend patents, and costs incurred to acquire trademarks and trade names are capitalized. Costs related to the internal development of technologies that are ultimately patented are expensed as incurred. Intangible assets, except those determined to have an indefinite life, are amortized using the straight-line method over management’s best estimate of the pattern of economic benefit over the estimated useful life of the assets. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Long-Lived Assets</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The carrying values of long-lived assets, including intangible assets subject to amortization, are reviewed when indicators of impairment, such as reductions in demand or significant economic slowdowns, are present. Reviews are performed to determine whether carrying value of an asset is impaired based on comparisons to undiscounted expected future cash flows. If this comparison indicates that there is impairment, the impaired asset is written down to fair value, which is typically calculated using discounted expected future cash flows. Impairment is based on the excess of the carrying amount over the fair value of those assets.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Other Comprehensive (Loss) Income</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Other comprehensive (loss) income encompasses the change in equity from transactions and other events and circumstances from non-owner sources and is included as a component of stockholders’ equity (deficit) but is excluded from net (loss) income. Accumulated other comprehensive gain (loss) consists of the effects of foreign currency translation adjustments and unrealized gains or losses on marketable securities classified as available for sale.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Foreign Currency Translation and Transactions</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Transactions of the Company’s German, Spanish, Australian, and Indian subsidiaries are denominated in their local currencies. The results of operations and cash flows are translated at average exchange rates during the period, and assets and liabilities are translated at end-of-period exchange rates. Translation gains or losses are shown as a component of accumulated other comprehensive gain (loss) in stockholders’ equity (deficit). Gains and losses resulting from foreign currency transactions, which are denominated in a currency other than the entity’s functional currency, are included in the consolidated statements of operations.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Revenue Recognition</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company’s products were sold exclusively through HSIC in North America from September 2006 through August 2010. Effective August 30, 2010, the Company’s products were sold domestically both directly to customers through its direct sales force and through non-exclusive distributors. Sales are recorded upon shipment and payment is generally due within 90 days or less. Internationally, the Company sells products through independent distributors, including HSIC. Revenue is recorded based on four basic criteria that must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred and title and the risks and rewards of ownership have been transferred to the customer or services have been rendered; (3) the price is fixed or determinable; and (4) collectability is reasonably assured. Revenue is recorded for all sales upon shipment assuming all other revenue recognition criteria are met.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Sales of the Company’s laser systems include separate deliverables consisting of the product, disposables used with the laser systems, installation, and training. For these sales, effective January 1, 2011, the Company applies the relative selling price method, which requires that arrangement consideration be allocated at the inception of an arrangement to all deliverables using the relative selling price method. This requires the Company to use (estimated) selling prices of each of the deliverables in the total arrangement. The sum of those prices is then compared to the arrangement, and any difference is applied to the separate deliverable ratably. This method also establishes a selling price hierarchy for determining the selling price of a deliverable, which includes: (1) vendor-specific objective evidence (“VSOE”) if available, (2) third-party evidence if vendor-specific objective evidence is not available, and (3) estimated selling price if neither vendor-specific nor third-party evidence is available. VSOE is determined based on the value the Company sells the undelivered element to a customer as a stand-alone product. Revenue attributable to the undelivered elements is included in deferred revenue when the product is shipped and is recognized when the related service is performed. Disposables not shipped at time of sale and installation services are typically shipped or installed within 30 days. Training is included in deferred revenue when the product is shipped and is recognized when the related service is performed or upon expiration of time offered under the agreement, typically within six months from date of sale. The adoption of the relative selling price method does not significantly change the value of revenue recognized. Deferred revenue attributable to undelivered elements, which primarily consists of training, totaled $1.7 million and $1.1 million as of December 31, 2012 and 2011, respectively.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Key judgments of the Company’s revenue recognition include the collectability of payment from the customer, the satisfaction of all elements of the arrangement having been delivered, and that no additional customer credits and discounts are needed. The Company evaluates the customer’s credit worthiness prior to the shipment of the product. Based on the assessment of the credit information available, the Company may determine the credit risk is higher than normally acceptable, and will either decline the purchase or defer the revenue until payment is reasonably assured. Future obligations required at the time of sale may also cause the Company to defer the revenue until the obligation is satisfied.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Although all sales are final, the Company accepts returns of products in certain, limited circumstances and records a provision for sales returns based on historical experience concurrent with the recognition of revenue. The sales returns allowance is recorded as a reduction of accounts receivable and revenue. As of December 31, 2012 and 2011, $110,000 and $110,000, respectively, was recorded as a reduction of accounts receivable for sales returns.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Extended warranty contracts, which are sold to non-distributor customers, are recorded as revenue on a straight-line basis over the period of the contracts, which is typically one year. Included in deferred revenue for each of the years ended December 31, 2012 and 2011, was $1.5 million and $1.1 million, respectively, for extended warranty contracts. This is inclusive of an extended service contract commitment assumed as part of a settlement, of which $3,000 will not be recognized as revenue until 2014 and beyond.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">For sales transactions involving used laser trade-ins, the Company records the purchased trade-ins as inventory at the fair value of the asset surrendered with the offset to accounts receivable. In determining the estimated fair value of used laser trade-ins, Management makes an assessment of usable parts, key components, and consider the ultimate resale value of the certified pre-owned (or “CPO”) laser with applicable margins. The Company sells these CPO laser trade-ins as refurbished lasers following its laser system revenue recognition policy. Trade-in rights are not established nor negotiated with customers during the initial sales transaction of the original lasers. Trade-in rights are promotional events used at Management’s discretion to encourage existing laser customers to purchase new lasers by offering perceived discounts in exchange for customers trading in original lasers. A customer is not required to trade-in a laser nor is the Company required to accept a trade-in, however, the promotional value offered in exchange for the trade-in laser is not offered without a laser trade-in. The transaction is treated as a monetary transaction as each sale transaction involving a customer trade-in includes significant boot of greater than 25% of the fair value of the exchange. As a monetary transaction, the sale is recognized following the Company’s laser system revenue recognition policy. There have been no sales transactions in which the cash consideration was less than 25% of the total transaction value.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company recognizes revenue for royalties under licensing agreements for our patented technology when the product using our technology is sold. The Company estimates and recognizes the amount earned based on historical performance and current knowledge about the business operations of our licensees. Historically, the Company’s estimates have generally been consistent with amounts reported by the licensees. Licensing revenue related to exclusive licensing arrangements is recognized concurrent with the related exclusivity period and totaled $0, $64,000, and $145,000 for the years ended December 31, 2012, 2011, and 2010, respectively.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">From time to time, the Company may offer sales incentives and promotions on its products. The cost of sales incentives are recorded at the date at which the related revenue is recognized as a reduction in revenue, increase in cost of goods sold or as a selling expense, as applicable, or later, in the case of incentives offered after the initial sale has occurred.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Provision for Warranty Expense</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company provides warranties against defects in materials and workmanship of its laser systems for specified periods of time. Waterlase systems sold domestically are covered by the Company’s warranty for a period of one year while the Company’s Diode systems warranty period is for two years from date of sale by the Company or the distributor to the end-user. Waterlase systems sold internationally are generally covered by the Company’s warranty for a period of sixteen months while its Diode systems warranty period is up to twenty eight months from date of sale to the international distributor. Estimated warranty expenses are recorded as an accrued liability with a corresponding provision to cost of revenue. This estimate is recognized concurrent with the recognition of revenue on the sale to the distributor or end-user. Warranty expenses expected to be incurred after one year from the time of sale to the distributor are classified as a long term warranty accrual. The Company’s overall accrual is based on its historical experience and Management’s expectation of future conditions, taking into consideration the location and type of customer and the type of laser, which directly correlate to the materials and components under warranty, the duration of the warranty period, and the logistical costs to service the warranty. Additional factors that may impact the Company’s warranty accrual include changes in the quality of materials, leadership and training of the production and services departments, knowledge of the lasers and workmanship, training of customers, and adherence to the warranty policies. Additionally, an increase in warranty claims or in the costs associated with servicing those claims would likely result in an increase in the accrual and a decrease in gross profit. The Company does not offer warranties on imaging products which are covered by the manufacturer’s warranties.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Changes in the initial product warranty accrual and the expenses incurred under our initial and extended warranties for the years ended December 31 were as follows (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="69%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Years Ended December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Initial warranty accrual, beginning balance</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,725</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,235</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Provision for estimated warranty cost</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,705</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,586</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,126</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Warranty expenditures</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,224</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,093</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,636</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Initial warranty accrual, ending balance</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,699</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,725</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total warranty accrual, long term</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">424</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total warranty accrual, current portion</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,699</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,218</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,301</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Shipping and Handling Costs and Revenues</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Shipping and handling costs are expensed as incurred and are recorded as a component of cost of revenue. Charges to customers for shipping and handling are included as a component of revenue.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Advertising Costs</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Advertising costs are expensed as incurred and totaled approximately $907,000, $444,000, and $610,000 for the years ended December 31, 2012, 2011, and 2010, respectively.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Engineering and Development</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Engineering and development expenses are generally expensed as incurred and consist of engineering personnel salaries and benefits, prototype supplies, contract services and consulting fees related to product development.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Income Taxes</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Differences between accounting for income taxes for financial statement purposes and accounting for tax return purposes are stated as deferred tax assets or deferred tax liabilities in the accompanying consolidated financial statements. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities. The Company establishes a valuation allowance when it is more likely than not that the deferred tax assets will not be realized.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On January 1, 2007, the Company adopted the interpretations issued by the Financial Accounting Standards Board (“FASB”) which establishes a single model to address accounting for uncertain tax positions. The interpretations clarify the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements and also provides guidance on de-recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Stock-Based Compensation</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">During the years ended December 31, 2012, 2011, and 2010, the Company recognized compensation cost related to stock options of $1.6 million, $1.5 million, and $727,000, respectively, based on the grant date fair value. The net impact to earnings for the years ended December 31, 2012, 2011, and 2010, was $(0.05), $(0.05) and $(0.03) per diluted share, respectively. The following table summarizes the income statement classification of compensation expense associated with share-based payments (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="75%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Years Ended December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cost of revenue</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">245</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">175</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sales and marketing</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">514</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">463</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">193</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">General and administrative</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">668</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">751</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">407</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Engineering and development</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">173</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">139</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">86</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,600</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,528</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">727</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December 31, 2012 and 2011, the Company had $1.9 million and $2.6 million, respectively, of total unrecognized compensation cost, net of estimated forfeitures, related to unvested share-based compensation arrangements granted under our existing plans. The cost is expected to be recognized over a weighted average period of 1.2 years.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Black-Scholes option valuation model is used in estimating the fair value of traded options. This option pricing model requires the Company to make several assumptions regarding the key variables used to calculate the fair value of its stock options. The risk-free interest rate used is based on the U.S. Treasury yield curve in effect for the expected lives of the options at their dates of grant. Since July 1, 2005, the Company has used a dividend yield of zero as it does not intend to pay cash dividends on its common stock in the foreseeable future. The most critical assumption used in calculating the fair value of stock options is the expected volatility of the Company’s common stock. Management believes that the historic volatility of the Company’s common stock is a reliable indicator of future volatility, and accordingly, a stock volatility factor based on the historical volatility of the Company’s common stock over a period of time is used in approximating the estimated volatility of new stock options. The expected term is estimated by analyzing the Company’s historical share option exercise experience over a five year period. Compensation expense is recognized using the straight-line method for all stock-based awards. Compensation expense is recognized only for those options expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations. Forfeitures are estimated at the time of the grant and revised as necessary in subsequent periods if actual forfeitures differ from those estimates.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The stock option fair values were estimated using the Black-Scholes option-pricing model with the following assumptions:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="75%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Expected term (years)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.70</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.54</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Volatility</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">97</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">105</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">91</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Annual dividend per share</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Risk-free interest rate</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.77</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.94</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">% </font></td> </tr> </table> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Net Loss Per Share — Basic and Diluted</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Basic net income (loss) per share is computed by dividing income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period. In computing diluted net income (loss) per share, the weighted average number of shares outstanding is adjusted to reflect the effect of potentially dilutive securities. Common shares outstanding, as included in the calculation of basic and diluted loss per share, includes retroactive adjustments to reflect increases resulting from stock dividends that have been paid through the date that these financial statements are issued.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Outstanding stock options and warrants to purchase approximately 4,713,000, 4,626,000, and 4,282,000 shares were not included in the calculation of diluted loss per share amounts for the years ended December 31, 2012, 2011, and 2010, respectively, as their effect would have been anti-dilutive.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Stock Dividends</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Board declared special one-half percent stock dividends during each of the quarters of 2012. The stock dividend declared during the quarter ended December 31, 2012 was payable December 28, 2012 to shareholders of record on December 14, 2012, the stock dividend declared during the quarter ended September 30, 2012 was payable September 28, 2012 to shareholders of record on September 14, 2012, the stock dividend declared during the quarter ended June 30, 2012 was payable June 25, 2012 to shareholders of record on June 8, 2012, and the stock dividend declared during the quarter ended March 31, 2012 was payable March 30, 2012 to shareholders of record on March 15, 2012. The Board deems these four stock dividends to be special dividends and there is no assurance, with respect to amount or frequency, that any stock dividend will be declared again in the future. All stock information presented, other than that related to stock options and warrants, has been adjusted to reflect the effects of these stock dividends. The number of shares issued as part of these quarterly stock dividends totaled 634,162 shares. During the year ended December 31, 2011, the Company declared and paid 1% stock dividends in each of the four quarters resulting in the issuance of 1,165,715 shares. The Board of Directors deems these four dividends to be special dividends and there is no assurance, with respect to amount or frequency, that any stock dividend will be declared again in the future. All stock information presented, other than that related to stock options and warrants, has been adjusted to reflect the effects of the stock dividends.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In February 2013, the Board of Directors announced a 2% annual stock dividend policy for 2013 and declared a one-half percent stock dividend (the “March Stock Dividend”) payable March 29, 2013 to stockholders of record on March 15, 2013. The Company expects to record the effects of the March Stock Dividend in the first quarter ending March 31, 2013.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Stock Repurchase Program</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On August 10, 2011, the Company announced that its Board of Directors authorized a stock repurchase program, pursuant to which the Company may repurchase up to an aggregate of 2,000,000 shares of the Company’s outstanding common stock. The stock repurchase program became effective on August 12, 2011. The Company expects to fund the stock repurchase program with existing cash and cash equivalents on hand. Any shares repurchased will be retired and shall resume the status of authorized and unissued shares. Repurchases of the Company’s common stock may be made from time to time through a variety of methods, including open market purchases, privately negotiated transactions or block transactions. The Company has no obligation to repurchase shares under the stock repurchase program, and the timing, actual number and value of the shares that are repurchased will be at the discretion of the Company’s management and will depend upon a number of considerations, including the trading price of the Company’s common stock, general market conditions, applicable legal requirements and other factors. The stock repurchase program will expire on August 12, 2013, unless the program is completed sooner, suspended, terminated, or otherwise extended. Pursuant to the stock repurchase program, the Company repurchased 133,365 shares and 100,500 shares of our common stock at a weighted average price of $1.73 and $2.68 during the years ended December 31, 2012 and 2011, respectively.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Recent Accounting Pronouncements</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Changes to U.S. GAAP are established by the FASB in the form of accounting standards updates (“ASU’s”) to the FASB’s Accounting Standards Codification (“ASC”).</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company considers the applicability and impact of all ASU’s. ASU’s not listed below were assessed and determined to not be applicable or are expected to have minimal impact on our consolidated financial position and results of operations.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Newly Adopted Accounting Standards</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In September 2011, the FASB issued guidance for the impairment testing of goodwill. The guidance permits an entity to first assess qualitative factors to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. This guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The Company adopted this guidance effective January 1, 2012. The adoption did not have a material impact on the Company’s consolidated financial statements.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In June 2011, the FASB updated the accounting guidance relating to presentation of comprehensive income. This guidance requires companies to present total comprehensive income, the components of net income, and the components of other comprehensive income (“OCI”) either in a single continuous statement of comprehensive income or in two, but consecutive, statements. Additionally, companies are required to present on the face of the consolidated financial statements the reclassification adjustments that are reclassified from OCI to net income, where the components of net income and the components of OCI are presented. This guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2011, and requires retrospective application to all periods presented. The Company adopted this guidance effective January 1, 2012 and elected to present a single continuous statement of comprehensive loss. The adoption did not have a material impact on the Company’s consolidated financial statements.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Accounting Standards not yet Adopted</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In July 2012, the FASB simplified the guidance for testing for impairment of indefinite-lived intangible assets other than goodwill. The changes are intended to reduce compliance costs. The revised guidance allows a qualitative approach for testing indefinite-lived intangible assets for impairment, similar to the recently issued impairment testing guidance for goodwill and allows the option to first assess qualitative factors (events and circumstances) that could have affected the significant inputs used in determining the fair value of the indefinite-lived intangible asset to determine whether it is more likely than not (meaning a likelihood of more than 50 percent) that the indefinite-lived intangible asset is impaired. An organization may choose to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to calculating its fair value. The amendments are effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted. Management believes that the adoption of this guidance will not have a material impact on the Company’s consolidated financial statements.</font></p> </div> </us-gaap:SignificantAccountingPoliciesTextBlock> | |||||||||||||||||||||
| <us-gaap:UseOfEstimates contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_B870F5ED-F5EC-4428-AC45-67FB54B7A2B7_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires the Company to make estimates and assumptions that affect amounts reported in the consolidated financial statements and the accompanying notes. Significant estimates in these consolidated financial statements include allowances on accounts receivable, inventory and deferred taxes, as well as estimates for accrued warranty expenses, indefinite-lived intangible assets and the ability of goodwill to be realized, revenue deferrals for multiple element arrangements, effects of stock-based compensation and warrants, contingent liabilities and the provision or benefit for income taxes. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may differ materially from those estimates.</font></p> </div> </us-gaap:UseOfEstimates> | |||||||||||||||||||||
| <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_DC1F772B-19D2-40FE-A4D6-DA1082BF5341_1_0"> <div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 1 — BASIS OF PRESENTATION</b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>The Company</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">BIOLASE, Inc., (the “Company”) incorporated in Delaware in 1987, is a biomedical company operating in one business segment that develops, manufactures, and markets lasers in dentistry and medicine and also markets and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Basis of Presentation</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The consolidated financial statements include the accounts of BIOLASE, Inc. and its wholly-owned subsidiaries. The Company has eliminated all material intercompany transactions and balances in the accompanying consolidated financial statements. Certain amounts for prior years have been reclassified to conform to the current year presentation.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires the Company to make estimates and assumptions that affect amounts reported in the consolidated financial statements and the accompanying notes. Significant estimates in these consolidated financial statements include allowances on accounts receivable, inventory and deferred taxes, as well as estimates for accrued warranty expenses, indefinite-lived intangible assets and the ability of goodwill to be realized, revenue deferrals for multiple element arrangements, effects of stock-based compensation and warrants, contingent liabilities and the provision or benefit for income taxes. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may differ materially from those estimates.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Fair Value of Financial Instruments</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company’s financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities, approximate fair value because of the short maturity of these items. Financial instruments consisting of lines of credit approximate fair value, as the interest rates associated with the lines of credit approximates the market rates for debt securities with similar terms and risk characteristics.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market or, if none exists, the most advantageous market, for the specific asset or liability at the measurement date (referred to as the “exit price”). The fair value should be based on assumptions that market participants would use, including a consideration of nonperformance risk. Level 1 measurement of fair value is quoted prices in active markets for identical assets or liabilities.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Concentration of credit risk, interest rate risk and foreign currency exchange rate risk</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Financial instruments which potentially expose the Company to a concentration of credit risk consist principally of cash and cash equivalents, restricted cash, and trade accounts receivable. The Company invests its cash and cash equivalents and restricted cash with established commercial banks. At times, balances may exceed federally insured limits. To minimize the risk associated with trade accounts receivable, management performs ongoing credit evaluations of customers’ financial condition and maintains relationships with the Company’s customers which allow management to monitor current changes in business operations respond as needed. The Company does not, generally, require customers to provide collateral before it sells them products; however is has required certain distributors to make prepayments for significant purchases of products. For the years ended December 31, 2012, 2011, and 2010, sales to Henry Schein, Inc. (“HSIC”) worldwide accounted for approximately 3%, 19%, and 38%, respectively, of our net sales.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Substantially all of the Company’s revenue is denominated in U.S. dollars, including sales to international distributors. Only a small portion of its revenue and expenses is denominated in foreign currencies, principally the Euro and Indian Rupee. The Company’s foreign currency expenditures primarily consist of the cost of maintaining offices, including the facilities, consulting services and employee-related costs. To date, the Company has not entered into any hedging contracts. Future fluctuations in the value of the U.S. dollar may, however, affect the price competitiveness of the Company’s products outside the United States.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Management’s primary objective in managing the Company’s cash balances has been preservation of principal and maintenance of liquidity to meet the Company’s operating needs. Most of the Company’s excess cash balances are invested in money market accounts in which there is minimal interest rate risk. An increase in the LIBOR rate associated with the Company’s lines of credit would increase the interest expense the Company must pay. The Company’s risk associated with fluctuation in interest expense is limited to its outstanding lines of credit balances. The Company does not use interest rate derivative instruments to manage exposure to interest rate changes.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Liquidity and Management’s Plans</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Although the Company generated $1.9 million of cash from operations during the quarter ended December 31, 2012, the Company has suffered recurring losses from operations and has not generated cash from operations for the three years ended December 31, 2012. In order for the Company to continue operations and discharge its liabilities and commitments in the normal course of business, the Company must sell its products directly to end-users and through distributors; establish profitable operations through increased sales and reduced operating expenses; and potentially raise additional funds, principally through the additional sales of securities or debt financings to meet its working capital needs.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company intends to increase sales by increasing its product offerings, expanding its direct sales force and its distributor relationships both domestically and internationally. Accordingly, the Company has taken steps during Fiscal 2012 to improve its financial condition and ultimately improve its financial results, including increasing its product offerings with the launch of the new Epic diode laser system, for which the Company received the CE Mark in late September 2012 and FDA clearance in October 2012, executing a definitive five-year agreement with Copenhagen-based 3Shape Corporation (“3Shape”), making the Company a distributor of 3Shape’s TRIOS intra-oral CAD/CAM scanning technologies for digital impression-taking solutions in the U.S. and Canada, expanding our direct sales force and certain distributor relationships, and establishing two revolving credit facilities to meet quarterly working capital needs.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font size="2">Management anticipates that the cash generated from operations and the borrowings available under the lines of credit with Comerica Bank will be sufficient to fund the working capital requirements of the Company for 2013.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">At December 31, 2012, the Company had approximately $7.5 million in working capital. The Company’s principal sources of liquidity at December 31, 2012 consisted of approximately $2.5 million in cash and cash equivalents, $11.7 million of net accounts receivable, and $6.4 million of available borrowings under two revolving credit facility agreements.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On May 24, 2012, the Company entered into two revolving credit facility agreements with Comerica Bank which provide for borrowings of up to $8.0 million. The Company had approximately $1.6 million of borrowings outstanding under these lines of credit as of December 31, 2012. See <i>Note 5 — Lines of Credit and Other Borrowings</i> for additional information.</font></p> </div> </us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock> | |||||||||||||||||||||
| <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_7ECDA275-10C8-429E-A309-04F96FDA642A_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Net Loss Per Share — Basic and Diluted</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Basic net income (loss) per share is computed by dividing income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period. In computing diluted net income (loss) per share, the weighted average number of shares outstanding is adjusted to reflect the effect of potentially dilutive securities. Common shares outstanding, as included in the calculation of basic and diluted loss per share, includes retroactive adjustments to reflect increases resulting from stock dividends that have been paid through the date that these financial statements are issued.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Outstanding stock options and warrants to purchase approximately 4,713,000, 4,626,000, and 4,282,000 shares were not included in the calculation of diluted loss per share amounts for the years ended December 31, 2012, 2011, and 2010, respectively, as their effect would have been anti-dilutive.</font></p> </div> </us-gaap:EarningsPerSharePolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_30C896F2-69F9-4E43-9EC0-0A47E4A7E272_1_0"> 136000 </us-gaap:AmortizationOfIntangibleAssets> | |||||||||||||||||||||
| <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_576D0318-F870-4043-983C-8178ED828C2E_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Fair Value of Financial Instruments</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company’s financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities, approximate fair value because of the short maturity of these items. Financial instruments consisting of lines of credit approximate fair value, as the interest rates associated with the lines of credit approximates the market rates for debt securities with similar terms and risk characteristics.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market or, if none exists, the most advantageous market, for the specific asset or liability at the measurement date (referred to as the “exit price”). The fair value should be based on assumptions that market participants would use, including a consideration of nonperformance risk. Level 1 measurement of fair value is quoted prices in active markets for identical assets or liabilities.</font></p> </div> </us-gaap:FairValueOfFinancialInstrumentsPolicy> | |||||||||||||||||||||
| <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_FAC95006-1709-4E2B-B44C-F30BDCE4A1EB_1_0"> <div> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company conducted its annual two-step impairment test of intangible assets and goodwill as of June 30, 2012 and determined that there was no impairment. The Company also tests its intangible assets and goodwill between the annual impairment test if events occur or circumstances change that would more likely than not reduce the fair value of the Company or its assets below their carrying amounts. No events have occurred that would trigger further impairment testing of the Company’s intangible assets and goodwill during the years ended December 31, 2012 and 2011.</font></p> </div> </us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock> | |||||||||||||||||||||
| <us-gaap:DebtIssuanceCosts contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_888902_2052E80D-0040-49B4-8977-4A5321E0705A_1_8"> 91000 </us-gaap:DebtIssuanceCosts> | |||||||||||||||||||||
| <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_53D2DE10-0A5D-4893-BE63-2F24A57FEBB5_1_0"> <div> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table presents the details of the Company’s intangible assets, related accumulated amortization and goodwill (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="38%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>As of December 31, 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>As of December 31, 2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gross</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Accumulated<br /> Amortization</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Impairment</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Net</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gross</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Accumulated<br /> Amortization</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Impairment</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Net</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Patents (4-10 years)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,914</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,833</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">81</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,914</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,702</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">212</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Trademarks (6 years)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">69</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(69</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">69</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(69</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other (4 to 6 years)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">817</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(598</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">219</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">593</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(593</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,800</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,500</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">300</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,576</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(2,364</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">212</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Goodwill (Indefinite life)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,926</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,926</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,926</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,926</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock> | |||||||||||||||||||||
| <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_946EE74F-44B9-4CFB-8F48-1FA1452C3E55_1_0"> <div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="81%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 153pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>ACCOUNTS RECEIVABLE (in thousands):</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Components of accounts receivable, net of allowances, are as follows:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Trade</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,456</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,583</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Royalties</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">45</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">179</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">287</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total receivables, net</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,680</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,899</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock> | |||||||||||||||||||||
| <us-gaap:InterestExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_17"> 239000 </us-gaap:InterestExpense> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_1_3"> 1.39 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue> | |||||||||||||||||||||
| <biol:TotalDeferredIncomeTaxExpenseBenefit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_EB76699F-1167-4388-A5B5-C52955FFE105_1_9"> 61000 </biol:TotalDeferredIncomeTaxExpenseBenefit> | |||||||||||||||||||||
| <biol:RecentAccountingPronouncementsPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_9B65E193-3C9A-4102-AE5E-14E18D9C2CD6_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Recent Accounting Pronouncements</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Changes to U.S. GAAP are established by the FASB in the form of accounting standards updates (“ASU’s”) to the FASB’s Accounting Standards Codification (“ASC”).</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company considers the applicability and impact of all ASU’s. ASU’s not listed below were assessed and determined to not be applicable or are expected to have minimal impact on our consolidated financial position and results of operations.</font></p> </div> </biol:RecentAccountingPronouncementsPolicyTextBlock> | |||||||||||||||||||||
| <biol:PropertyPlantAndEquipmentUsefulLifeTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_1EF9C8E0-4E74-4B42-8AA8-7BEA1AC98AE0_1_0"> <div> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The cost of property, plant and equipment is depreciated using the straight-line method over the following estimated useful lives of the respective assets, except for leasehold improvements, which are depreciated over the lesser of the estimated useful lives of the respective assets or the related lease terms.</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="86%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Building</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Leasehold improvements</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3 to 5 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Equipment and computers</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3 to 5 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Furniture and fixtures</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5 years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> </table> </div> </biol:PropertyPlantAndEquipmentUsefulLifeTableTextBlock> | |||||||||||||||||||||
| <biol:EffectiveIncomeTaxRateReconciliationOtherReconcilingItems contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_888902_13F71043-305B-458B-B4BC-65D9E07CB772_1_10"> 0.006 </biol:EffectiveIncomeTaxRateReconciliationOtherReconcilingItems> | |||||||||||||||||||||
| <biol:IndefiniteLivedIntangibleAssetsUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_9D215F03-32D0-40AE-A557-828365C1BCDB_4001_1"> Indefinite life </biol:IndefiniteLivedIntangibleAssetsUsefulLife> | |||||||||||||||||||||
| <biol:ShareRepurchasesPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_2247C7DF-E04E-4B5F-80F4-7CB574E4A81E_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Stock Repurchase Program</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On August 10, 2011, the Company announced that its Board of Directors authorized a stock repurchase program, pursuant to which the Company may repurchase up to an aggregate of 2,000,000 shares of the Company’s outstanding common stock. The stock repurchase program became effective on August 12, 2011. The Company expects to fund the stock repurchase program with existing cash and cash equivalents on hand. Any shares repurchased will be retired and shall resume the status of authorized and unissued shares. Repurchases of the Company’s common stock may be made from time to time through a variety of methods, including open market purchases, privately negotiated transactions or block transactions. The Company has no obligation to repurchase shares under the stock repurchase program, and the timing, actual number and value of the shares that are repurchased will be at the discretion of the Company’s management and will depend upon a number of considerations, including the trading price of the Company’s common stock, general market conditions, applicable legal requirements and other factors. The stock repurchase program will expire on August 12, 2013, unless the program is completed sooner, suspended, terminated, or otherwise extended. Pursuant to the stock repurchase program, the Company repurchased 133,365 shares and 100,500 shares of our common stock at a weighted average price of $1.73 and $2.68 during the years ended December 31, 2012 and 2011, respectively.</font></p> </div> </biol:ShareRepurchasesPolicyTextBlock> | |||||||||||||||||||||
| <biol:UnrecognizedTaxBenefitsThatWouldImpactAdditionalPaidInCapital contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_13CA9E60-756F-4695-950A-21890BF81FFE_1_0"> 6400000 </biol:UnrecognizedTaxBenefitsThatWouldImpactAdditionalPaidInCapital> | |||||||||||||||||||||
| <biol:EngineeringAndDevelopmentCostsPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_F9B7FD40-9B98-4296-91CF-DCB20C6EA16B_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Engineering and Development</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Engineering and development expenses are generally expensed as incurred and consist of engineering personnel salaries and benefits, prototype supplies, contract services and consulting fees related to product development.</font></p> </div> </biol:EngineeringAndDevelopmentCostsPolicyTextBlock> | |||||||||||||||||||||
| <biol:StockIssuedDuringPeriodValueWarrantsExercised contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9007_1000040"> 6000 </biol:StockIssuedDuringPeriodValueWarrantsExercised> | |||||||||||||||||||||
| <biol:NonRecurringRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_1"> 1141000 </biol:NonRecurringRevenue> | |||||||||||||||||||||
| <biol:OtherEquityInstrumentsCompensation contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_12"> 23000 </biol:OtherEquityInstrumentsCompensation> | |||||||||||||||||||||
| <biol:DecreasedRevenuesPursuantToTwoThousandAndTwelveTerminationAgreement contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_1815F145-1AB3-43A1-8428-6245CE3105DF_1_1"> 1100000 </biol:DecreasedRevenuesPursuantToTwoThousandAndTwelveTerminationAgreement> | |||||||||||||||||||||
| <biol:LicenseFeesAndRoyaltyRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_2"> 165000 </biol:LicenseFeesAndRoyaltyRevenue> | |||||||||||||||||||||
| <biol:NumberRevolvingCreditFacilityAgreements contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="Agreement" decimals="0" id="id_888902_5CB263AF-C4E1-4AA8-BAC5-BB6364A61622_1_4"> 2 </biol:NumberRevolvingCreditFacilityAgreements> | |||||||||||||||||||||
| <biol:DerecognizedAccruedWarrantiesPursuantToTwoThousandAndTwelveTerminationAgreement contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_1815F145-1AB3-43A1-8428-6245CE3105DF_1_4"> 142000 </biol:DerecognizedAccruedWarrantiesPursuantToTwoThousandAndTwelveTerminationAgreement> | |||||||||||||||||||||
| <biol:NonRecurringCostOfRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_5"> 1141000 </biol:NonRecurringCostOfRevenue> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_1_2"> 0.00 </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend> | |||||||||||||||||||||
| <biol:CashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptionsTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_F2A02D1A-5BAE-4603-8A4A-F131F20E52F1_1_0"> <div> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Cash proceeds, along with fair value disclosures related to grants, exercises, and vesting options, are as follows for the years ended December 31 (in thousands, except per share amounts):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="74%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Twelve Months Ended</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>December 31,</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2010</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Proceeds from stock options exercised</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">455</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,244</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">199</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tax benefit related to stock options exercised(1)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">N/A</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">N/A</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">N/A</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intrinsic value of stock options exercised(2)</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">91</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,328</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">111</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted-average fair value of options granted</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.39</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.97</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total fair value of shares vested during the year</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,737</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,259</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">713</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> </table> <p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(1)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Excess tax benefits received related to stock option exercises are presented as financing cash inflows. Currently the Company does not receive a tax benefit related to the exercise of stock options due to its net operating losses.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(2)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The intrinsic value of stock options exercised is the amount by which the market price of the stock on the date of exercise exceeded the market price of the stock on the date of grant.</font></td> </tr> </table> </div> </biol:CashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptionsTableTextBlock> | |||||||||||||||||||||
| <biol:NoIndividualCountryOtherThanUnitedStatesRepresentsMoreThanTenPercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_F6551FB0-5793-4D0A-BCDD-92EC7113145F_1_0"> No individual international country represented more than 10% of net revenue </biol:NoIndividualCountryOtherThanUnitedStatesRepresentsMoreThanTenPercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermOne contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_476465DC-2D5F-480E-BD50-D963BA3E4E6B_1_0"> P3Y8M12D </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermOne> | |||||||||||||||||||||
| <biol:ProductsAndServicesRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_0"> 58332000 </biol:ProductsAndServicesRevenue> | |||||||||||||||||||||
| <biol:ReversalOfSalesAndMarketingServiceLiabilitiesPursuantToTwoThousandAndTwelveTerminationAgreement contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_1815F145-1AB3-43A1-8428-6245CE3105DF_1_5"> 350000 </biol:ReversalOfSalesAndMarketingServiceLiabilitiesPursuantToTwoThousandAndTwelveTerminationAgreement> | |||||||||||||||||||||
| <biol:AgreedUponPurchasePricePursuantToTwoThousandAndTwelveTerminationAgreement contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_A37384E9-D0F7-4B54-A302-3F439B04ADE3_1_0"> 1100000 </biol:AgreedUponPurchasePricePursuantToTwoThousandAndTwelveTerminationAgreement> | |||||||||||||||||||||
| <biol:NonRecurringEvents contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_4685E425-5C38-46BD-A0F2-13872DB1A041_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 11 — NON-RECURRING EVENT</b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On April 12, 2012, the Company completed the 2012 Termination Agreement with HSIC whereby the Company purchased HSIC’s inventory of Waterlase MD Turbo laser systems for approximately $1.1 million and HSIC released its liens on the Company’s assets. Pursuant to the terms of the 2012 Termination Agreement, the Company paid the entire purchase price by offsetting accounts receivable currently due from HSIC from sales made in the normal course of business. None of the funds used to offset the purchase price were related to the original sales of the MD Turbo laser systems that were purchased. During the year ended December 31, 2012, the Company sold all laser systems purchased under this arrangement at margins consistent with the Company’s comparable laser products.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">As a result of the transaction, the Company recorded a decrease to accounts receivable of approximately $1.1 million with a corresponding decrease to revenue to pay for the purchase of the Waterlase MD Turbo laser systems. The Company also recorded an increase to inventory for the same amount with a corresponding decrease to cost of revenue to record the inventory acquired. As such, while the Company’s revenues and cost of revenues were both reduced by $1.1 million to record the effects of the transaction, there was no effect on the Company’s gross profit during the year ended December 31, 2012. Additionally, as a result of the transaction, during the year ended December 31, 2012, the Company de-recognized approximately $155,000 of accounts receivable due from HSIC related to support services previously provided to HSIC and approximately $142,000 of accrued warranties previously provided to HSIC and reversed accrued sales and marketing service liabilities of approximately $350,000.</font></p> </div> </biol:NonRecurringEvents> | |||||||||||||||||||||
| <biol:ShareBasedCompensationNetImpactOnEarningPerShareDiluted contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_1813445F-7B13-4B49-8C60-F0A3C90E693C_1_1"> -0.05 </biol:ShareBasedCompensationNetImpactOnEarningPerShareDiluted> | |||||||||||||||||||||
| <biol:AmortizationOfDiscountsOnLinesOfCredit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_8"> 43000 </biol:AmortizationOfDiscountsOnLinesOfCredit> | |||||||||||||||||||||
| <biol:LineOfCreditFacilityAggregateCommitmentFeeAmount contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_18ACFD68-E0ED-4C53-9B2D-D9ECD439E461_1_1"> 240000 </biol:LineOfCreditFacilityAggregateCommitmentFeeAmount> | |||||||||||||||||||||
| <biol:DecreasedReceivablesPursuantToTwoThousandAndTwelveTerminationAgreement contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_1815F145-1AB3-43A1-8428-6245CE3105DF_1_0"> 1100000 </biol:DecreasedReceivablesPursuantToTwoThousandAndTwelveTerminationAgreement> | |||||||||||||||||||||
| <biol:PaymentsOfStockRepurchaseCosts contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_F97F06E2-2C08-40B8-A29A-9DBB90A6A696_1_38"> 235000 </biol:PaymentsOfStockRepurchaseCosts> | |||||||||||||||||||||
| <biol:PercentageOfSalesConcentrationToOneCustomer contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_888902_F2A94BE9-307B-412C-9F16-7877D048A40A_1_0"> 0.03 </biol:PercentageOfSalesConcentrationToOneCustomer> | |||||||||||||||||||||
| <biol:DecreasedCostOfRevenuesPursuantToTwoThousandAndTwelveTerminationAgreement contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_1815F145-1AB3-43A1-8428-6245CE3105DF_1_2"> 1100000 </biol:DecreasedCostOfRevenuesPursuantToTwoThousandAndTwelveTerminationAgreement> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodFairValue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_1_4"> 1737000 </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodFairValue> | |||||||||||||||||||||
| <biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9007_1000034"> 23000 </biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments> | |||||||||||||||||||||
| <biol:ConcentrationsTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_56ED2ACE-3FFA-452A-A589-4AB46E34615C_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 10 — CONCENTRATIONS</b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Revenue from Waterlase systems, the Company’s principal product line, which includes the iPlus and the MD Turbo, comprised 63%, 60%, and 32% of total net revenues for the years ended December 31, 2012, 2011, and 2010, respectively. Revenue from Diode systems comprised 11%, 19%, and 30% of total revenue for the same periods. Revenue from consumables and other comprised 10%, 11%, and 16% of total revenue for the same periods. Revenue from imaging systems comprised 6%, 0%, and 0% of total net revenue for the same periods. Revenue from services comprised 10%, 9%, and 16% of total net revenue for the same periods. Revenue from license fees and royalties comprised 0%, 1%, and 6% of total net revenue for the same periods.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Approximately 3%, 19%, and 38% of the Company’s revenue in 2012, 2011, and 2010, respectively, was generated through sales to HSIC worldwide.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company maintains its cash and cash equivalent accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">No individual customer represented more than 10% of the Company’s accounts receivable at December 31, 2012 and 2011.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> </p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company currently purchases certain key components of its products from single suppliers. Although there are a limited number of manufacturers of these key components, management believes that other suppliers could provide similar key components on comparable terms. A change in suppliers, however, could cause delays in manufacturing and a possible loss of sales, which could adversely affect the Company’s results of operations.</font></p> </div> </biol:ConcentrationsTextBlock> | |||||||||||||||||||||
| <biol:SalesToCustomersLocatedWithinUnitedStates contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_888902_A4E9705E-B209-41B7-A974-72655DFC36E9_1_0"> 0.71 </biol:SalesToCustomersLocatedWithinUnitedStates> | |||||||||||||||||||||
| <biol:DerecognizedAccountsReceivablePursuantToTwoThousandAndTwelveTerminationAgreement contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_888902_1815F145-1AB3-43A1-8428-6245CE3105DF_1_3"> 155000 </biol:DerecognizedAccountsReceivablePursuantToTwoThousandAndTwelveTerminationAgreement> | |||||||||||||||||||||
| <biol:NewAccountingStandardsNotYetAdoptedPolicyTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_55D9D53C-3C0F-4400-A34C-58213C5C468F_1_0"> <div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Accounting Standards not yet Adopted</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In July 2012, the FASB simplified the guidance for testing for impairment of indefinite-lived intangible assets other than goodwill. The changes are intended to reduce compliance costs. The revised guidance allows a qualitative approach for testing indefinite-lived intangible assets for impairment, similar to the recently issued impairment testing guidance for goodwill and allows the option to first assess qualitative factors (events and circumstances) that could have affected the significant inputs used in determining the fair value of the indefinite-lived intangible asset to determine whether it is more likely than not (meaning a likelihood of more than 50 percent) that the indefinite-lived intangible asset is impaired. An organization may choose to bypass the qualitative assessment for any indefinite-lived intangible asset in any period and proceed directly to calculating its fair value. The amendments are effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted. Management believes that the adoption of this guidance will not have a material impact on the Company’s consolidated financial statements.</font></p> </div> </biol:NewAccountingStandardsNotYetAdoptedPolicyTextBlock> | |||||||||||||||||||||
| <biol:SalesToCustomersLocatedOutsideOfUnitedStates contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_888902_A4E9705E-B209-41B7-A974-72655DFC36E9_1_1"> 0.29 </biol:SalesToCustomersLocatedOutsideOfUnitedStates> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredVestedInPeriodIntrinsicValue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_3001_5"/> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpiredVestedWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_13001_20"> 4.84 </biol:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpiredVestedWeightedAverageExercisePrice> | |||||||||||||||||||||
| <biol:ScheduleOfValuationAndQualifyingAccountsAndAllowancesDisclosureTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_5B14E9A7-AF5A-4D36-873B-6D611331DE9D_1_0"> <div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="57%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Balance at</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Beginning</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>of Year</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Charges</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>(Reversals) to Cost<br /> or Expenses</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Deductions</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Balance at</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>End of Year</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Year Ended December 31, 2012:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for doubtful accounts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">289</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">241</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(226</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">304</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for sales returns</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for tax valuation</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,784</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(443</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,341</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Year Ended December 31, 2011:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for doubtful accounts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">311</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">74</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(96</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">289</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for sales returns</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for tax valuation</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">34,250</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(466</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,784</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Year Ended December 31, 2010:</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for doubtful accounts</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">421</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(80</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(30</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">311</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for sales returns</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">110</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Allowance for tax valuation</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30,177</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,073</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">34,250</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> </table> </div> </biol:ScheduleOfValuationAndQualifyingAccountsAndAllowancesDisclosureTableTextBlock> | |||||||||||||||||||||
| <biol:ScheduleOfFutureMinimumLeaseIncomeUnderNoncancelableOperatingLeasesTableTextBlock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" id="id_888902_F7777CD8-06D8-4E15-97FF-0FF9D4A95F4E_1_0"> <div> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Future minimum rental commitments under operating lease agreements with non-cancelable terms greater than one year for each of the years ending December 31 are as follows (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="90%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">2013</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">683</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">2014</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">618</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">192</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Thereafter</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">—</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 2em"><font style="FONT-FAMILY: Times New Roman" size="2">Total future minimum lease obligations</font></p> </td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,493</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div> </biol:ScheduleOfFutureMinimumLeaseIncomeUnderNoncancelableOperatingLeasesTableTextBlock> | |||||||||||||||||||||
| <biol:CostOfRevenuePriorToNonrecurringEvent contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_888902_315E1147-065B-49F2-BA10-EE165A68782B_1_4"> 32019000 </biol:CostOfRevenuePriorToNonrecurringEvent> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetsAcquired contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x497458" unitRef="iso4217_USD" decimals="0" id="id_888902_C9DFDE58-49CF-46F4-9731-60C7BFD5A968_1001_0"> 224000 </us-gaap:FiniteLivedIntangibleAssetsAcquired> | |||||||||||||||||||||
| <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x497458" id="id_888902_C9DFDE58-49CF-46F4-9731-60C7BFD5A968_1001_1"> P4Y </us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife> | |||||||||||||||||||||
| <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x497458" unitRef="iso4217_USD" decimals="INF" id="id_888902_C9DFDE58-49CF-46F4-9731-60C7BFD5A968_1001_3"> 200000 </us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1> | |||||||||||||||||||||
| <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x497458" unitRef="iso4217_USD" decimals="0" id="id_888902_C9DFDE58-49CF-46F4-9731-60C7BFD5A968_1001_2"> 5000 </us-gaap:AmortizationOfIntangibleAssets> | |||||||||||||||||||||
| <us-gaap:AssetImpairmentCharges contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x497675_510903x511397" unitRef="iso4217_USD" decimals="0" id="id_888902_25C32206-C119-4393-8649-46DE850C6709_1003_3"> 0 </us-gaap:AssetImpairmentCharges> | |||||||||||||||||||||
| <us-gaap:SalesRevenueNet contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x498006" unitRef="iso4217_USD" decimals="-3" id="id_888902_F5DDECB5-1E3B-4851-A5D4-8558DD026906_1001_0"> 40524000 </us-gaap:SalesRevenueNet> | |||||||||||||||||||||
| <us-gaap:SalesRevenueNet contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x505266" unitRef="iso4217_USD" decimals="-3" id="id_888902_F5DDECB5-1E3B-4851-A5D4-8558DD026906_2001_1"> 16832000 </us-gaap:SalesRevenueNet> | |||||||||||||||||||||
| <us-gaap:TreasuryStockAcquiredAverageCostPerShare contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_502360x564264" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_F8984708-319D-4BC9-B04D-FBC67D0ED533_1002_2"> 1.73 </us-gaap:TreasuryStockAcquiredAverageCostPerShare> | |||||||||||||||||||||
| <us-gaap:StockRepurchasedDuringPeriodShares contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_502360x564264" unitRef="shares" decimals="INF" id="id_888902_F8984708-319D-4BC9-B04D-FBC67D0ED533_1002_1"> 133365 </us-gaap:StockRepurchasedDuringPeriodShares> | |||||||||||||||||||||
| <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_503845x508355" unitRef="pure" decimals="4" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_1002_6"> 0.0077 </us-gaap:FairValueAssumptionsRiskFreeInterestRate> | |||||||||||||||||||||
| <us-gaap:FairValueAssumptionsExpectedDividendPayments contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_503845x508355" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_1002_5"> 0.00 </us-gaap:FairValueAssumptionsExpectedDividendPayments> | |||||||||||||||||||||
| <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_503845x508355" unitRef="pure" decimals="4" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_1002_4"> 0.9955 </us-gaap:FairValueAssumptionsExpectedVolatilityRate> | |||||||||||||||||||||
| <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_503845x508355" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_1002_2"> P5Y </us-gaap:FairValueAssumptionsExpectedTerm> | |||||||||||||||||||||
| <us-gaap:InterestExpenseBorrowings contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_503845x508355" unitRef="iso4217_USD" decimals="0" id="id_888902_2052E80D-0040-49B4-8977-4A5321E0705A_1001_6"> 232000 </us-gaap:InterestExpenseBorrowings> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_503845x508355" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_1002_8"> 2014-05-01 </us-gaap:LineOfCreditFacilityExpirationDate1> | |||||||||||||||||||||
| <biol:ClassOfWarrantOrRightDateFromUpToWhichWarrantsOrRightsExercisable contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_503845x508355" id="id_888902_2B02B296-BA3A-46D9-9D06-5D0CBB12C142_1002_3"> 2017-05-24 </biol:ClassOfWarrantOrRightDateFromUpToWhichWarrantsOrRightsExercisable> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504051x551546" id="id_888902_A3E54DBF-C3B3-4272-9980-3C37B0F0DEDD_1001_0"> P5Y </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1> | |||||||||||||||||||||
| <biol:AmortizationOfUnamortizedCompensationCost contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504051x652048" unitRef="iso4217_USD" decimals="0" id="id_888902_616FB663-6E84-42CA-98EA-755D44DFF527_1001_3"> 183000 </biol:AmortizationOfUnamortizedCompensationCost> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504296x510320" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_1001_2"> 668000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504296x549651" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_2001_1"> 514000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504296x555087" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_3001_0"> 245000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504296x595048" unitRef="iso4217_USD" decimals="-3" id="id_888902_F63B0673-59FD-4EC3-B472-52423CA641CB_4001_3"> 173000 </us-gaap:AllocatedShareBasedCompensationExpense> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_510903x498304" id="id_888902_E8735C14-DCFC-4862-B751-4C3678AC0ABC_1001_1"> P3Y </us-gaap:PropertyPlantAndEquipmentUsefulLife> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_510903x533438" id="id_888902_E8735C14-DCFC-4862-B751-4C3678AC0ABC_2001_3"> P3Y </us-gaap:PropertyPlantAndEquipmentUsefulLife> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_512758x501065" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_4001_2"> P4Y </us-gaap:FiniteLivedIntangibleAssetUsefulLife> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_512758x502477" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_4003_2"> P4Y </us-gaap:FiniteLivedIntangibleAssetUsefulLife> | |||||||||||||||||||||
| <biol:SaleOfAssetsOrEarningPowerThresholdPercentageToTriggerEvent contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_642484x693936" unitRef="pure" decimals="2" id="id_888902_AECA8B8F-9D1D-47A9-99BA-B9A456E3F11D_1001_1"> 0.50 </biol:SaleOfAssetsOrEarningPowerThresholdPercentageToTriggerEvent> | |||||||||||||||||||||
| <biol:BeneficialOwnershipThresholdPercentageToTriggerEvent contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_642484x693936" unitRef="pure" decimals="2" id="id_888902_AECA8B8F-9D1D-47A9-99BA-B9A456E3F11D_1001_0"> 0.15 </biol:BeneficialOwnershipThresholdPercentageToTriggerEvent> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x514053_510903x498304" id="id_888902_E8735C14-DCFC-4862-B751-4C3678AC0ABC_3001_2"> P5Y </us-gaap:PropertyPlantAndEquipmentUsefulLife> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x514053_510903x533438" id="id_888902_E8735C14-DCFC-4862-B751-4C3678AC0ABC_4001_4"> P5Y </us-gaap:PropertyPlantAndEquipmentUsefulLife> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x514053_512758x501065" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_5001_3"> P10Y </us-gaap:FiniteLivedIntangibleAssetUsefulLife> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x514053_512758x502477" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_5003_3"> P6Y </us-gaap:FiniteLivedIntangibleAssetUsefulLife> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537828" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_1_1"> 0.72 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537828" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_1_2"> 1.99 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537828" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_1_5"> P5Y6M </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537829" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2_1"> 2.00 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537829" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2_2"> 2.99 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537829" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_2_5"> P3Y10M28D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537830" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_3_1"> 3.00 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537830" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_3_2"> 3.99 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537830" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_3_5"> P3Y6M </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537831" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_4_1"> 4.00 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537831" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_4_2"> 4.99 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537831" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_4_5"> P4Y6M </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537832" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_5_1"> 5.00 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537832" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_5_2"> 5.99 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537832" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_5_5"> P4Y2M19D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537833" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_6_1"> 6.00 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537833" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_6_2"> 9.99 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537833" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_6_5"> P3Y1M13D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537834" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_7_1"> 10.00 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537834" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_7_2"> 13.99 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537834" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_7_5"> P1Y3M22D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537835" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_8_1"> 14.00 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537835" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_8_2"> 18.99 </us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit> | |||||||||||||||||||||
| <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537835" id="id_888902_A3D499A3-2E13-4F62-BE52-47DD7D02A86D_8_5"> P1Y5M5D </us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
| <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x500724" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9005_800043"> 40000 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax> | |||||||||||||||||||||
| <us-gaap:NetIncomeLoss contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x503287" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9006_900042"> -3056000 </us-gaap:NetIncomeLoss> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_500038"> 142000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_500033"> 1600000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue> | |||||||||||||||||||||
| <us-gaap:StockDividendsShares contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_400041"> 634000 </us-gaap:StockDividendsShares> | |||||||||||||||||||||
| <us-gaap:StockRepurchasedDuringPeriodValue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_500037"> 235000 </us-gaap:StockRepurchasedDuringPeriodValue> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_400030"> 214000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross> | |||||||||||||||||||||
| <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_500031"> 455000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised> | |||||||||||||||||||||
| <us-gaap:StockRepurchasedDuringPeriodShares contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_400036"> 133000 </us-gaap:StockRepurchasedDuringPeriodShares> | |||||||||||||||||||||
| <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_500035"> 250000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition> | |||||||||||||||||||||
| <biol:StockIssuedDuringPeriodValueWarrantsExercised contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_500040"> 6000 </biol:StockIssuedDuringPeriodValueWarrantsExercised> | |||||||||||||||||||||
| <biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="iso4217_USD" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_500034"> 23000 </biol:AdjustmentsToAdditionalPaidInCapitalNonEmployeeEquityInstruments> | |||||||||||||||||||||
| <biol:StockIssuedDuringPeriodSharesPurchaseWarrantsExercised contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144" unitRef="shares" decimals="-3" id="id_888902_E396BA1E-940E-4147-BFE5-1EBB8A970094_9001_400039"> 31000 </biol:StockIssuedDuringPeriodSharesPurchaseWarrantsExercised> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_506932x500424" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_1_2"> 241000 </us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_506932x500424" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_1_3"> 226000 </us-gaap:ValuationAllowancesAndReservesDeductions> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_506932x502651" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2_2"/> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_506932x502651" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_2_3"/> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_506932x533644" unitRef="iso4217_USD" decimals="-3" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_3_2"> -443000 </us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense> | |||||||||||||||||||||
| <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_506932x533644" unitRef="iso4217_USD" xsi:nil="true" id="id_888902_C50D3A72-86D9-48C5-A90D-A3F0E7F82CE2_3_3"/> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_507611x652001" unitRef="pure" decimals="4" id="id_888902_2052E80D-0040-49B4-8977-4A5321E0705A_2001_5"> 0.0025 </us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage> | |||||||||||||||||||||
| <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_507611x652129" unitRef="pure" decimals="4" id="id_888902_2052E80D-0040-49B4-8977-4A5321E0705A_3001_4"> 0.0025 </us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage> | |||||||||||||||||||||
| <biol:ResearchAndDevelopmentFederalTaxCreditCarryforwardsExpirationDateYear contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_508681x532681" id="id_888902_E0472D81-9381-41D6-8B9F-C1F85FCC62EC_1001_4"> 2018 </biol:ResearchAndDevelopmentFederalTaxCreditCarryforwardsExpirationDateYear> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x549700" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_1001_4"> 0.10 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x651997" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_2001_1"> 0.11 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x652137" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_3001_0"> 0.63 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x652157" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_4001_3"> 0.06 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x693138" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_5001_5"> 0.00 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <biol:PercentageOfNetRevenue contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x694007" unitRef="pure" decimals="2" id="id_888902_20D3A685-2294-4064-9A7B-216B1FC36A4A_6001_2"> 0.10 </biol:PercentageOfNetRevenue> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_510903x500372" id="id_888902_E8735C14-DCFC-4862-B751-4C3678AC0ABC_5001_5"> P5Y </us-gaap:PropertyPlantAndEquipmentUsefulLife> | |||||||||||||||||||||
| <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_510903x510947" id="id_888902_E8735C14-DCFC-4862-B751-4C3678AC0ABC_6001_0"> P30Y </us-gaap:PropertyPlantAndEquipmentUsefulLife> | |||||||||||||||||||||
| <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_512758x512398" id="id_888902_9014F04E-6A99-4BF6-8501-FECDB394F802_3002_1"> P6Y </us-gaap:FiniteLivedIntangibleAssetUsefulLife> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_584109x517783" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_14001_13"> 1.80 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_584109x517783" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_14001_13"> 614000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_584109x517784" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_7E941084-1536-45F0-A06D-67643F498E4F_15001_14"> 0.95 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_584109x517784" unitRef="shares" decimals="INF" id="id_888902_338D2B88-87D5-4BE8-A415-EA4362E1E5C4_15001_14"> 568000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod> | |||||||||||||||||||||
| <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_623961x624861" unitRef="iso4217_USD" decimals="-5" id="id_888902_387698F4-28CC-4DD4-B8AB-4392D7A7974B_1002_3"> 1800000 </us-gaap:ProceedsFromIssuanceOfCommonStock> | |||||||||||||||||||||
| <biol:ProceedsFromSaleOfCommonStockNetOfIssuanceCosts contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_623961x624861" unitRef="iso4217_USD" decimals="-5" id="id_888902_387698F4-28CC-4DD4-B8AB-4392D7A7974B_1002_4"> 1700000 </biol:ProceedsFromSaleOfCommonStockNetOfIssuanceCosts> | |||||||||||||||||||||
| <biol:TransactionIssuanceCosts contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_623961x624861" unitRef="iso4217_USD" decimals="0" id="id_888902_387698F4-28CC-4DD4-B8AB-4392D7A7974B_1002_5"> 124000 </biol:TransactionIssuanceCosts> | |||||||||||||||||||||
| <biol:PreferredStockPurchaseRightExpirationDate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_642484x693936" id="id_888902_AECA8B8F-9D1D-47A9-99BA-B9A456E3F11D_2001_4"> 2018-12-31 </biol:PreferredStockPurchaseRightExpirationDate> | |||||||||||||||||||||
| <biol:PreferredStockPurchaseRightExpirationDate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_642484x693936_681893x634572" id="id_888902_AECA8B8F-9D1D-47A9-99BA-B9A456E3F11D_3001_3"> 2008-12-31 </biol:PreferredStockPurchaseRightExpirationDate> | |||||||||||||||||||||
| <biol:PercentageOfSalesConcentrationToOneCustomer contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_652106x652160" unitRef="pure" decimals="2" id="id_888902_46E3080C-9291-48CC-BA34-5B0094D808B2_1001_0"> 0.03 </biol:PercentageOfSalesConcentrationToOneCustomer> | |||||||||||||||||||||
| <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_652146x532799" unitRef="pure" decimals="4" id="id_888902_3E8BAF06-B992-41B0-B401-A4EECA8BA525_1002_5"> 0.0065 </us-gaap:FairValueAssumptionsRiskFreeInterestRate> | |||||||||||||||||||||
| <us-gaap:FairValueAssumptionsExpectedDividendPayments contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_652146x532799" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_888902_3E8BAF06-B992-41B0-B401-A4EECA8BA525_1002_4"> 0.00 </us-gaap:FairValueAssumptionsExpectedDividendPayments> | |||||||||||||||||||||
| <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_652146x532799" unitRef="pure" decimals="4" id="id_888902_3E8BAF06-B992-41B0-B401-A4EECA8BA525_1002_3"> 1.0037 </us-gaap:FairValueAssumptionsExpectedVolatilityRate> | |||||||||||||||||||||
| <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_652146x532799" id="id_888902_3E8BAF06-B992-41B0-B401-A4EECA8BA525_1002_2"> P4Y9M18D </us-gaap:FairValueAssumptionsExpectedTerm> | |||||||||||||||||||||
| <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="eol_PE753-----1210-K0003_STD_366_20121231_0_652146x532799" unitRef="iso4217_USD" decimals="0" id="id_888902_3E8BAF06-B992-41B0-B401-A4EECA8BA525_1002_6"> 7000 </us-gaap:AdjustmentOfWarrantsGrantedForServices> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE753-----1210-K0003_STD_37_20120507_0_504051x551546" unitRef="iso4217_USD_per_shares" decimals="2" id="id_888902_AE56A57B-A0BC-4D6A-BCDE-FFC39653A8B1_1001_1"> 2.55 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue> | |||||||||||||||||||||
| <biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpireFromDateOfGrant contextRef="eol_PE753-----1210-K0003_STD_37_20120507_0_504051x551546" id="id_888902_AE56A57B-A0BC-4D6A-BCDE-FFC39653A8B1_1001_2"> P5Y </biol:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpireFromDateOfGrant> | |||||||||||||||||||||
| <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate contextRef="eol_PE753-----1210-K0003_STD_39_20121108_0_509379x517821" id="id_888902_5B9507FF-0F92-49B6-9E24-CDE916B5E9E4_1001_3"> 2015-11-07 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate> | |||||||||||||||||||||
| <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE753-----1210-K0003_STD_90_20110331_0" unitRef="pure" decimals="2" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_7_2"> 0.01 </us-gaap:PreferredStockDividendRatePercentage> | |||||||||||||||||||||
| <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE753-----1210-K0003_STD_91_20110630_0" unitRef="pure" decimals="2" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_8_2"> 0.01 </us-gaap:PreferredStockDividendRatePercentage> | |||||||||||||||||||||
| <us-gaap:DeferredRevenueRevenueRecognized contextRef="eol_PE753-----1210-K0003_STD_91_20110630_0_512086x652097" unitRef="iso4217_USD" decimals="0" id="id_888902_4547267C-DEB4-42C5-BB82-8A0B4C0A8220_1001_0"> 375000 </us-gaap:DeferredRevenueRevenueRecognized> | |||||||||||||||||||||
| <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="eol_PE753-----1210-K0003_STD_91_20120331_0" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_3_3"> 2012-03-15 </us-gaap:DividendsPayableDateOfRecordDayMonthAndYear> | |||||||||||||||||||||
| <biol:SpecialStockDividendsDeclared contextRef="eol_PE753-----1210-K0003_STD_91_20120331_0" unitRef="pure" decimals="3" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_3_0"> 0.005 </biol:SpecialStockDividendsDeclared> | |||||||||||||||||||||
| <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="eol_PE753-----1210-K0003_STD_91_20120630_0" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_4_3"> 2012-06-08 </us-gaap:DividendsPayableDateOfRecordDayMonthAndYear> | |||||||||||||||||||||
| <biol:SpecialStockDividendsDeclared contextRef="eol_PE753-----1210-K0003_STD_91_20120630_0" unitRef="pure" decimals="3" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_4_0"> 0.005 </biol:SpecialStockDividendsDeclared> | |||||||||||||||||||||
| <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE753-----1210-K0003_STD_92_20110930_0" unitRef="pure" decimals="2" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_9_2"> 0.01 </us-gaap:PreferredStockDividendRatePercentage> | |||||||||||||||||||||
| <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="eol_PE753-----1210-K0003_STD_92_20120930_0" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_5_3"> 2012-09-14 </us-gaap:DividendsPayableDateOfRecordDayMonthAndYear> | |||||||||||||||||||||
| <biol:SpecialStockDividendsDeclared contextRef="eol_PE753-----1210-K0003_STD_92_20120930_0" unitRef="pure" decimals="3" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_5_0"> 0.005 </biol:SpecialStockDividendsDeclared> | |||||||||||||||||||||
| <us-gaap:PreferredStockDividendRatePercentage contextRef="eol_PE753-----1210-K0003_STD_92_20111231_0" unitRef="pure" decimals="2" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_10_2"> 0.01 </us-gaap:PreferredStockDividendRatePercentage> | |||||||||||||||||||||
| <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE753-----1210-K0003_STD_92_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_888902_2543E3DF-4D1E-4969-8DDF-60D0C9215BCD_1_0"> 1900000 </us-gaap:NetCashProvidedByUsedInOperatingActivities> | |||||||||||||||||||||
| <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="eol_PE753-----1210-K0003_STD_92_20121231_0" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_6_3"> 2012-12-14 </us-gaap:DividendsPayableDateOfRecordDayMonthAndYear> | |||||||||||||||||||||
| <biol:SpecialStockDividendsDeclared contextRef="eol_PE753-----1210-K0003_STD_92_20121231_0" unitRef="pure" decimals="3" id="id_888902_D901B7A9-5131-45F2-BB66-259A6ED9BBA2_6_0"> 0.005 </biol:SpecialStockDividendsDeclared> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_92_20121231_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-10-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_92_20111231_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-10-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_92_20120930_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-07-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-09-30 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_92_20110930_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-07-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-09-30 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_91_20120630_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-04-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-06-30 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_91_20120331_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-03-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_91_20110630_0_512086x652097"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis"> biol:TwoThousandTenProcterAndGambleCompanyAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-04-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-06-30 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_91_20110630_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-04-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-06-30 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_90_20110331_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-03-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_39_20121108_0_509379x517821"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> biol:WarrantTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-10-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-11-08 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_37_20120507_0_504051x551546"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis"> biol:ConsultantMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-04-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-05-07 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_652146x532799"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:LineOfCreditFacilityAgreementAmendmentAxis"> biol:FirstAmendmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_652106x652160"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:SignificantCustomerAxis"> biol:HsicWorldwideMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_642484x693936_681893x634572"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:PreferredStockAxis"> biol:PreferredStockPurchaseRightsUnderStockholderRightsPlanMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:PreferredStockPurchaseAgreementAxis"> biol:InitialMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_642484x693936"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:PreferredStockAxis"> biol:PreferredStockPurchaseRightsUnderStockholderRightsPlanMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_623961x624861"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:RegisteredDirectOfferingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_584109x517784"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardSharesGrantedByTypeAxis"> biol:ScenarioTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_584109x517783"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardSharesGrantedByTypeAxis"> biol:ScenarioOneMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_512758x512398"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:TrademarksMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_510903x510947"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:BuildingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_510903x500372"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:FurnitureAndFixturesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x694007"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:ConsumableAndOtherMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x693138"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:LicenseFeesAndRoyaltiesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x652157"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:ImagingSystemMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x652137"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:WaterlaseSystemsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x651997"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:DiodeSystemsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_510496x549700"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:ServiceMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_508681x532681"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis"> biol:FederalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_507611x652129"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> biol:DomesticRevolverCreditFacilityMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_507611x652001"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> biol:ExImRevolverMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_506932x533644"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> biol:DeferredIncomeTaxValuationAllowancesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_506932x502651"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForSalesReturnsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_506932x500424"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForDoubtfulAccountsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x511144"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x503287"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_505872x500724"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537835"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeEightMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537834"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeSevenMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537833"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeSixMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537832"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeFiveMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537831"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeFourMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537830"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeThreeMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537829"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x537828"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeOneMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x514053_512758x502477"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:OtherIntangibleAssetsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x514053_512758x501065"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x514053_510903x533438"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> biol:EquipmentAndOtherRelatedMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x514053_510903x498304"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LeaseholdImprovementsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_642484x693936"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:PreferredStockAxis"> biol:PreferredStockPurchaseRightsUnderStockholderRightsPlanMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MinimumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_512758x502477"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:OtherIntangibleAssetsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MinimumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_512758x501065"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MinimumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_510903x533438"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> biol:EquipmentAndOtherRelatedMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MinimumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504957x513639_510903x498304"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LeaseholdImprovementsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MinimumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504296x595048"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> biol:EngineeringAndDevelopmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504296x555087"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> biol:CostOfRevenueMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504296x549651"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> biol:SalesAndMarketingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504296x510320"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> us-gaap:GeneralAndAdministrativeExpenseMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504051x652048"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis"> biol:CeoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_504051x551546"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis"> biol:ConsultantMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_503845x508355"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_502360x564264"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis"> biol:StockRepurchaseProgramMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x505266"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> us-gaap:SegmentGeographicalGroupsOfCountriesGroupTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x498006"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> us-gaap:SegmentGeographicalGroupsOfCountriesGroupOneMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x497675_510903x511397"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LandAndBuildingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> country:DE </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0_501891x497458"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> country:IN </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_366_20121231_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2012-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_652106x652160"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:SignificantCustomerAxis"> biol:HsicWorldwideMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_623961x532774"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:ControlledEquityOfferingSalesAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_584109x517783"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardSharesGrantedByTypeAxis"> biol:ScenarioOneMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x694007"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:ConsumableAndOtherMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x693138"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:LicenseFeesAndRoyaltiesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x652157"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:ImagingSystemMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x652137"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:WaterlaseSystemsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x651997"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:DiodeSystemsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_510496x549700"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:ServiceMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_506932x533644"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> biol:DeferredIncomeTaxValuationAllowancesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_506932x502651"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForSalesReturnsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_506932x500424"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForDoubtfulAccountsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x511144"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x503287"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_505872x500724"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_504296x595048"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> biol:EngineeringAndDevelopmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_504296x555087"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> biol:CostOfRevenueMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_504296x549651"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> biol:SalesAndMarketingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_504296x510320"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> us-gaap:GeneralAndAdministrativeExpenseMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_503845x610237"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> biol:LoanAndSecurityAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_502360x564264"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis"> biol:StockRepurchaseProgramMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_501891x505266"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> us-gaap:SegmentGeographicalGroupsOfCountriesGroupTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0_501891x498006"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> us-gaap:SegmentGeographicalGroupsOfCountriesGroupOneMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20111231_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_652106x652160"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:SignificantCustomerAxis"> biol:HsicWorldwideMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_584109x517784"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardSharesGrantedByTypeAxis"> biol:ScenarioTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_584109x517783"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardSharesGrantedByTypeAxis"> biol:ScenarioOneMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x694007"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:ConsumableAndOtherMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x693138"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:LicenseFeesAndRoyaltiesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x652157"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:ImagingSystemMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x652137"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:WaterlaseSystemsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x651997"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:DiodeSystemsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_510496x549700"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis"> biol:ServiceMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_506932x533644"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> biol:DeferredIncomeTaxValuationAllowancesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_506932x502651"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForSalesReturnsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_506932x500424"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForDoubtfulAccountsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x511144"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x503287"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_505872x500724"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_504296x595048"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> biol:EngineeringAndDevelopmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_504296x555087"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> biol:CostOfRevenueMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_504296x549651"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> biol:SalesAndMarketingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_504296x510320"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"> us-gaap:GeneralAndAdministrativeExpenseMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_503845x610237"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> biol:LoanAndSecurityAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_501891x505266"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> us-gaap:SegmentGeographicalGroupsOfCountriesGroupTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0_501891x498006"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> us-gaap:SegmentGeographicalGroupsOfCountriesGroupOneMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_365_20101231_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_33_20110802_0_623961x652398"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:SecuritiesPurchaseAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-07-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-08-02 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_33_20110802_0_504957x514053_623961x652398"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:SecuritiesPurchaseAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-07-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-08-02 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_31_20111231_0_504051x652048"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis"> biol:CeoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-12-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-12-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_31_20090924_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2009-08-25 </startDate> | |||||||||||||||||||||
| <endDate> 2009-09-24 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_31_20100531_0_507199x693142"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:MidcapFinancialLlcAndSiliconValleyBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-05-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-05-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_31_20060131_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2006-01-01 </startDate> | |||||||||||||||||||||
| <endDate> 2006-01-31 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_30_20110630_0_623961x652398"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:SecuritiesPurchaseAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-06-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-06-30 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_30_20100930_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2010-09-01 </startDate> | |||||||||||||||||||||
| <endDate> 2010-09-30 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_30_20120524_0_507199x551171"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:ComericaBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-04-25 </startDate> | |||||||||||||||||||||
| <endDate> 2012-05-24 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_30_20120524_0_501572x498232_507199x551171"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:ComericaBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2012-04-25 </startDate> | |||||||||||||||||||||
| <endDate> 2012-05-24 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_28_20130228_0_506663x511390_507199x551171"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:ComericaBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2013-02-01 </startDate> | |||||||||||||||||||||
| <endDate> 2013-02-28 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_28_20130228_0_506663x511390"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2013-02-01 </startDate> | |||||||||||||||||||||
| <endDate> 2013-02-28 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_28_20130228_0_501819x545944_506663x511390"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DividendsAxis"> biol:StockDividendsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2013-02-01 </startDate> | |||||||||||||||||||||
| <endDate> 2013-02-28 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_28_20110228_0_507199x693142"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:MidcapFinancialLlcAndSiliconValleyBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <startDate> 2011-02-01 </startDate> | |||||||||||||||||||||
| <endDate> 2011-02-28 </endDate> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_652146x532799"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:LineOfCreditFacilityAgreementAmendmentAxis"> biol:FirstAmendmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_642484x693936_681893x634572"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:PreferredStockAxis"> biol:PreferredStockPurchaseRightsUnderStockholderRightsPlanMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:PreferredStockPurchaseAgreementAxis"> biol:InitialMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_642484x693936"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:PreferredStockAxis"> biol:PreferredStockPurchaseRightsUnderStockholderRightsPlanMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_623961x624861"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:RegisteredDirectOfferingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_513696x537356"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> biol:SeriesBJuniorParticipatingPreferredStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x512398"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:TrademarksMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x502477"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:OtherIntangibleAssetsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_512758x501065"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x513379"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:ComputerEquipmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x512000"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LandMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x510947"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:BuildingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x503469"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:ConstructionInProgressMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x500372"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:FurnitureAndFixturesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_510903x498304"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LeaseholdImprovementsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_508681x532681"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis"> biol:FederalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_508681x532680"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis"> biol:StateMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_508454x652096"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> biol:TwoThousandTwoStockIncentivePlanMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_507611x652129"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> biol:DomesticRevolverCreditFacilityMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_507611x652001"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> biol:ExImRevolverMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_506932x533644"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> biol:DeferredIncomeTaxValuationAllowancesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_506932x502651"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForSalesReturnsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_506932x500424"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForDoubtfulAccountsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_505872x511144"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_505872x503287"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_505872x502884"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_505872x500724"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537835"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeEightMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537834"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeSevenMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537833"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeSixMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537832"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeFiveMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537831"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeFourMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537830"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeThreeMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537829"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x537828"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> biol:RangeOneMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_504957x514053"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_503845x508355"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> us-gaap:LineOfCreditMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_501891x531305"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> biol:InternationalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_501891x497675_510903x511397"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LandAndBuildingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> country:DE </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0_501572x498232"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121231_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_623961x532774"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:ControlledEquityOfferingSalesAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x512398"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:TrademarksMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x502477"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:OtherIntangibleAssetsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_512758x501065"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x513379"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:ComputerEquipmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x512000"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LandMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x510947"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:BuildingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x503469"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:ConstructionInProgressMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x500372"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:FurnitureAndFixturesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_510903x498304"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LeaseholdImprovementsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_506932x533644"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> biol:DeferredIncomeTaxValuationAllowancesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_506932x502651"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForSalesReturnsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_506932x500424"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForDoubtfulAccountsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_505872x511144"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_505872x503287"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_505872x502884"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_505872x500724"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_504051x652048"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis"> biol:CeoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0_501891x531305"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> biol:InternationalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20111231_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20101231_0_506932x533644"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> biol:DeferredIncomeTaxValuationAllowancesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20101231_0_506932x502651"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForSalesReturnsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20101231_0_506932x500424"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForDoubtfulAccountsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20101231_0_505872x511144"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20101231_0_505872x503287"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20101231_0_505872x502884"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20101231_0_505872x500724"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20101231_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20091231_0_506932x533644"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> biol:DeferredIncomeTaxValuationAllowancesMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2009-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20091231_0_506932x502651"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForSalesReturnsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2009-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20091231_0_506932x500424"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis"> us-gaap:AllowanceForDoubtfulAccountsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2009-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20091231_0_505872x511144"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2009-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20091231_0_505872x503287"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2009-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20091231_0_505872x502884"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2009-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20091231_0_505872x500724"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2009-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20091231_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2009-12-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20120630_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-06-30 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20110930_0_512086x652097"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis"> biol:TwoThousandTenProcterAndGambleCompanyAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-09-30 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20110630_0_623961x652398"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:SecuritiesPurchaseAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-06-30 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20100930_0_623961x577488"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:FirstTrancheMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-09-30 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20100531_0_507199x693142"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:MidcapFinancialLlcAndSiliconValleyBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-05-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20130308_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2013-03-08 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20130228_0_506663x511390_507199x551171_508971x533701"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis"> biol:RemainingAmountMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:ComericaBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2013-02-28 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20130228_0_506663x511390_507199x551171"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:ComericaBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2013-02-28 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20110407_0_623961x624861"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:RegisteredDirectOfferingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-04-07 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121108_0_509379x517821"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> biol:WarrantTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-11-08 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121108_0_504957x514053_509379x517821"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> biol:WarrantTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-11-08 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20121108_0_504957x513639_509379x517821"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis"> biol:WarrantTwoMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MinimumMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-11-08 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20120821_0_501891x497675_510903x511397"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LandAndBuildingMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis"> country:DE </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-08-21 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20120524_0_507611x652129"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> biol:DomesticRevolverCreditFacilityMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-05-24 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20120524_0_507611x652001"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> biol:ExImRevolverMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-05-24 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20120524_0_507199x551171"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:ComericaBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-05-24 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20120524_0_501572x498232_507199x551171"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> us-gaap:RevolvingCreditFacilityMember </xbrldi:explicitMember> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:ComericaBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-05-24 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20120524_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-05-24 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20120507_0_504051x551546"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTitleOfIndividualAxis"> biol:ConsultantMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2012-05-07 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20110228_0_507199x693142"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis"> biol:MidcapFinancialLlcAndSiliconValleyBankMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2011-02-28 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20101223_0_623961x532774"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="biol:CommonEquityOfferingProgramAxis"> biol:ControlledEquityOfferingSalesAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-12-23 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20100810_0_502360x564264"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| <segment> | |||||||||||||||||||||
| <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis"> biol:StockRepurchaseProgramMember </xbrldi:explicitMember> | |||||||||||||||||||||
| </segment> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2010-08-10 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <context id="eol_PE753-----1210-K0003_STD_0_20060131_0"> | |||||||||||||||||||||
| <entity> | |||||||||||||||||||||
| <identifier scheme="http://www.sec.gov/CIK"> 0000811240 </identifier> | |||||||||||||||||||||
| </entity> | |||||||||||||||||||||
| <period> | |||||||||||||||||||||
| <instant> 2006-01-31 </instant> | |||||||||||||||||||||
| </period> | |||||||||||||||||||||
| </context> | |||||||||||||||||||||
| <unit id="sqft"> | |||||||||||||||||||||
| <measure> utr:sqft </measure> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <unit id="shares"> | |||||||||||||||||||||
| <measure> shares </measure> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <unit id="pure"> | |||||||||||||||||||||
| <measure> pure </measure> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <unit id="iso4217_USD"> | |||||||||||||||||||||
| <measure> iso4217:USD </measure> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <unit id="iso4217_USD_per_A"> | |||||||||||||||||||||
| <divide> | |||||||||||||||||||||
| <unitNumerator> | |||||||||||||||||||||
| <measure> iso4217:USD </measure> | |||||||||||||||||||||
| </unitNumerator> | |||||||||||||||||||||
| <unitDenominator> | |||||||||||||||||||||
| <measure> utr:A </measure> | |||||||||||||||||||||
| </unitDenominator> | |||||||||||||||||||||
| </divide> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <unit id="iso4217_USD_per_shares"> | |||||||||||||||||||||
| <divide> | |||||||||||||||||||||
| <unitNumerator> | |||||||||||||||||||||
| <measure> iso4217:USD </measure> | |||||||||||||||||||||
| </unitNumerator> | |||||||||||||||||||||
| <unitDenominator> | |||||||||||||||||||||
| <measure> shares </measure> | |||||||||||||||||||||
| </unitDenominator> | |||||||||||||||||||||
| </divide> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <unit id="iso4217_USD_per_Unit"> | |||||||||||||||||||||
| <divide> | |||||||||||||||||||||
| <unitNumerator> | |||||||||||||||||||||
| <measure> iso4217:USD </measure> | |||||||||||||||||||||
| </unitNumerator> | |||||||||||||||||||||
| <unitDenominator> | |||||||||||||||||||||
| <measure> biol:Unit </measure> | |||||||||||||||||||||
| </unitDenominator> | |||||||||||||||||||||
| </divide> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <unit id="Securities"> | |||||||||||||||||||||
| <measure> biol:Securities </measure> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <unit id="iso4217_USD_per_Right"> | |||||||||||||||||||||
| <divide> | |||||||||||||||||||||
| <unitNumerator> | |||||||||||||||||||||
| <measure> iso4217:USD </measure> | |||||||||||||||||||||
| </unitNumerator> | |||||||||||||||||||||
| <unitDenominator> | |||||||||||||||||||||
| <measure> biol:Right </measure> | |||||||||||||||||||||
| </unitDenominator> | |||||||||||||||||||||
| </divide> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <unit id="Agreement"> | |||||||||||||||||||||
| <measure> biol:Agreement </measure> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <unit id="Segment"> | |||||||||||||||||||||
| <measure> biol:Segment </measure> | |||||||||||||||||||||
| </unit> | |||||||||||||||||||||
| <xbrll:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended"> | |||||||||||||||||||||
| <xbrll:loc xlink:href="#id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_1001_2" xlink:label="id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_1001_2" xlink:type="locator"/> | |||||||||||||||||||||
| <xbrll:loc xlink:href="#id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_1001_3" xlink:label="id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_1001_3" xlink:type="locator"/> | |||||||||||||||||||||
| <xbrll:loc xlink:href="#id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_3001_5" xlink:label="id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_3001_5" xlink:type="locator"/> | |||||||||||||||||||||
| <xbrll:loc xlink:href="#id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_1_1" xlink:label="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_1_1" xlink:type="locator"/> | |||||||||||||||||||||
| <xbrll:loc xlink:href="#id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_1_2" xlink:label="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_1_2" xlink:type="locator"/> | |||||||||||||||||||||
| <xbrll:loc xlink:href="#id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_2_1" xlink:label="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_2_1" xlink:type="locator"/> | |||||||||||||||||||||
| <xbrll:loc xlink:href="#id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_2_2" xlink:label="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_2_2" xlink:type="locator"/> | |||||||||||||||||||||
| <xbrll:loc xlink:href="#id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_3_1" xlink:label="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_3_1" xlink:type="locator"/> | |||||||||||||||||||||
| <xbrll:loc xlink:href="#id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_3_2" xlink:label="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_3_2" xlink:type="locator"/> | |||||||||||||||||||||
| <xbrll:footnote xlink:label="footnote_95175617" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> The intrinsic value of stock options exercised is the amount by which the market price of the stock on the date of exercise exceeded the market price of the stock on the date of grant. </xbrll:footnote> | |||||||||||||||||||||
| <xbrll:footnote xlink:label="footnote_95175622" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> Excess tax benefits received related to stock option exercises are presented as financing cash inflows. Currently the Company does not receive a tax benefit related to the exercise of stock options due to its net operating losses. </xbrll:footnote> | |||||||||||||||||||||
| <xbrll:footnote xlink:label="footnote_95175627" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> The intrinsic value calculation does not include negative values. This can occur when the fair market value on the reporting date is less than the exercise price of a grant. </xbrll:footnote> | |||||||||||||||||||||
| <xbrll:footnoteArc xlink:from="id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_1001_2" xlink:to="footnote_95175627" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/> | |||||||||||||||||||||
| <xbrll:footnoteArc xlink:from="id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_1001_3" xlink:to="footnote_95175627" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/> | |||||||||||||||||||||
| <xbrll:footnoteArc xlink:from="id_888902_6FF74BEA-4F26-4CD1-9474-FB0EE3D80C26_3001_5" xlink:to="footnote_95175627" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/> | |||||||||||||||||||||
| <xbrll:footnoteArc xlink:from="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_1_1" xlink:to="footnote_95175622" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/> | |||||||||||||||||||||
| <xbrll:footnoteArc xlink:from="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_1_2" xlink:to="footnote_95175617" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/> | |||||||||||||||||||||
| <xbrll:footnoteArc xlink:from="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_2_1" xlink:to="footnote_95175622" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/> | |||||||||||||||||||||
| <xbrll:footnoteArc xlink:from="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_2_2" xlink:to="footnote_95175617" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/> | |||||||||||||||||||||
| <xbrll:footnoteArc xlink:from="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_3_1" xlink:to="footnote_95175622" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/> | |||||||||||||||||||||
| <xbrll:footnoteArc xlink:from="id_888902_D20149A7-61D2-4E60-82B0-B0281B5525B0_3_2" xlink:to="footnote_95175617" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/> | |||||||||||||||||||||
| </xbrll:footnoteLink> | |||||||||||||||||||||
| </xbrl> | |||||||||||||||||||||